• HOME
  •  > 
  • 臨床医学：内科
  •  > 
  • 精神医学
  •  >  講座　精神疾患の臨床　3　不安または恐怖関連症群　強迫症　ストレス関連症群　パーソナリティ症

講座　精神疾患の臨床　3　不安または恐怖関連症群　強迫症　ストレス関連症群　パーソナリティ症

出版社： 中山書店
著者：
発行日： 2021-02-10
分野： 臨床医学：内科  >  精神医学
ISBN： 9784521748238
電子書籍版： 2021-02-10 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

17,600 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

17,600 円(税込)

購入する

商品紹介

ICD-11においてICD-10やDSM-5から最もドラスティックに変更となり，今後さらなる変更が加えられていく可能性が高い注目の領域を取り上げている．
疾患概念の変遷，ICD-11の診断ガイドラインの内容，残されている課題（議論の余地）に加え，症状や病態，治療法なども解説．
今日のclinical utility（臨床的有用性）を最大限に反映した内容が盛り込まれている．

目次

  • 1章　不安または恐怖関連症群
    　不安または恐怖関連症群 総説
    　全般不安症
    　パニック症
    　　Topics　パニック症の脳内機序
    　　Topics　パニック症と自閉スペクトラム症
    　広場恐怖症
    　限局性恐怖症
    　社交不安症
    　分離不安症
    　場面緘黙
    　他の不安または恐怖関連症
    　　Topics　不安または恐怖関連症群に対する森田療法

    2章　強迫症または関連症群
    　強迫症または関連症群 総説
    　強迫症
    　　Topics　強迫症に対する脳深部刺激療法
    　身体醜形症
    　自己臭関係付け症（自己臭症）
    　心気症
    　ためこみ症
    　　Topics　ためこみ症とsqualor症候群
    　向身体性反復行動症群
    　その他の強迫症または関連症群

    3章　ストレス関連症群
    　ストレス関連症群 総説
    　心的外傷後ストレス症
    　複雑性心的外傷後ストレス症
    　遷延性悲嘆症
    　適応反応症
    　　Topics　適応反応症と復職支援
    　反応性アタッチメント症
    　脱抑制性対人交流症
    　急性ストレス反応
    　　Topics　ストレス関連症に対するEMDR

    4章　パーソナリティ症および関連特性群と作為症群
    　パーソナリティ症および関連特性群 総説
    　現代のパーソナリティ症の捉え方
    　　Topics　虐待とパーソナリティ症
    　　Topics　衝動的問題行動
    　顕著なパーソナリティ特性またはパターン
    　ボーダーラインパターン
    　　Topics　ボーダーラインパターンの人は減っている？
    　その他のパーソナリティ症群
    　作為症群

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 不安または恐怖関連症群

P.10 掲載の参考文献
1) Knight DC, et al. Amygdala and hippocampal activity during acquisition and extinction of human fear conditioning. Cogn Affect Behav Neurosci 2004 ; 4 : 317-325.
PubMed
2) Kessler RC, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity survey. Arch Gen Psychiatry 1994 ; 51 : 8-19.
PubMed
3) Kessler RC, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005 ; 62 : 593-602.
PubMed
4) Kessler RC, et al. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2005 ; 62 : 617-627.
 
5) Kessler RC, et al. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 2012 ; 21 : 169-184.
PubMed
6) 川上憲人. こころの健康についての疫学調査に関する研究. 平成18年度厚生労働科学研究費補助金 (こころの健康科学研究事業) こころの健康についての疫学調査に関する研究総括報告書. 2006.
 
7) 川上憲人ほか. II 有病率および受診行動・精神障害等の有病率および受診行動. 川上憲人, 精神疾患の有病率等に関する大規模疫学調査研究 : 世界精神保健日本調査セカンド総合研究報告書. 2016 ; 30-66.
 
8) Kroenke K, et al. Anxiety disorders in primary care : Prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007 ; 146 : 317-325.
PubMed
9) Fava M, et al. Anxiety disorders in major depression. Compr Psychiatry 2000 ; 41 : 97-102.
PubMed
10) Baxter AJ, et al. The global burden of anxiety disorders in 2010. Psychol Med 2014 ; 44 : 2363-2374.
PubMed
11) Beard G. Neurasthenia, or nervous exhaustion. Boston Med Surg J 1869 ; 80 : 217-221.
PubMed
12) フロイト (著), 高橋義孝ほか (訳). 精神分析入門 下. 新潮文庫 ; 1977.
 
13) World Health Organization. International statistical classification of diseases, injuries, and causes of death, 6th revision. World Health Organization ; 1949.
 
14) 中根允文ほか (監修). ICD-10 精神科診断ガイドブック. 中山書店 ; 2013.
 
15) World Health Organization. International statistical classification of diseases, injuries, and causes of death, 8th revision. World Health Organization ; 1967.
 
16) World Health Organization. International statistical classification of diseases, injuries, and causes of death, 9th revision. World Health Organization ; 1979.
 
17) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association ; 1952.
 
18) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, 3rd edition. American Psychiatric Association ; 1980.
 
19) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. American Psychiatric Association ; 1994/高橋三郎ほか (訳). DSM-IV 精神疾患の診断・統計マニュアル. 医学書院 ; 1996.
 
20) World Health Organization. International statistical classification of diseases, injuries, and causes of death, 7th revision. World Health Organization ; 1955.
 
21) World Health Organization. ICD-11 for mortality and morbidity statistics (ICD-11 MMS) 2018 version. https://icd.who.int/browse11/l-m/en
 
22) 久田信行ほか. Selective mutismの訳語は「選択性緘黙」か「場面緘黙」か? 不安症研究 2014 ; 6 : 4-6.
 
23) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised. American Psychiatric Association ; 1987/高橋三郎ほか (訳). DSM-III-R 精神障害の診断・統計マニュアル. 医学書院 ; 1988.
 
24) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 2nd edition. American Psychiatric Association ; 1968.
 
25) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision. American Psychiatric Association ; 2000/高橋三郎ほか (訳). DSM-IV-TR 精神疾患の診断・統計マニュアル 新訂版. 医学書院 ; 2002.
 
26) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edition. American Psychiatric Association ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
27) 清水栄司ほか. 「不安障害」から「不安症」への病名変更案について. 不安障害研究 2014 ; 5 : 116-121.
 
28) 融道男ほか. ICD-10 精神および行動の障害-臨床記述と診断ガイドライン. 医学書院 ; 2005.
 
P.24 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition. American Psychiatric Association ; 2013.
 
2) Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder : The GAD-7. Arch Intern Med 2006 ; 166 (10) : 1092.
PubMed
3) Revicki DA, et al. Humanistic and economic burden of generalized anxiety disorder in North America and Europe. J Affect Disord 2012 ; 140 (2) : 103-112.
 
4) 日本精神神経学会. ICD-11 診断ガイドライントレーニングセミナー 2019年版資料.
 
5) Slee A, et al. Pharmacological treatments for generalised anxiety disorder : A systematic review and network meta-analysis. Lancet 2019 ; 393 (10173) : 768-777.
PubMed
6) 杉若弘子. セルフコントロールの実験臨床心理学. 風間書房 ; 2003.
 
7) 坂野雄二. 不安障害に対する認知行動療法. 精神神経学雑誌 2012 ; 114 : 1077-1084.
 
8) Hofmann SG, Otto MW. Cognitive Behavioral Therapy for Social Anxiety Disorder. Taylor & Frances Group ; 2008.
 
9) Roshanaei-Moghaddam B, et al. Relative effects of CBT and pharmacotherapy in depression versus anxiety : Is medication somewhat better for depression, and CBT somewhat better for anxiety? Depress Anxiety 2011 ; 28 (7) : 560-567.
PubMed
10) Lindsay WR, et al. A controlled trial of treatments for generalized anxiety. Br J Clin Psychol 1987 ; 26 : 3-15.
PubMed
11) Bandelow B, et al. Efficacy of treatments for anxiety disorders : A meta-analysis. Int Clin Psychopharmacol 2015 ; 30 (4) : 183-192.
PubMed
12) Carl E, et al. Psychological and pharmacological treatments for generalized anxiety disorder (GAD) : A meta-analysis of randomized controlled trials. Cogn Behav Ther 2020 ; 49 (1) : 1-21.
 
13) Newman MG, Borkovec TD. Cognitive behavioral therapy for worry and eneralized anxiety disorder. In : Simos G (ed). Cognitive Behaviour Therapy : A Guide for the Practising Clinician. Taylor & Francis ; 2002, pp150-172.
 
14) Curry JF, et al. Treatment for Adolescents with Depression Study (TADS). Cognitive Behavior Therapy Manual-Introduction, Rationale, and Adolescent Sessions. Duke University Medical Center. Retrieved 2008-06-18. 2005. https://aaronkrasner.com/wp-content/uploads/2017/10/TADS_CBT.pdf
 
15) Buist A, et al. Generalized anxiety disorder : Course and risk factors in pregnancy. J Affect Disord 2011 ; 131 (1) : 277-283.
PubMed
16) Eke A, et al. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth : A systematic review and meta-analysis. BJOG 2016 ; 123 (12) : 1900-1907.
PubMed
17) Tran H, Robb AS. SSRI use during pregnancy. Semin Perinatol 2015 ; 39 (7) : 545-547.
PubMed
18) Creswell C, et al. Assessment and management of anxiety disorders in children and adolescents. Arch Dis Child 2014 ; 99 (7) : 674-678.
PubMed
19) McVoy M, Findling R. Child and adolescent psychopharmacology update. Psychiatr Clin North Am 2009 ; 32 (1) : 111-133.
PubMed
20) Connolly SD, et al. Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007 ; 46 (2) : 267-283.
 
21) Zhang X, et al. Generalized anxiety in community-dwelling elderly : Prevalence and clinical characteristics. J Affect Disord 2014 ; 172 : 24-29.
PubMed
22) Goncalves DC, Byrne GJ. Interventions for generalized anxiety disorder in older adults : Systematic review and meta-analysis. J Anxiety Disord 2012 ; 26 (1) : 1-11.
PubMed
23) Abejuela HR, Osser DN. The psychopharmacology algorithm project at the harvard south shore program : An algorithm for generalized anxiety disorder. Harv Rev Psychiatry 2016 ; 24 (4) : 243.
PubMed
24) Robinson J, et al. Role of self-medication in the development of comorbid anxiety and substance use disorders : A longitudinal investigation. Arch Gen Psychiatry 2011 ; 68 (8) : 800.
PubMed
25) 中島義明ほか (編). 心理学辞典. 有斐閣 ; 1999.
 
26) Ruscio AM, et al. Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe. JAMA Psychiatry 2017 ; 74 (5) : 465-475.
PubMed
27) 村松公美子. GAD-7 日本語版の妥当性・有用性の検討. 心身医学 2010 ; 50 : 592.
Medical*Online
28) 本岡寛子ほか. 「心配」の自己評定式質問紙-Penn State Worry Questionnaire (PSWQ) 日本語版の信頼性と妥当性の検討. カウンセリング研究 2009 ; 42 (3) : 247-255.
 
29) 岡嶋美代. 第4章 ERPを強迫性障害からすべての不安障害に適用する. 神村栄一 (編), 認知行動療法 実践レッスン. 金剛出版 ; 2014.
 
National Institute for Health and Care Excellence (NICE). Clinical Guideline : Generalised anxiety disorder and panic disorder in adults. https://www.nice.org.uk/guidance/cg113
 
Rapee RM, et al. Measurement of perceived control over anxiety-related events. Behavior Therapy 1996 ; 27 (2) : 279-293.
 
Schmidt NB, et al. Randomized controlled trial of false safety behavior elimination therapy : A unified cognitive behavioral treatment for anxiety psychopathology. Behavior Therapy 2012 ; 43 (3) : 518-532.
PubMed
P.35 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). American Psychiatric Publishing ; 2013, pp187-231/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition (DSM-III). American Psychiatric Publishing ; 1980/高橋三郎ほか訳. DSM-III 精神障害の分類と診断の手引き. 医学書院 ; 1982.
 
3) 貝谷久宣. 白隠の大往生. ケセラセラ 2010 ; 62 : pp1-2. http://www.fuanclinic.com/files/queserasera/2010_62_autumn.pdf (2020.06.08閲覧)
 
4) Da Costa JM. On irritable heart : A clinical study of a functional cardiac disorder and its consequence. Am J Med Sci 1871 ; 121 : 2-52.
 
5) Freud S. On the grounds for detaching a particular syndrome from neurasthenia under the description "anxiety neurosis". The standard edition of the complete psychological works of Sigmund Freud Vol. 3 (1893-1899). Hogarth Press ; 1894, pp76-106.
 
6) 塩入俊樹. 不安障害の歴史. 塩入俊樹ほか (編), 不安障害診療のすべて. 医学書院 ; 2013, pp2-19.
 
7) Kessler RC, et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National comorbidity Survey Replication. Arch Gen Psychiatry 2006 ; 63 (4) : 415-424.
PubMed
8) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth edition. American Psychiatric Publishing ; 1994/高橋三郎ほか (訳). DSM-IV 精神疾患の診断・統計マニュアル. 医学書院 ; 1994.
 
9) Alonso J, Lepine JP. Overview of Key Data From the European Study of the Epidemiology of Mental Disorders (ESEMeD). J Clin Psychiatry 2007 ; 68 (suppl 2) : 3-9.
 
10) 川上憲人ほか. 世界精神保健日本調査セカンド. http://wmhj2.jp/WMHJ2-2016R.pdf (2020.06.08閲覧)
 
11) World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders : Clinical descriptions and diagnostic guidelines. World Health Organization ; 1992/融道男ほか (監訳). ICD-10 精神および行動の障害-臨床記述と診断ガイドライン 新訂版. 医学書院 ; 2005.
 
12) Kessler RC, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007 ; 6 (3) : 168-176.
PubMed
13) World Health Organization. ICD-11 ガイドライン案. https://gcp.network/en/private/icd-11-guidelines/grouping (2020.06.08閲覧)
 
14) 日本精神神経学会. ICD-11 診断ガイドライントレーニングセミナー 2019年版資料.
 
15) World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders : Diagnostic criteria for research. World Health Organization ; 1993/中根允文ほか (訳). ICD-10 精神および行動の障害-DCR研究用診断基準 新訂版. 医学書院 ; 2008.
 
16) 高塩理. パニック症 (障害) とうつ病-大学病院専門外来の経験をふまえて. 臨床精神薬理 2014 ; 17 : 1716-1721.
 
17) 武田真紀ほか. 社会不安障害, パニック障害, 全般性不安障害の有病率調査-郵送によるアンケート調査. 精神経誌 2003 ; 105 (11) : 1342-1343.
 
18) Starcevic V. Anxiety Disorders in Adults : A Clinical Guide. Oxford University Press ; 2009.
 
19) Bighelli I, et al. Antidepressants versus placebo for panic disorder in adults. Cochrane Database Syst Rev 2018 ; 4 (4) : CD010676.
PubMed
20) Keller MB, Hanks DL. Anxiety symptom relief in depression treatment outcomes. J Clin Psychiatry 1995 ; 56 (Suppl 6) : 22-29.
 
21) Nam YY, et al. Comorbid panic disorder as an independent risk factor for suicide attempts in depressed outpatients. Comprehensive Psychiatry 2016 ; 67 : 13-18.
PubMed
22) Sala R, et al. Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population. J Psychiatr Res 2012 ; 46 (7) : 865-872.
 
23) Goodwin RD, Hoven CW. Bipolar-panic comorbidity in the general population : Prevalence and associated morbidity. J Affect Disord 2002 ; 70 (1) : 27-33.
PubMed
24) Toniolo RA, et al. Clinical significance of lifetime panic disorder in the course of bipolar disorder type I. Compr Psychiatry 2009 ; 50 (1) : 9-12.
PubMed
25) Dyer ML, et al. Associations of child and adolescent anxiety with later alcohol use and disorders : A systematic review and meta-analysis of prospective cohort studies. Addiction 2019 ; 114 (6) : 968-982.
PubMed
26) Kossowsky J, et al. The separation anxiety hypothesis of panic disorder revisited : A meta-analysis. Am J Psychiatry 2013 ; 170 (7) : 768-781.
PubMed
27) Battaglia M, et al. Early-life risk factors for panic and separation anxiety disorder : Insights and outstanding questions arising from human and animal studies of CO2 sensitivity. Neurosci Biobehav Rev 2014 ; 46 Pt 3 : 455-464.
 
28) American Psychiatric Association. Practice Guideline for the Treatment of Patients with Panic Disorder, second edition. American Psychiatric Association 2009.
 
29) Katschnig H, Amering M. The long-term course of panic disorder and its predictors. J Clin Psychopharmacol 1998 ; 6 : 6S-11S.
 
30) Noyes R Jr., et al. Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants. J Affect Disord 1989 ; 16 (2-3) : 249-257.
 
31) Perugi G, et al. Diagnosis and treatment of agoraphobia with panic disorder. CNS Drugs 2007 ; 21 : 741-764.
PubMed
32) 桑原秀樹, 塩入俊樹. パニック障害に対する薬物療法終了の基準とその方法. 臨床精神薬理 2014 ; 17 (4) : 489-498.
 
33) 塩入俊樹, 高井健太朗. 不安症群における寛解と再発, そして再発予防-パニック症, 社交不安症, 全般不安症について. 精神科治療学 2018 ; 33 (9) : 1079-1086.
 
34) Bruce SE, et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder : A 12-year prospective study. Am J Psychiatry 2005 ; 162 (6) : 1179-1187.
PubMed
35) Hendriks SM, et al. Longterm disability in anxiety disorders. BMC Psychiatry 2016 ; 16 : 248. doi : 10.1186/s12888-016-0946-y.
 
36) Yonkers KA, et al. Chronicity, relapse, and illness-course of panic disorder, social phobia, and generalized anxiety disorder : Findings in men and women from 8 years of followup. Depress Anxiety 2003 ; 17 (3) : 173-179.
PubMed
37) 関洋一 (編). パニック障害 (パニック症) の認知行動療法マニュアル (治療者用). https://www.mhlw.go.jp/file/06-Seisakujouhou-12200000-Shakaiengokyokushougaihokenfukushibu/0000113842.pdf (2020.06.08閲覧)
 
38) Slaap BR, den Boer JA. The prediction of nonresponse to pharmacotherapy in panic disorder : A review. Depress Anxiety 2001 ; 14 : 112-122.
PubMed
39) Doyle AC, Pollack MH. Establishment of remission criteria for anxiety disorders. J Clin Psychiatry 2003 ; 64 : 40-45.
PubMed
40) Fava GA, Mangelli L. Subclinical symptoms of panic disorder : New insights into pathophysiology and treatment. Psychother Psychosom 1999 ; 68 : 281-289.
PubMed
41) Gardos G. Long-term treatment of panic disorder with agoraphobia in private practice. J Psychiatr Pract 2000 ; 6 : 140-146.
PubMed
42) Katon W, et al. Panic disorder : Residual symptoms after the acute attacks abate. Compr Psychiatry 1987 ; 28 : 151-158.
PubMed
43) Marchesi C, et al. The effect of pharmacotherapy on personality disorders in panic disorder : A one year naturalistic study. J Affect Disord 2005 ; 89 : 189-194.
PubMed
44) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision. American Psychiatric Publishing ; 2000/高橋三郎ほか (訳). DSM-IV-TR 精神疾患の診断・統計マニュアル 新訂版. 医学書院 ; 2004.
 
45) 塩入俊樹. パニック症の神経解剖学的モデルについて. 不安症研究 2019 ; 11 (1) : 35-46.
 
46) Bechara A, et al. Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans. Science 1995 ; 269 : 1115-1118.
 
47) 塩入俊樹. 不安障害の病態について-Stress-induced Fear Circuitry Disordersを中心に. 精神経誌 2010 ; 112 : 797-805.
 
48) Klein DF. False suffocation alarms, spontaneous panics, and related-conditions : An integrative hypothesis. Archives of General Psychiatry 1993 ; 50 (4) : 306-317.
PubMed
49) Sakai Y, et al. Cerebral glucose metabolism associated with a fear network in panic disorder. Neurosciences 2005 ; 24 : 540-546.
 
50) Bandelow B, et al. The diagnosis of and treatment recommendations for anxiety disorders. Dtsch Arztebl Int 2014 ; 111 : 473-480.
PubMed
51) Katzman MA, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry 2014 ; 14 (Suppl 1) : S1. doi : 10.1186/1471-244X-14-S1-S1.
 
52) Spindelegger C, et al. Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders. Mol Psychiatry 2009 ; 14 (11) : 1040-1050.
PubMed
53) Kang EH, et al. Regional brain metabolism and treatment response in panic disorder patients : An [18F] FDGPET study. Neuropsychobiology 2012 ; 66 (2) : 106-111.
PubMed
American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). American Psychiatric Publishing ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
塩入俊樹ほか (編). 不安障害診療のすべて. 医学書院 ; 2013.
 
関洋一 (編). パニック障害 (パニック症) の認知行動療法マニュアル (治療者用). https://www.mhlw.go.jp/file/06-Seisakujouhou-12200000-Shakaiengokyokushougaihokenfukushibu/0000113842.pdf
 
塩入俊樹. パニック症の神経解剖学的モデルについて. 不安症研究 2019 ; 11 (1) : 35-46.
 
P.42 掲載の参考文献
1) Gorman JM, et al. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 2000 ; 157 : 493-505.
PubMed
2) Massana G, et al. Amygdalar atrophy in panic disorder patients detected by volumetric magnetic resonance imaging. Neuroimage 2003 ; 19 : 80-90.
 
3) Asami T, et al. Smaller volumes in the lateral and basal nuclei of the amygdala in patients with panic dis-order. PLoS One 2018 ; 13 : e0207163.
 
4) Radua J, et al. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry 2010 ; 67 : 701-711.
PubMed
5) Asami T, et al. Sexually dimorphic gray matter volume reduction in patients with panic disorder. Psychiatry Res 2009 ; 173 : 128-134.
PubMed
6) Lai CH, Wu YT. Fronto-temporo-insula gray matter alterations of first-episode, drug-naive and very late-onset panic disorder patients. J Affect Disord 2012 ; 140 : 285-291.
PubMed
7) Wu Y, et al. Gray matter changes in panic disorder : A voxel-based meta-analysis and meta-analytic connectivity modeling. Psychiatry Res Neuroimaging 2018 ; 282 : 82-89.
PubMed
8) Yoshida H, et al. Structural abnormalities in nucleus accumbens in patients with panic Disorder. J Affect Disord 2020 ; 271 : 201-206
 
9) Protopopescu X, et al. Increased brainstem volume in panic disorder : A voxel-based morphometric study. Neuroreport 2006 ; 17 : 361-363.
PubMed
P.47 掲載の参考文献
1) White SW, et al. Anxiety children and adolescents with autism spectrum disorders. Clin Psychol Rev 2009 ; 29 : 216-229.
PubMed
2) Kanner L. Autistic disturbances of affective contact. Nervous Child 1943 ; 2 : 217-250.
 
3) Bekker MH, Mens-Verhulst J. Anxiety disorders : Sex differences in prevalence, degree, and background, but gender-neutral treatment. Gend Med 2007 ; 4 : S178-S193.
PubMed
4) Simonoff E, et al. Psychiatric disorders in children with autism spectrum disorders : Prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 2008 ; 47 : 921-929.
 
5) Buck TR, et al. Psychiatric comorbidity and medication use in adults with autism spectrum disorder. J Autism Dev Disord 2014 ; 44 : 3063-3971.
PubMed
6) Hallet V, et al. Exploring anxiety symptoms in a large-scale twin study of children with autism spectrum disorders, their co-twins and controls. J Child Psychol Psychiatry 2013 ; 54 : 1176-1185.
 
7) Magiati I, et al. Anxiety symptoms in young people with autism spectrum disorder attending special schools : Associations with gender, adaptive functioning and autism symptomatology. Autism 2016 ; 20 : 306-320.
PubMed
P.59 掲載の参考文献
1) 日本精神神経学会. ICD-11 診断ガイドライントレーニングセミナー 2019年版資料.
 
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). American Psychiatric Publishing ; 2013/日本精神神経学会 (日本語版用語監修). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
3) Westphal C. Die Agoraphobie, eine neuropathesche Erscheinung. Aechiv Psychiatr Nervernkr 1872 ; 3 : 138-161.
 
4) 塩入俊樹. 不安症群/不安障害-診断と概念の変遷. 三村將 (編), DSM-5を読み解く 4. 不安症群, 強迫症および関連症群, 心的外傷およびストレス因関連障害群, 解離症群, 身体症状症および関連症群. 中山書店 ; 2014, pp2-17.
 
5) American Psychiatric Association. Diagnostic and Statistical manual of Mental Disorders. 3rd edition. American Psychiatric Publishing ; 1980/高橋三郎ほか (訳). DSM-III 精神障害の分類と診断の手引き. 医学書院 ; 1982.
 
6) 塩入俊樹. DSM-5のインパクト-臨床・研究への活用と課題 : 不安症群. 精神経誌 2015 ; 117 (10) : 851-861.
 
7) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, third edition, revised. American Psychiatric Publishing ; 1987/高橋三郎 (訳). DSM-III-R 精神障害の診断・統計マニュアル. 医学書院 ; 1988.
 
8) Asmundson GJ, et al. Panic Disorder and Agoraphobia : An Overview and Commentary on DSM-5 Changes. Depress Anxiety 2014 ; 31 (6) : 480-486.
PubMed
9) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth edition. American Psychiatric Publishing ; 1994/高橋三郎ほか (訳). DSM-IV 精神疾患の診断・統計マニュアル. 医学書院 ; 1994.
 
10) World Health Organization. International Classification of Diseases, ninth revision. World Health Organization ; 1978.
PubMed
11) World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders : Clinical descriptions and diagnostic guidelines. World Health Organization ; 1992/中根允文ほか (監訳). ICD-10 精神および行動の障害-臨床記述と診断ガイドライン 新訂版. 医学書院 ; 2005.
 
12) World Health Organization : ICD-11ガイドライン案. https://gcp.network/en/private/icd-11-guidelines/grouping (2020.06.10閲覧)
 
13) Kessler RC, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005 ; 62 (6) : 593-602.
PubMed
14) Kessler RC, et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006 ; 63 (4) : 415-424.
PubMed
15) Wittchen HU, et al. The relationship of agoraphobia and panic in a community sample of adolescents and young adults. Arch Gen Psychiatry 1998 ; 55 (11) : 1017-1024.
 
16) Goodwin RD, et al. The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsycho-Pharmacol 2005 ; 15 (4) : 435-443.
 
17) 川上憲人ほか. 世界精神保健日本調査セカンド. http://wmhj2.jp/WMHJ2-2016R.pdf
 
18) 貝谷久宜ほか. DSM-5 ドラフトにおける精神障害 5. 不安障害. 臨床精神医学 2012 ; 41 (5) : 577-587.
 
19) Andreescu C, Varon D. New research on anxiety disorders in the elderly and an update on evidence-based treatments. Curr Psychiatry Rep 2015 ; 17 (7) : 53. doi : 10.1007/s11920-015-0595-8.
 
20) Tibi L, et al. An admixture analysis of age of onset in agoraphobia. J Affect Disord 2015 ; 180 : 112-115.
PubMed
21) Perugi G, et al. Diagnosis and treatment of agoraphobia with panic disorder. CNS Drugs 2007 ; 21 (9) : 741-764.
PubMed
22) Rosenbaum JF, et al (eds). Panic Disorder and Its Treatment. Marcel Dekker ; 1998.
 
23) Ziegler RG. Anxiety Disorders in Children : Applying a Cognitive-Behavioral Technique That Can Be Integrated With Pharmacotherapy or Other Psychosocial Interventions. In : Ellison JM (ed). Integrative Treatment of Anxiety Disorders. American Psychiatric Press ; 1996.
 
24) Aschenbrand SG, et al. Is childhood separation anxiety disorder a predictor of adult panic disorder and agoraphobia? : A seven-year longitudinal study. J Am Acad Child Adolesc Psychiatry 2003 ; 42 (12) : 1478-1485.
PubMed
25) Faravelli C, et al. Prevalence of traumatic early life events in 31 agoraphobic patients with panic attacks. Am J Psychiatry 1985 ; 142 (12) : 1493-1494.
PubMed
26) Tweed JL, et al. The effects of childhood parental death and divorce on six-month history of anxiety disorders. Br J Psychiatry 1989 ; 154 : 823-828.
PubMed
27) Wittchen, HU, et al. Agoraphobia and panic. Prospective-longitudinal relations suggest a rethinking of diagnostic concepts. Psychother Psychosom 2008 ; 77 (3) : 147-157.
PubMed
28) Kossowsky J, et al. The separation anxiety hypothesis of panic disorder revisited : A meta-analysis. Am J Psychiatry 2013 ; 170 (7) : 768-781.
PubMed
29) Battaglia M, et al. Early-life risk factors for panic and separation anxiety disorder : Insights and outstanding questions arising from human and animal studies of CO2 sensitivity. Neurosci Biobehav Rev 2014 ; 46 Pt 3 : 455-464.
 
30) Wittchen, H.U, et al. Agoraphobia : A review of the diagnostic classificatory position and criteria. Depress Anxiety 2010 ; 27 (2) : 113-133.
PubMed
31) Wilson KA, Hayward C. A prospective evaluation of agoraphobia and depression symptoms following panic attacks in a community sample of adolescents. J Anxiety Disord 2005 ; 19 (1) : 87-103.
 
32) Slade T, Grisham JR. A taxometric investigation of agoraphobia in a clinical and a community sample. J Anxiety Disord 2009 ; 23 (6) : 799-805.
 
33) Kendler KS, et al. Fears and phobias : Reliability and heritability. Psychol Med 1999 ; 29 (3) : 539-553.
PubMed
34) Bienvenu OJ, et al. Low extraversion and high neuroticism as indices of genetic and environmental risk for social phobia, agoraphobia, and animal phobia. Am J Psychiatry 2007 ; 164 (11) : 1714-1721.
PubMed
35) de Beurs E, et al. Continuous monitoring of panic. Acta Psychiatr Scand 1994 ; 90 (1) : 38-45.
PubMed
36) Hettema, JM, et al. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 2005 ; 62 (2) : 182-189.
PubMed
37) Deckert J, et al. GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation : A potential neurogenetic pathway to panic disorder. Mol Psychiatry 2017 ; 22 (10) : 1431-1439.
PubMed
38) Noyes R Jr, et al. Relationship between panic disorder and agoraphobia. A family study. Arch Gen Psychiatry 1986 ; 43 (3) : 227-232.
PubMed
39) Mosing MA, et al. Genetic and environmental influences on the co-morbidity between depression, panic disorder, agoraphobia, and social phobia : A twin study. Depress Anxiety 2009 ; 26 (11) : 1004-1011.
PubMed
40) Smoller JW, et al. The genetic basis of panic and phobic anxiety disorders. Am J Med Genet C Semin Med Genet 2008 ; 148C (2) : 118-126.
PubMed
41) Garvey, M.J., Noyes, R. Jr. NAG level differences in panic disorder and agoraphobia. J Anxiety Disord 2005 ; 19 (7) : 818-825.
 
42) Wagner EY, et al. Evidence for chronic low-grade systemic inflammation in individuals with agoraphobia from a population-based prospective study. PLoS One 2015 ; 10 (4) : e0123757. doi : 10.1371/journal.pone.0123757.
 
43) Hardt J, et al. The role of childhood stress in symptoms of social phobia and agoraphobia in adulthood. Z Psychosom Med Psychother 2018 ; 64 (2) : 144-157.
PubMed
44) Kendler KS, et al. Parenting and adult mood, anxiety and substance use disorders in female twins : An epidemiological, multi-informant, retrospective study. Psychol Med 2000 ; 30 (2) : 281-294.
PubMed
45) Moitra E, et al. Impact of stressful life events on the course of panic disorder in adults. J Affect Disord 2011 ; 134 (1-3) : 373-376.
 
46) Wang PS, et al. Twelve-month use of mental health services in the United States : Results from the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005 ; 62 (6) : 629-640.
PubMed
47) Goisman RM, et al. DSM-IV and the disappearance of agoraphobia without a history of panic disorder-new data on a controversial diagnosis. Am J Psychiatry 1995 ; 152 (10) : 1438-1443.
PubMed
48) Nocon A. Die Stellung der Agoraphobie in modernen diagnostischen Klassifikationssystemen : Beitrag zu einer nosologischen Kontroverse [Dissertation] : Technische Universitat Dresden ; 2009.
 
49) Perna G, et al. Antianxiety medications for the treatment of complex agoraphobia : Pharmacological interventions for a behavioral condition. Neuropsychiatr Dis Treat 2011 ; 7 : 621-637.
PubMed
50) Bandelow B, et al. The diagnosis of and treatment recommendations for anxiety disorders. Dtsch Arztebl Int 2014 ; 111 (27-28) : 473-480.
 
51) Katzman MA, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry 2014 ; 14 (Suppl 1) : S1.
 
52) Bandelow B, et al. Enduring effects of psychological treatments for anxiety disorders : Meta-analysis of follow-up studies. Br J Psychiatry 2018 ; 212 (6) : 333-338.
PubMed
53) Porter E, Chambless DL. A systematic review of predictors and moderators of improvement in cognitivebehavioral therapy for panic disorder and agoraphobia. Clin Psychol Rev 2015 ; 42 : 179-192.
PubMed
54) Strohle A, et al. The Diagnosis and Treatment of Anxiety Disorders. Dtsch Arztebl Int 2018 ; 115 (37) : 611-620.
 
55) 熊野宏昭, 久保木富房. パニック障害ハンドブック-治療ガイドラインと診療の実際. 医学書院 ; 2008. http://hikumano.umin.ac.jp/PD_guideline.pdf
 
56) 塩入俊樹. パニック症の神経解剖学的モデルについて. 不安症研究 2019 ; 11 (1) : 35-46.
 
57) 熊野宏昭. パニック障害の認知行動療法. 不安症研究 2014 ; 6 (1) : 34-42.
 
58) Morrow BA, et al. The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience 1999 ; 92 (2) : 555-564.
 
59) 樋口輝彦ほか (編). <専門医のための精神科臨床リュミエール> 25. 向精神薬のリスク・ベネフィット. 中山書店 ; 2011, pp177-189.
 
60) Ponnusamy R, et al. Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice. Learn Mem 2005 ; 12 (4) : 399-406.
PubMed
61) Otto MW, et al. Efficacy of D-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry 2010 ; 67 (4) : 365-370.
PubMed
62) Siegmund A, et al. D-cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial. J Psychiatr Res 2011 ; 45 (8) : 1042-1047.
PubMed
63) Otto MW, et al. Randomized Trial of D-Cycloserine Enhancement of Cognitive-Behavioral Therapy for Panic Disorder. Depress Anxiety 2016 ; 33 (8) : 737-745.
PubMed
64) Zelikowsky M, et al. Cholinergic blockade frees fear extinction from its contextual dependency. Biol Psychiatry 2013 ; 73 (4) : 345-352.
PubMed
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Publishing ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
塩入俊樹ほか (編). 不安障害診療のすべて. 医学書院 ; 2013.
 
Wittchen, HU, et al. Agoraphobia : A review of the diagnostic classificatory position and criteria. Depress Anxiety 2010 ; 27 : 113-133.
PubMed
P.72 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition. American Psychiatric Association ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
2) Eaton WW, et al. Specific phobias. Lancet Psychiatry 2018 ; 5 (8) : 678-686.
PubMed
3) Bijl RV, et al. Prevalence of psychiatric disorder in the general population : Results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998 ; 33 (12) : 587-595.
PubMed
4) Eaton WW, et al. The Epidemiologic Catchment Area Program of the National Institute of Mental Health. Public Health Rep 1981 ; 96 (4) : 319-325.
PubMed
5) Stinson FS, et al. The epidemiology of DSM-IV specific phobia in the USA : Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 2007 ; 37 (7) : 1047-1059.
PubMed
6) Magee WJ, et al. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 1996 ; 53 (2) : 159-168.
PubMed
7) Hettema JM, et al. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001 ; 158 (10) : 1568-1578.
PubMed
8) Hettema JM, et al. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 2005 ; 62 (2) : 182-189.
PubMed
9) Van Houtem C M H H, et al. A review and meta-analysis of the heritability of specific phobia subtypes and corresponding fears. J Anxiety Disord 2013 ; 27 (4) : 379-388.
 
10) Hettema JM, et al. A population-based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry 2006 ; 163 (5) : 857-864.
PubMed
11) Bienvenu OJ, et al. Low extraversion and high neuroticism as indices of genetic and environmental risk for social phobia, agoraphobia, and animal phobia. Am J Psychiatry 2007 ; 164 (11) : 1714-1721.
PubMed
12) Linares Ila MP, et al. Neuroimaging in specific phobia disorder : A systematic review of the literature. Braz J Psychiatry 2012 ; 34 (1) : 101-111.
 
13) Andrews G, et al (eds). Stress-Induced and Fear Circuitry Disorders : Refining the Research Agenda for DSM-V. American Psychiatric Publishing ; 2009.
 
14) 塩入俊樹. 社交不安障害 (SAD) の神経生物学的検討 : Fear-circuitry dysfunctionの観点から. 臨床精神薬理 2010 ; 13 (4) : 711-721.
 
15) Depla MF, et al. Specific fears and phobias in the general population : Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 2008 ; 43 (3) : 200-208.
PubMed
16) Becker ES, et al. Epidemiology of specific phobia subtypes : Findings from the Dresden Mental Health Study. Eur Psychiatry 2007 ; 22 (2) : 69-74.
PubMed
17) Katzman MA, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry 2014 ; 14 (Suppl 1) : S1.
 
18) Bandelow B, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders-first revision. World J Biol Psychiatry 2008 ; 9 (4) : 248-312.
PubMed
19) Wolitzky-Taylor KB, et al. Psychological approaches in the treatment of specific phobias : A meta-analysis. Clin Psychol Rev 2008 ; 28 (6) : 1021-1037.
PubMed
20) Hood HK, et al. Evidence-Based Assessment and Treatment of Specific Phobias in Adults. Springer ; 2012.
 
21) Ressler KJ, et al. Cognitive enhancers as adjuncts to psychotherapy : Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004 ; 61 (11) : 1136-1144.
PubMed
22) Minns S, et al. Immersive 3D exposure-based treatment for spider fear : A randomized controlled trial. Anxiety Disord 2019 ; 61 : 37-44.
 
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5). American Psychiatric Association ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の分類と診断の手引. 医学書院 ; 2014.
 
Eaton WW, et al. Specific phobias. Lancet Psychiatry 2018 ; 5 (8) : 678-686.
PubMed
Andrews G, et al (eds). Stress-Induced and Fear Circuitry Disorders : Refining the Research Agenda for DSM-V. American Psychiatric Publishing ; 2009.
 
P.81 掲載の参考文献
1) Nagata T, et al. Generalized social anxiety disorder : A still-neglected anxiety disorder 3 decades since Liebowitz's review. Psychiatry Clin Neurosci 2015 ; 69 (12) : 724-740.
 
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders : DSM-5. American Psychiatric Publishing ; 2013.
 
3) Baldwin DS, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder : A revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol 2014 ; 28 (5) : 403-439.
PubMed
4) 永田利彦. 現代のうつ病と社交不安障害 (SAD). 臨床精神薬理 2010 ; 13 (4) : 723-730.
 
5) 永田利彦ほか. 社会不安障害患者における大うつ病性障害の生涯診断. 精神医学 2004 ; 46 (4) : 381-387.
 
6) 永田利彦ほか. 摂食障害における社会不安障害. 精神医学 2007 ; 49 (2) : 129-135.
 
7) Marks IM, Gelder MG. Different ages of onset in varieties of phobia. Am J Psychiatry 1966 ; 123 (2) : 218-221.
PubMed
8) Liebowitz MR, et al. Social phobia. Review of a neglected anxiety disorder. Arch Gen Psychiatry 1985 ; 42 (7) : 729-736.
PubMed
9) Kagan J. The Human Spark : The Science of Human Development. Basic Books ; 2013.
 
10) Nagata T, et al. Comorbid social withdrawal (hikikomori) in outpatients with social anxiety disorder : Clinical characteristics and treatment response in a case series. Int J Soc Psychiatry 2013 ; 59 (1) : 73-78.
 
11) 高橋徹. 対人恐怖-相互伝達の分析. 医学書院 ; 1976.
 
12) Nagata T, et al. Correlations between the offensive subtype of social anxiety disorder and personality disorders. Psychiatry Clin Neurosci 2011 ; 65 (4) : 341-348.
PubMed
13) Stein MB, Stein DJ. Social anxiety disorder. Lancet 2008 ; 371 (9618) : 1115-1125.
PubMed
14) Gingnell M, et al. Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder : Randomised controlled fMRI trial. Br J Psychiatry 2016 ; 209 (3) : 229-235.
PubMed
15) Frick A, et al. Neuroimaging, genetic, clinical, and demographic predictors of treatment response in patients with social anxiety disorder. J Affect Disord 2020 ; 261 : 230-237.
PubMed
16) Magee WJ, et al. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 1996 ; 53 (2) : 159-168.
PubMed
17) Kessler RC, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005 ; 62 (6) : 617-627.
PubMed
18) Ruscio AM, et al. Social fears and social phobia in the USA : Results from the National Comorbidity Survey Replication. Psychol Med 2008 ; 38 (1) : 15-28.
PubMed
19) Grant BF, et al. The epidemiology of social anxiety disorder in the United States : Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005 ; 66 (11) : 1351-1361.
PubMed
20) 川上憲人. 精神疾患の有病率等に関する大規模疫学調査研究 : 世界精神保健日本調査セカンド 総合研究報告書, 厚生労働省厚生労働科学研究費補助金 (障害者対策総合研究事業) (H25-精神-一般-006). 2016.
 
21) Stein MB, Kean YM. Disability and quality of life in social phobia : Epidemiologic findings. Am J Psychiatry 2000 ; 157 (10) : 1606-1613.
PubMed
22) Marks IM. The classification of phobic disorders. Br J Psychiatry 1970 ; 116 (533) : 377-386.
PubMed
23) Koyuncu A, et al. Comorbidity in social anxiety disorder : Diagnostic and therapeutic challenges. Drugs Context 2019 ; 8 : 212573.
PubMed
24) Mannuzza S, et al. Generalized social phobia. Reliability and validity. Arch Gen Psychiatry 1995 ; 52 (3) : 230-237.
PubMed
25) 吉村知穂. 非定型うつ病を併存した社交不安障害の臨床像. 阪市医誌 2011 ; 60 (1・2) : 17-24.
 
26) Schneier FR, et al. The social anxiety spectrum. Psychiatr Clin North Am 2002 ; 25 (4) : 757-774.
PubMed
27) 永田利彦ほか. 社会不安障害におけるパーソナリティー障害-大うつ病性障害との関連. 精神医学 2004 ; 46 (7) : 685-690.
 
28) 永田利彦. アルコール使用障害と不安障害の併存. 精神神経誌 2009 ; 111 (7) : 837-842.
 
29) Miloyan B, Van Doorn G. Longitudinal association between social anxiety disorder and incident alcohol use disorder : Results from two national samples of US adults. Soc Psychiatry Psychiatr Epidemiol 2019 ; 54 (4) : 469-475.
PubMed
30) Gunstad J, Phillips KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry 2003 ; 44 (4) : 270-276.
PubMed
31) 永田利彦ほか. 身体醜形障害のcomorbidityを有する社会不安障害について. 精神医学 2005 ; 47 (10) : 1113-1118.
 
32) 永田利彦. 不安症を併存する双極性障害の治療-自閉スペクトラム症, 境界性パーソナリティ障害の視点から. 不安症研究 2019 ; 11 (1) : 24-34.
 
33) 岡田俊. 社交不安・緘黙と自閉スペクトラム症. 精神科 2018 ; 33 (5) : 444-448.
 
34) 永田利彦ほか. 就労支援事業が就労につながった全般性社交不安障害 (回避性パーソナリティ障害) の2症例. 精神医学 2009 ; 51 (12) : 1157-1163.
 
35) Clark DM, Wells A. A cognitive model of social phobia. In : Heimberg RG, et al (eds). Social Phobia : Diagnosis, Assessment, and Treatment. Guilford Press ; 1995, pp69-93.
 
36) 吉永尚紀, 清水英司. 社交不安障害 (社交不安症) の認知行動療法マニュアル (治療者用). 不安症研究 2016 (特別号) : 42-93.
 
37) Mayo-Wilson E, et al. Psychological and pharmacological interventions for social anxiety disorder in adults : A systematic review and network meta-analysis. Lancet Psychiatry 2014 ; 1 (5) : 368-376.
PubMed
38) Linehan MM. Validation and Psychotherapy. In : Bohart AC, et al (eds). Empathy Reconsidered : New Directions in Psychotherapy. American Psychological Association ; 1997, pp353-392.
 
39) 永田利彦. 摂食障害とパーソナリティ障害-過食, 嗜癖, そしてプロトタイプアプローチ. 児童青年精神医学とその近接領域 2019 ; 60 (2) : 169-179.
Medical*Online
40) 笠原嘉ほか. 正視恐怖, 体臭恐怖. 医学書院 ; 1972.
 
41) 山下格. 対人恐怖. 金原出版 ; 1977.
 
42) 永田利彦ほか. 社会不安障害における価値観-古典的対人恐怖との関連. 精神医学 2004 ; 46 (2) : 141-147.
 
43) 永田利彦ほか. 社会不安障害に対する薬物療法-古典的対人恐怖, ひきこもりとの関連. 精神医学 2004 ; 46 (9) : 933-939.
 
P.95 掲載の参考文献
1) 日本精神神経学会. ICD-11 診断ガイドライントレーニングセミナー 2019年版資料.
 
2) J. ボウルビィ. 黒田実郎ほか (訳). I 愛着行動. 母子関係の理論 (1) 新版. 岩崎学術出版社 ; 1991.
 
3) Battaglia M, et al. A genetically informed study of the association between childhood separation anxiety, sensitivity to CO. Arch Gen Psychiatry 2009 ; 66 : 64-71.
 
4) D'Amato FR, et al. Unstable maternal environment, separation anxiety, and heightened CO. PLoS One 2011 ; 6 (4) : e18637.
PubMed
5) Battaglia M, et al. Early-life risk factors for panic and separation anxiety disorder : Insights and outstanding questions arising from human and animal studies of CO2 sensitivity. Neurosci Biobehav Rev 2014 ; 46 (3) : 455-464.
 
6) Silove D, et al. Is early separation anxiety a specific precursor of panic disorder-agoraphobia? A community study. Psychol Med 1995 ; 25 : 405-411.
PubMed
7) Silove D, Rees S. Separation anxiety disorder across the lifespan : DSM-5 lifts age restriction on diagnosis. Asian J Psychiatr 2014 ; 11 : 98-101.
PubMed
8) 敷島千鶴ほか. 一般的信頼に及ぼす遺伝と環境の影響-行動遺伝学的・進化心理学的アプローチ. 社会心理学研究 2006 ; 22 (1) : 48-57.
 
9) Tasdemir A, et al. Assessment of co-morbidity of adult separation anxiety in patients with bipolar disorder. Nord J Psychiatry 2016 ; 70 (2) : 93-102.
PubMed
10) Kins E, et al. Separation anxiety in families with emerging adults. J Fam Psychol 2013 ; 27 (3) : 495-505.
PubMed
11) Hock E, et al. Maternal separation anxiety : Mother-infant separation from the maternal perspective. Child Dev 1989 ; 60 : 793-802.
 
12) Lutz WJ, Hock E. Maternal separation anxiety : Relations to adult attachment representations in mothers of infants. J Genet Psychol 1995 ; 156 (1) : 57-72.
PubMed
13) Soenens B, et al. Toward a domain-specific approach to the study of parental psychological control : Distinguishing between dependency-oriented and achievement-oriented psychological control. J Pers 2010 ; 78 (1) : 217-256.
 
14) Wood JJ. Parental intrusiveness and children's separation anxiety in a clinical sample. Child Psychiatry Hum Dev 2006 ; 37 (1) : 73-78.
 
15) Arnett JJ. Emerging adulthood : A theory of development from the late teens through the twenties. Am Psychol 2000 ; 55 (5) : 469-480.
PubMed
16) Costa B, et al. Mutation analysis of oxytocin gene in individuals with adult separation anxiety. Psychiatry Res 2009 ; 168 : 87-93.
PubMed
17) Redlich R, et al. Are you gonna leave me? Separation anxiety is associated with increased amygdala responsiveness and volume. Soc Cogn Affect Neurosci 2015 ; 10 (2) : 278-284.
PubMed
18) Kossowsky J, et al. Separation anxiety disorder in children : Disorder-specific responses to experimental separation from the mother. J Child Psychol Psychiatry 2012 ; 53 (2) : 78-87.
 
19) Cartwright-Hatton S, et al. Anxiety in a neglected population : Prevalence of anxiety disorders in preadolescent children. Clin Psychol Rev 2006 ; 26 (7) : 817-833.
 
20) Masi G, et al. Separation Anxiety Disorder in Children and Adolescents : Epidemiology, Diagnosis and Management. CNS Drugs 2001 ; 15 (2) : 93-104.
PubMed
21) Beesdo-Baum K, Knappe S. Developmental epidemiology of anxiety disorders. Child Adolesc Psychiatr Clin N Am 2012 ; 21 (3) : 457-478.
PubMed
22) Battaglia M, et al. Distinct trajectories of separation anxiety in the preschool years : Persistence at school entry and early-life associated factors. J Child Psychol Psychiatry 2016 ; 57 (1) : 39-46.
PubMed
23) Battaglia M, et al. Early childhood trajectories of separation anxiety : Bearing on mental health, academic achievement, and physical health from mid-childhood to preadolescence. Depress Anxiety 2017 ; 34 (10) : 918-927.
PubMed
24) Copeland WE, et al. Longitudinal patterns of anxiety from childhood to adulthood : The Great Smoky Mountains Study. J Am Acad Child Adolesc Psychiatry 2014 ; 53 (1) : 21-33.
PubMed
25) 齊藤万比古ほか. ADHDの二次障害. 精神科治療学 2010 ; 25 : 787-792.
 
26) Copeland WE, et al. Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Arch Gen Psychiatry 2009 ; 66 (7) : 764-772.
PubMed
27) Shear K, et al. Prevalence and correlates of estimated DSM-IV child and adult separation anxiety disorder in the National Comorbidity Survey Replication. Am J Psychiatry 2006 ; 163 (6) : 1074-1083.
PubMed
28) Mohatt J, et al. Treatment of separation, generalized, and social anxiety disorders in youths. Am J Psychiatry 2014 ; 171 (7) : 741-748.
PubMed
29) Colleen M, et al. Comorbidity of Anxiety and Depression in Children and Adolescents : 20 Years After. Psychol Bull 2014 ; 140 (3) : 816-845.
 
30) Silove D, et al. Pediatric-Onset and Adult-Onset Separation Anxiety Disorder Across Countries in the World Mental Health Survey. Am J Psychiatry 2015 ; 172 (7) : 647-656.
PubMed
31) Silove D, et al. The prevalence and correlates of adult separation anxiety disorder in an anxiety clinic. BMC Psychiatry 2010 ; 10 : 21.
 
32) Pini S, et al. Frequency and clinical correlates of adult separation anxiety in a sample of 508 outpatients with mood and anxiety disorders. Acta Psychiatr Scand 2010 ; 122 (1) : 40-46.
 
33) Miniati M, et al. Predictors of response among patients with panic disorder treated with medications in a naturalistic follow-up : The role of adult separation anxiety. J Affect Disord 2012 ; 136 : 675-679.
 
34) Tasdemir A, et al. Assessment of co-morbidity of adult separation anxiety in patients with bipolar disorder. Nord J Psychiatry 2016 ; 70 (2) : 93-102.
PubMed
35) Vanderwerker LC, et al. An exploration of associations between separation anxiety in childhood and complicated grief in later life. J Nerv Ment Dis 2006 ; 194 (2) : 121-123.
 
36) Silove D, et al. Brief report--associations of personality disorder with early separation anxiety in patients with adult separation anxiety disorder. J Pers Disord 2011 ; 25 (1) : 128-133.
PubMed
37) J. ボウルビィ. 黒田実郎ほか (訳). II 分離不安. 母子関係の理論 (1) 新版. 岩崎学術出版社 ; 1991.
 
38) 木部則雄. 子どもの精神分析 II-クライン派による現代の子どもへのアプローチ. 岩崎学術出版社 ; 2012.
 
39) Connolly SD, Bernstein GA. Work Group on Quality Issues. Practice Parameter for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders. J Am Acad Child Adolesc Psychiatry 2007 ; 46 (2) : 267-283.
 
40) Spence SH. 石川信一 (日本語版作成). 日本語版SCAS (Spence Children's Anxiety Scale) スペンス児童用不安尺度 使用手引. 三京房 ; 2015.
 
41) Wehry AM, et al. Assessment and Treatment of Anxiety Disorders in Children and Adolescent. Curr Psychiatry Rep 2015 ; 17 (7) : 591.
 
42) March JS, et al. The Multidimensional Anxiety Scale for Children (MASC) : Factor Structure, Reliability, and Validity. Am Acad Child Adolesc Psychiatry 1997 ; 36 (4) : 554-565.
PubMed
43) 安藤美華代. 日本語版Multidimensional Anxiety Scale for Childrenの信頼性・妥当性に関する検討. 岡山大学大学院教育学研究科研究集録 2008 ; 139 : 35-42.
 
44) March JS. Test Review : Multidimensional Anxiety Scale for Children. Can J Sch Psychol 2013 ; 30 (1) : 70-77.
 
45) Craske M, et al. Severity Measure for Separation Anxiety Disorder － Child Age 11-17. American Psychiatric Association Online Assessment Measures 2013. https://www.psychiatry.org/psychiatrists/practice/dsm/educational-resources/assessment-measures
 
46) Brown TA, Barlow DH. Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS-5) -Adult Version. Oxford University Press ; 2014.
 
47) Manicavasagar V, et al. A Self-Report Questionnaire for Measuring Separation Anxiety in Adulthood. Compr Psychiatry 2003 ; 44 (2) : 146-153.
PubMed
48) Finsaas MC, et al. Psychometric analysis of the adult separation anxiety symptom questionnaire : Item functioning and invariance across gender and time. Psychol Assess 2020 ; 32 (6) : 582-593.
PubMed
49) Craske M, et al. Severity Measure for Separation Anxiety Disorder－Adult. American Psychiatric Association Online Assessment Measures 2013. https://www.psychiatry.org/psychiatrists/practice/dsm/educational-resources/assessment-measures
 
50) 石川信一. 日本における子どもの不安症に対する認知行動療法. 不安症研究 2017 ; 9 (1) : 57-64.
 
51) Mohr C. Schneider S. Intensive Treatments for Separation Anxiety Disorder in Children and Adolescents. Psychopathology Review 2014 ; 1 (1) : 201-208.
 
52) Schneider S, et al. Disorder-Specific Cognitive-Behavioral Therapy for Separation Anxiety Disorder in Young Children : A Randomized Waiting-List-Controlled Trial. Psychother Psychosom 2011 ; 80 : 206-215.
PubMed
53) Schneider S, et al. The Efficacy of a Family-Based Cognitive-Behavioral Treatment for Separation Anxiety Disorder in Children Aged 8-13 : A Randomized Comparison With a General Anxiety Program. J Consult Clin Psychol 2013 ; 81 (5) : 932-940.
 
54) Lavallee K, et al. Transgenerational improvements following child anxiety treatment : An exploratory examination. PLoS One 2019 ; 14 (2) : e0212667. https://doi.org/10.1371/journal
 
55) Pincus DB, et al. The Implementation of Modified Parent-Child Interaction Therapy for Youth with Separation Anxiety Disorder. Cogn Behav Pract 2008 ; 15 : 118-125.
 
56) Lieneman CC, et al. Parent-Child Interaction Therapy : Current perspective. Psychol Res Behav Manag 2017 ; 10 : 239-256.
PubMed
57) 小俣和義. 同一治療者による母子並行面接の意味-分離不安を呈した小学生女児とその母親に対する面接の過程を通して. 心理臨床学研究 1997 ; 15 (1) : 46-57.
 
58) 荻原はるみ, 長坂正文. 分離不安をかかえた不登校男児の遊戯療法-箱庭表現と治療構造に注目して. 箱庭療法学研究 2013 ; 25 (3) : 53-64.
 
59) 山元麻由美. 分離不安傾向のある女児との箱庭療法過程-宝物と共に成長していくこと. 箱庭療法学研究 2013 ; 24 (2) : 53-66.
 
60) Milrod B, et al. Adult separation anxiety in treatment nonresponders with anxiety disorders : Delineation of the syndrome and exploration of attachment-based psychotherapy and biomarkers. Compr Psychiatry 2016 ; 66 : 139-145.
PubMed
61) 南里幸一郎. 治療の「中断」が分離不安のwork throughにもたらすもの. 精神分析研究 1997 ; 41 (4) : 400-402.
 
62) 渡部京太. 不安症の薬物治療. 中村和彦 (編), 児童・青年期精神疾患の薬物治療ガイドライン. じほう ; 2018, pp113-124.
 
63) Franklin R, et al. A randomized controlled pilot trial of vilazodone for adult separation anxiety disorder. Depress Anxiety 2017 ; 34 : 1085-1095.
 
Milrod B, et al. Childhood separation anxiety and the pathogenesis and treatment of adult anxiety. Am J Psychiatry 2014 ; 171 (1) : 34-43.
PubMed
渡部京太. 分離不安障害. 臨床精神医学 2016 ; 45 : 211-215.
 
P.105 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition. American Psychiatric Association ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
2) Carlson JS, et al. Prevalence and treatment of selective mutism in clinical practice : A survey of child and adolescent psychiatrists. J Child Adolesc Psychopharmacol 1994 ; 4 (4) : 281-291.
 
3) Steinhausen HC, Juzi C. Elective mutism : An analysis of 100 cases. J Am Acad Child Adolesc Psychiatry 1996 ; 35 (5) : 606-614.
 
4) Kumpulainen K, et al. Selective mutism among second-graders in elementary school. Eur Child Adolesc Psychiatry 1998 ; 7 (1) : 24-29.
PubMed
5) Sharkey L, McNicholas F. Selective mutism : A prevalence study of primary school children in the Republic of Ireland. Ir J Psychol Med 2012 ; 29 : 36-40.
PubMed
6) Bergman RL, et al. Prevalence and description of selective mutism in a school-based sample. J Am Acad Child Adolesc Psychiatry 2002 ; 41 : 938-946.
 
7) Elizur Y, Perednik R. Prevalence and description of selective mutism in immigrant and native families : A controlled study. J Am Acad Child Adolesc Psychiatry 2003 ; 42 : 1451-1459.
PubMed
8) Karakaya I, et al. Selective mutism : A school-based crosssectional study from Turkey. Eur Child Adolesc Psychiatry 2008 ; 17 : 114-117.
PubMed
9) 久田信行ほか. 場面緘黙 (選択性緘黙) の多様性-その臨床と教育. 不安症研究 2016 ; 8 (1) : 31-45.
 
10) Alexandra H, Nili M. Selective Mutism. Curr Opin Pediatr 2016 ; 28 (1) : 114-120.
 
11) Kussmaul A. Die Storungen der sprache : versuch einer pathologie der sprache. Verlag von F. C. W. Vogel ; 1877.
 
12) Tramer M. Elektiver mutismus bei kindern. Z Kinderpsychiatr 1934 ; 1 : 30-35.
 
13) 矢澤久史. 場面緘黙児に関する研究の展開. 東海学院大学紀要 2008 ; (2) : 179-187.
 
14) McHolm E, et al. Helping your child with selective mutism : Practical steps to overcome a fear of speaking. New Harbinger Publications ; 2005.
 
15) Robin G. Les troubles nerveux et psychiques de l'enfant. guide pratique de de'pistage et d'orientation e'ducative. Nathan ; 1935/吉倉範光 (訳). 異常児-その鑑別と保導. 白水社 ; 1940.
 
16) かんもくネット 場面緘黙とは. http://kanmoku.org/kanmokutoha.html
 
17) 久田信行ほか. Selective mutismの訳語は「選択性緘黙」か「場面緘黙」か? 不安症研究 2014 ; 6 (1) : 4-6.
 
18) 根來秀樹, 大西貴子. 場面緘黙 (選択性かん黙). 臨床精神医学 2011 ; 40 (増刊) : 371-373.
Medical*Online
19) 河井芳文, 河井英子. 場面緘黙児の心理と指導. 田研出版 ; 1994.
 
20) かんもくネット 場面緘黙質問票 (SMQ-R). http://kanmoku.org/SMQ-R.pdf
 
21) Gensthaler A, et al. Evaluation of a novel parent-rated scale for selective mutism. Assessment 2020 ; 27 (5) : 1007-1015.
PubMed
22) Black B, Uhde TW. Psychiatric Characteristics of Children With Selective Mutism : A Pilot Study. J Am Acad Child Adolesc Psychiatry 1995 ; 34 (7) : 847-856.
PubMed
23) Kristensen H. Selective Mutism and Comorbidity With Developmental Disorder/Delay, Anxiety Disorder, and Elimination Disorder. J Am Acad Child Adolesc Psychiatry 2000 ; 39 (2) : 249-256.
PubMed
24) Giddan JJ, et al. Selective Mutism in Elementary School : Multidisciplinary Interventions. Lang Speech Hear Serv Sch 1997 ; 28 (2), 127-133.
 
25) Dummit ES, et al. Systematic Assessment of 50 Children With Selective Mutism. J Am Acad Child Adolesc Psychiatry 1997 ; 36 (5) : 653-660.
PubMed
26) Cohan SL, et al. Refining the classification of children with selective mutism : A latent profile analysis. J Clin Child Adolesc Psychol 2008 ; 37 : 770-784.
PubMed
27) Mulligan CA, et al. Selective mutism : Identification of subtypes and implications for treatment. J Educ Hum Dev 2015 ; 4 : 79-96.
 
28) Tancer NK. Elective mutism : A review of the literature. In : Lahey BB, et al (eds). Advances clinical child psychology and psychiatry. Springer ; 1992, pp265-288.
 
29) 高木潤野 (研究代表者). 縦断的調査による場面緘黙の実態解明と効果的な介入手法の確立 (JSPS科研費 JP19H01703).
 
30) Manassis K, et al. The sounds of silence : Language, cognition, and anxiety in selective mutism. J Am Acad Child Adolesc Psychiatry 2007 ; 46 (9) : 1187-1195.
PubMed
31) Gensthaler A, et al. Selective mutism : The fraternal twin of childhood social phobia. Psychopathology 2016 ; 49 (2) : 95-107.
PubMed
32) Chavira DA, et al. Selective mutism and social anxiety disorder : All in the family? J Am Acad Child Adolesc Psychiatry 2007 ; 46 (11) : 1464-1472.
PubMed
33) Bergman RL, et al. Integrated behavior therapy for selective mutism : A randomized controlled pilot study. Behav Res Ther 2013 ; 51 (10) : 680-689.
PubMed
34) Muris P, et al. Children Who Are Anxious in Silence : A Review on Selective Mutism, the New Anxiety Disorder in DSM-5. Clin Child Fam Psychol Rev 2015 ; 18 (2) : 151-169.
PubMed
35) Steinhausen HC, et al. A long-term outcome study of selective mutism in childfood. J Child Psychol Psychiatry 2006 ; 47 : 751-756.
 
36) Driessen J, et al. Anxiety in Children with Selective Mutism : A Meta-analysis. Child Psychiatry Hum Dev 2020 ; 51 : 330-341.
PubMed
37) Biederman J, et al. Further Evidence of Association Between Behavioral Inhibition and Social Anxiety in Children. Am J Psychiatry 2001 ; 158 (10) : 1673-1679.
PubMed
38) Hirshfeld-Becker DR, et al. Behavioral inhibition in preschool children at risk is a specific predictor of middle childhood social anxiety : A five-year follow-up. J Dev Behav Pediatr 2007 ; 28 (3) : 225-233.
PubMed
39) Toppelberg CO, et al. Differential Diagnosis of Selective Mutism in Bilingual Children. J Am Acad Child Adolesc Psychiatry 2005 ; 44 (6) : 592-595.
 
40) Remschmid H, et al. A Follow-Up Study of 45 Patients With Elective Mutism. Eur Arch Psychiatry Clin Neurosci 2001 ; 251 (6) : 284-296.
 
41) Oerbeck B, et al. A randomized controlled trial of a home and school-based intervention for selective mutism-Defocused communication and behavioural techniques. Child Adolesc Ment Health 2013 ; 19 : 192-198.
 
42) Sharkey L, Nicholas F. Female monozygotic twins with selective mutism : A case report. J Dev Behav Pediatr 2006 ; 27 : 129-133.
 
43) Tachibana R, et al. Elective mutism in twins. Japanese Journal of Child and Adolescent Psychiatry 1982 ; 23 : 277-286.
 
44) Stein MB, et al. A Common Genetic Variant in the Neurexin Superfamily Member CNTNAP2 Is Associated With Increased Risk for Selective Mutism and Social Anxiety-Related Traits. Biol Psychiatry 2011 ; 69 (9) : 825-831.
PubMed
45) Stein MB, et al. A Polymorphism of the beta1-adrenergic Receptor Is Associated With Low Extraversion. Biol Psychiatry 2004 ; 56 (4) : 217-224.
PubMed
46) Stein MB, et al. COMT Polymorphisms and Anxiety-Related Personality Traits. Neuropsychopharmacology 2005 ; 30 (11) : 2092-2102.
PubMed
47) 塩入俊樹. 社交不安障害の神経生物学的検討-Fear-circuitry disfunction の観点から. 臨床精神薬理 2010 ; 13 : 711-721.
 
48) Klein ER, et al. Assessing Spoken Language Competence in Children With Selective Mutism : Using Parents as Test Presenters. Commun Disord Q 2012 ; 34 : 184-195.
 
49) Muchnik C, et al. Abnormalities in Auditory Efferent Activities in Children With Selective Mutism. Audiol Neurootol 2013 ; 18 (6) : 353-361.
PubMed
50) Carbone D, et al. Behavioral and Socio-Emotional Functioning in Children With Selective Mutism : A Comparison With Anxious and Typically Developing Children Across Multiple Informants. J Abnorm Child Psychol 2010 ; 38 (8) : 1057-1067.
PubMed
51) Kolvin I, Fundudis T. Elective mute children : Psychological development and background factors. J Child Psychol Psychiatry 1981 ; 22 (3) : 219-232.
PubMed
52) James A, et al. Cognitive Behavioural Therapy for Anxiety Disorders in Children and Adolescents. Cochrane Database Syst Rev 2005 ; (4).
 
53) Cohan SL, et al. Practitioner Review : Psychosocial Interventions for Children With Selective Mutism : A Critical Evaluation of the Literature From 1990-2005. J Child Psychol Psychiatry 2006 ; 47 (11) : 1085-1097.
PubMed
54) Ostergaard KR. Treatment of selective mutism based on cognitive behavioural therapy, psychopharmacology and combination therapy-A systematic review. Nord J Psychiatry 2018 ; 72 (4) : 240-250.
PubMed
55) Oerbeck B, et al. Selective Mutism : Follow-Up Study 1 Year After End of Treatment. Eur Child Adolesc Psychiatry 2015 ; 24 (7) : 757-766.
PubMed
56) Black B, Uhde TW. Treatment of Elective Mutism With Fluoxetine : A Double-Blind, Placebo-Controlled Study. J Am Acad Child Adolesc Psychiatry 1994 ; 33 (7) : 1000-1006.
PubMed
57) Dummit ES III, et al. Fluoxetine Treatment of Children With Selective Mutism : An Open Trial. J Am Acad Child Adolesc Psychiatry 1996 ; 35 (5) : 615-621.
 
58) Manassis K, et al. SSRIs in a Case of Selective Mutism. J Psychiatry Neurosci 2013 ; 38 (1) : E1-2.
 
59) Manassis K, Tannock R. Comparing Interventions for Selective Mutism : A Pilot Study. Can J Psychiatry 2008 ; 53 (10) : 700-703.
PubMed
60) 高木潤野. 場面緘黙当事者・経験者から見た「場面緘黙」-「大人のかんもくフォーラム」シンポジウムの記録から. 長野大学紀要 2018 ; 40 (1) : 27-47.
 
61) 金原洋治. 開業小児科医を受診した選択性緘黙の臨床像と短期予後の検討. 子どもの心とからだ 日本小児心身医学会雑誌 2018 ; 27 (1) : 54-58.
Medical*Online
金原洋治, 高木潤野. イラストでわかる子どもの場面緘黙サポートガイド-アセスメントと早期対応のための50の指針. 合同出版 ; 2018.
 
金原洋治 (監修), はやしみこ (著). どうして声が出ないの? -マンガでわかる場面緘黙. 学苑社 ; 2013.
 
らせんゆむ (著), かんもくネット (解説). 私はかんもくガール. 合同出版 ; 2015.
 
P.119 掲載の参考文献
1) ICD-11 for Mortality and Morbidity Statistics (Version : 04/2019) https://icd.who.int/browse11/l-m/en
 
2) American Psychiatric association. Diagnostic and Statistical Manual of Mental Disorders. 5th edition (DSM-5). American Psychiatric Publishing ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
3) American Psychiatric association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text revision (DSM-IV-TR). American Psychiatric Publishing ; 2000/高橋三郎ほか (訳). DSM-IV-TR 精神疾患の診断・統計マニュアル, 新訂版. 医学書院 ; 2004.
 
4) 融道男ほか (監訳). ICD-10 精神および行動の障害臨床記述と診断ガイドライン. 医学書院 ; 1993.
 
5) American Psychiatric association. Quick Reference to the Diagnostic Criteria from DSM-III-R. American Psychiatric Publishing ; 1987/高橋三郎ほか (訳). DSM-III-R 精神障害の診断の手引, 第2版. 医学書院 ; 1988.
 
6) Fardet L, et al. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry 2012 ; 169 : 491-497.
PubMed
P.125 掲載の参考文献
1) 森田正馬. 神経質の本態及療法. <森田正馬全集> 第2巻. 白揚社 ; 1928/1974, pp279-393.
 
2) 森田正馬. 神経衰弱及強迫観念の根治法. <森田正馬全集> 第2巻. 白揚社 ; 1926/1974, pp67-278.
 
3) 中村敬. 森田療法. 岩崎徹也ほか (編). <臨床精神医学講座> 15. 精神療法. 中山書店 ; 1999, pp117-134.
 
4) 中村敬. 不安障害の森田療法 1) パニック障害・広場恐怖と全般性不安障害. 精神科治療学 2011 ; 26 (増刊号) : 89-93.
 
5) 森田正馬. 恋愛の心理. <森田正馬全集> 第7巻. 白揚社 ; 1924/1975, pp23-183.
 
6) 中村敬. 不安の薬と精神療法-主体の経験を視座にして. 精神経誌 2004 ; 106 : 582-586.
 
7) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, Fifth Edition. American Psychiatric Publishing ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
8) Akiskal HS. Toward a definition of generalized anxiety disorder as an anxious temperament type. Acta Psychiatr Scand 1998 ; Suppl. 393 : 66-73.
 
9) 中村敬. 社会不安障害 (対人恐怖症) の森田療法. 精神経誌 2006 ; 108 : 754-759.
 
10) 中村敬. 神経質理論・再考-「生の欲望」と「思想の矛盾」に着目して. 日本森田療法学会雑誌 2020 ; 31 : 15-19.
 
中村敬. パニック障害の初診面接 診断から初期治療へ. 日本精神神経学会 精神療法委員会 (編), エキスパートに学ぶ精神科初診面接. 医学書院 ; 2018, pp72-88.
 
中村敬. 不安症群の患者に対する精神療法的アプローチ. 中村敬 (編), 日常診療における精神療法-10分間で何ができるか. 星和書店 ; 2016, pp85-97.
 
北西憲二, 中村敬 (編). 森田療法で読む社会不安障害とひきこもり. 白揚社 ; 2007.
 

2章 強迫症または関連症群

P.137 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition. APA ; 1980.
 
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision. APA ; 2000.
PubMed
3) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5). APA ; 2013.
 
4) 多賀千明. 歴史的展望と診断. 上島国利ほか (編), エキスパートによる強迫性障害 (OCD) 治療ブック. 星和書店 ; 2010, pp1-8.
 
5) Freud S. Hemmung, symptom, und angst. International Psychoanalytischer Verlag ; 1926/加藤正明 (訳), 制止, 症状, 不安. 選集 10. 日本教文社 ; 1966, pp241-306.
 
6) 森田正馬. 神経質及本態ト療法. <呉秀三教授在職25周年記念論文集> 第2巻. 1921.
 
7) 高橋徹. 神経症と不安障害の概念と歴史的展望. 松下正明ほか (編), <臨床精神医学講座> 5. 神経症性障害, ストレス関連障害. 中山書店 ; 1997, pp3-13.
 
8) Fernandez-Cordoba E, Lopez-Ibor Alino J. Clomipramine in psychiatric patients resistant to other treatments. Actas Luso-Espanolas de Neurologia y Psychiatria 1967 ; 26 : 119-147.
 
9) Renynghe de Voxrie GV. Anafranil (G-34586) in obsessive neurosis. Acta Neurol Belg 1968 ; 68 : 787-792.
 
10) DeVeaugh-Geiss J, Katz R. Clomipramine in the treatment of obsessive- compulsive disorder. In : Goodman WK, et al (eds). Obsessive-Compulsive Disorder : Contemporary Issues in Treatment. Lawrence Erlbaum Associates ; 2000, pp315-332.
 
11) Marks IM, et al. Clomipranine and exposure for obsessive compulsive rituals. Br J Psychiatry 1980 ; 138 : 1-25.
 
12) Montgomery SA. Clomipramine in obsessional neurosis : A placebo-controlled trial. Pharmaceut Med 1980 ; 1 : 189-192.
 
13) Thoren P, et al. Clomipramine treatment of obsessive-compulsive disorder. 1. A controlled clinical trial. Arch Gen Psychiatry 1980 ; 17 : 1281-1285.
 
14) Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with OCD. Arch Gen Psychiatry 1991 ; 48 : 730-738.
 
15) Greist JH, et al. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. Arch Gen Psychiatry 1995 ; 52 : 53-60.
PubMed
16) Eysenck HJ. Learning theory and behavior therapy. J Ment Sci 1959 ; 105 : 61-75.
PubMed
17) Wolpe J. Psychotherapy by Reciprocal inhibition. Stanford University Press ; 1958.
 
18) Meyer V. Modification of expectations in cases of obsessional rituals. Behav Res Ther 1966 ; 4 : 273-280.
PubMed
19) Rachman S, et al. The treatment of chronic obsessive-compulsive neurosis. Behav Res Ther 1971 ; 9 : 237-247.
PubMed
20) Foa EB, Goldstein A. Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis. Behav Ther 1978 ; 9 : 821-829.
 
21) Feighner JP, et al. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972 ; 26 : 57-63.
PubMed
22) Spitzer RL, et al. Research Diagnostic Criteria (RDC) for a selected group of functional disorders. Biometric Research Department, New York State Psychiatric Institute ; 1978.
 
23) Rudin E. Ein Bertrag zur Frage der Zwangskrankheit insebesondere inhere hereditaren Beziehungen. Arch Psychiatr Nervenkr 1953 ; 191 : 14-54.
 
24) Stroll AL, et al. Increasing frequency of the diagnosis of obsessive-compulsive disorder. Am J Psychiatry 1992 ; 149 : 638-640.
 
25) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised. APA ; 1987.
 
26) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. APA ; 1994.
 
27) 松永寿人. 強迫性障害の現在とこれから-DSM-5に向けた今後の動向をふまえて. 精神経誌 2012 ; 114 : 1023-1030.
 
28) 松永寿人ほか. 典型例を知る-強迫性障害. 精神科治療学 2012 ; 27 : 929-934.
 
29) Milad MR, Rauch SL. Obsessive-compulsive disorder : Beyond segregated cortico-striatal pathways. Trends in Cognitive Sciences 2012 ; 16 : 43-51.
PubMed
30) World Health Organization. The ICD-10 classification of mental and behavioral disorders. WHO ; 1992/融道男ほか (監訳). ICD-10 精神および行動の障害. 医学書院 ; 1992.
 
31) 松永寿人. 強迫症の診断概念, そして中核病理に関するパラダイムシフト-神経症, あるいは不安障害から強迫スペクトラムへ. 不安症研究 2015 ; 6 (2) : 86-99.
 
32) Bartz JA, Hollander E. Is obsessive-compulsive disorder an anxiety disorder? Prog Neuropsychopharmacol Biol Psychiatry 2006 ; 30 : 338-352.
PubMed
33) Phillips KA, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety 2010 ; 27 : 528-555.
PubMed
34) Hollander E, et al. Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders : Diagnostic and dimensional issues. CNS Spectr 2007 ; 12 (suppl 3) : 5-13.
 
35) 松永寿人, 林田和久. 強迫スペクトラム障害の概念とその病態, 最新の動向. 臨床精神薬理 2011 ; 14 : 1025-1031.
 
36) Stein DJ, Hollander E. The spectrum of obsessive-compulsive related disorders. In : Hollander E (ed). Obsessive-Compulsive Related Disorders. American Psychiatric Press ; 1993.
 
37) Bloch MH, et al. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 2008 ; 165 : 1532-1542.
PubMed
38) Mataix-Cols D, et al. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005 ; 162 : 228-238.
PubMed
39) Mataix-Cols D, et al. Hording disorder : A new diagnosis for DSM-V? Depress Anxiety 2010 ; 27 : 556-572.
 
40) Feusner JD, et al. Olfactory reference syndrome : Issues for DSM-V. Depress Anxiety 2010 ; 27 : 592-599.
PubMed
41) Veale D, Matsunaga H. Body Dysmorphic Disorder and Olfactory Reference Disorder : Proposals for ICD-11. Braz J Psychiatry (Rev Bras Psiquiatr) 2014 ; 36 (suppl 1) : 14-20.
 
42) 小林伸行ほか. 排ガス (おなら) 臭を主訴とする自己臭症に過敏性腸症候群が高率に併発する. 心身医 2015 ; 55 : 1380-1385.
Medical*Online
43) Stein DJ, et al. Trichotillomania (hair pulling disorder), skin picking disorder and stereotypic movement disorder : Toward DSM-V. Depress Anxiety 2010 ; 27 : 611-626.
PubMed
44) Stein DJ, et al. The classification of Obsessive-Compulsive and Related Disorders in the ICD-11. J Affect Disord 2016 ; 190 : 663-674.
PubMed
45) 松永寿人. 身体表現性障害 (身体症状症) におけるこだわり. 臨床精神医学 2017 ; 46 (8) : 1001-1007.
Medical*Online
46) Katz J, et al. Chronic pain, psychopathology, and DSM-5 somatic symptom disorder. Can J Psychiatry 2015 ; 60 : 160-167.
PubMed
47) Tsang A, et al. Common chronic pain conditions in developed and developing countries : Gender and age differences and comorbidity with depression-anxiety disorders. J Pain 2008 ; 9 : 883-891.
PubMed
48) Stein DJ. Hypochondriasis in ICD-11. World Psychiatry 2012 ; 11 (suppl 1) : 100-104.
 
49) Brewer JA, Potenza MN. The neurobiology and genetics of impulsive control disorders ; relationships to drug addictions. Biochem Pharmacol 2008 ; 75 : 63-75.
PubMed
50) Torregrossa MM, et al. Impulsivity, compulsivity, and habit : The role of orbitofrontal cortex revisited. Biol Psychiatry 2008 ; 63 : 253-255.
PubMed
51) 松永寿人ほか. 皮膚科専門医が知っておきたい強迫症および関連症. 片岡葉子 (編), <MB Derma> 301. こころと皮膚. 全日本病院出版会 ; 2020.
 
Hollander E, et al. Obsessive-Compulsive Spectrum Disorders : Refining the Research Agenda for DSM-V. AM PSYCHIATRIC ASSOCIATION PUB ; 2011.
 
Kogan CS, et al. Accuracy of diagnostic judgments using ICD-11 vs. ICD-10 diagnostic guidelines for obsessive-compulsive and related disorders. J Affect Disord 2020 ; 273 : 328-340.
PubMed
松永寿人. 強迫症および関連症群/強迫性障害および関連障害群 ; 診断と概念の変遷. 三村將 (編), DSM-5を読み解く 4. 不安症群, 強迫症および関連症群, 心的外傷およびストレス因関連障害群, 解離症群, 身体症状症および関連症群. 中山書店 ; 2014, pp82-94.
 
P.152 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition. American Psychiatric Association ; 1980.
 
2) Freud S. Hemmung, symptom, und angst. International Psychoanalytischer Verlag ; 1926/加藤正明 (訳). 制止, 症状, 不安. <フロイド選集> 10. 不安の問題. 日本教文社 ; 1966, pp241-306.
 
3) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text revision. American Psychiatric Association ; 2000.
 
4) Bartz JA, Hollander E. Is obsessive-compulsive disorder an anxiety disorder? Prog Neuropsychopharmacol Biol Psychiatry 2006 ; 30 ; 338-352.
PubMed
5) 松永寿人. 強迫性障害の現在とこれから-DSM-5に向けた今後の動向をふまえて. 精神経誌 2012 ; 114 : 1023-1030.
 
6) 松永寿人. 強迫症の診断概念, そして中核病理に関するパラダイムシフト-神経症, あるいは不安障害から強迫スペクトラムへ. 不安症研究 2015 ; 6 (2) : 86-99.
 
7) Hollander E, et al. Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders ; diagnostic and dimensional issues. CNS Spectr 2007 ; 12 (suppl 3) : 5-13.
 
8) Phillips KA, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety 2010 ; 27 : 528-555.
PubMed
9) Stein DJ, Hollander E. The spectrum of obsessive-compulsive-related disorders. In : Hollander E (ed). American Psychiatric Press ; 1993.
 
10) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5). American Psychiatric Association ; 2013.
 
11) Stein DJ, et al. The classification of Obsessive-Compulsive and Related Disorders in the ICD-11 J Affect Disord 2016 ; 190 : 663-674.
PubMed
12) 松永寿人ほか. 平成から令和へ, 強迫症の疾患概念における変遷. 臨床精神医学 2020 ; 49 (2) : 247-254.
Medical*Online
13) Stein DJ, et al. Obsessive-compulsive disorder. Nat Rev Dis Primers 2019 ; 5 : 52.
PubMed
14) Dell'osso B, Altamura AC. Duration of untreated psychosis and duration of untreated illness : New vistas. CNS Spectr 2010 ; 15 : 238-246.
PubMed
15) Nakajima A, et al. Ten-year follow-up study of Japanese patients with obsessive-compulsive disorder. Psychiatr Clin Neurosci 2018 ; 72 : 502-512.
 
16) 松永寿人ほか. 強迫症状やコモビディテイ (comorbidity) の特徴と臨床的意義-symptom dimensionを含めて. 精神科治療学 2017 ; 32 (3) : 301-307.
 
17) 松永寿人. 強迫症におけるストレス-その臨床的意義と治療を中心に. 臨床精神薬理 2018 ; 21 (4) : 497-504.
 
18) Stein DJ. Obsessive-compulsive disorder. Lancet 2002 ; 360 : 397-405.
PubMed
19) Baxter LR, et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987 ; 44 : 211-218.
PubMed
20) Whiteside SP, et al. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 2004 ; 132 : 69-79.
PubMed
21) Menzies L, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder : The orbitofronto-striatal model revisited. Neurosci Biobehav Rev 2008 ; 32 : 525-549.
PubMed
22) Saxena S, et al. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry 1998 ; 173 : 26-37.
 
23) Milad MR, Rauch SL. Obsessive-compulsive disorder : Beyond segregated cortico-striatal pathways. Trends Cogn Sci 2012 ; 16 : 43-51.
PubMed
24) World Health Organization. ICD-11 for Mortality and Morbidity Statistics. (Version : 04/2019). https://icd.who.int/browse11/l-m/en
 
25) Matsunaga H, et al. Personality disorders in patients with obsessive compulsive disorder in Japan. Acta Psychiatr Scand 1998 ; 98 : 128-134.
PubMed
26) Goodman W, et al. The Yale-Brown Obsessive-Compulsive Scale, I : Development, use, and reliability. Arch Gen Psychiatry 1989 ; 46 : 1006-1011.
PubMed
27) Goodman W, et al. The Yale-Brown Obsessive-Compulsive Scale, II : Validity. Arch Gen Psychiatry 1989 ; 46 : 1012-1016.
PubMed
28) Mataix-Cols D, et al. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005 ; 162 : 228-238.
PubMed
29) Matsunaga H, et al. Symptom Structure in Japanese Patients with Obsessive-Compulsive Disorder. Am J Psychiatry 2008 ; 165 : 251-253.
PubMed
30) Bloch MH, et al. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 2008 ; 165 : 1532-1542.
PubMed
31) Pauls DL, et al. Obsessive-compulsive disorder : An integrative genetic and neurobiological perspective. Nat Rev Neurosci 2014 ; 15 : 410-424.
PubMed
32) 松永寿人. 強迫スペクトラム障害における強迫とこだわり-強迫性 (compulsivity) の観点から. 日本精神科診断学雑誌 2018 ; 11 (1) : 39-48.
 
33) Ferrao YA, et al. Sensory phenomena associated with repetitive behaviors in obsessive-compulsive disorder : An exploratory study of 1001 patients. Psychiatry Res 2012 ; 197 : 253-258.
PubMed
34) 金生由紀子. チック障害との関連によるOCDの検討. 精神経誌 2009 ; 111 : 810-815.
 
35) 本田慎一, 中尾智博. 強迫性障害の神経基盤. 臨床精神医学 2015 ; 44 : 1457-1465.
Medical*Online
36) 多賀千明. 歴史的展望と診断. 上島国利ほか (編), エキスパートによる強迫性障害 (OCD) 治療ブック. 星和書店 ; 2010, pp1-8.
 
37) World Health Organization. The ICD-10 classification of mental and behavioral disorders. World Health Organization ; 1992/融道男ほか (監訳). ICD-10 精神および行動の障害. 医学書院 ; 1993.
 
38) Matsunaga H, Seedat S. Obsessive-Compulsive Spectrum Disorders : Cross-National and Ethnic Issues. CNS Spectr 2007 ; 12 : 392-400.
PubMed
39) Diniz JB, et al. Impact of age at onset and duration of illness on the expression of comorbidities in obsessive-compulsive disorder. J Clin Psychiatry 2004 ; 65 : 22-27.
PubMed
40) 有川綾子ほか. 強迫関連症 (Obsessive-compulsive and related disorders ; OCRD) を複数併存していた一例. 精神経誌 2015 ; 117 (11) : 893-901.
 
41) Brakoulias V, et al. The rates of co-occurring behavioural addictions in treatment-seeking individuals with obsessive-compulsive disorder : A preliminary report. Int J Psychiatr Clin Pract 2020 ; 24 : 173-175.
 
42) Bejerot S. An autistic dimension : A proposed subtype of obsessive-compulsive disorder. Autism 2007 ; 11 : 101-111.
PubMed
43) Ivarsson T, Melin K. Autism spectrum traits in children and adolescents with obsessive-compulsive disorder (OCD). J Anxiety Disord 2008 ; 22 : 969-978.
PubMed
44) Mito H, et al. The Impacts of Elevated Autism Spectrum Disorder Traits on Clinical and Psychosocial Features and Long-Term Treatment Outcome in Adult Patients with Obsessive-Compulsive Disorder. Compr Psychiatry 2014 ; 55 : 1526-1533.
PubMed
45) Denys D, et al. Axis I and II comorbidity in a large sample of patients with obsessive-compulsive disorder. J Affect Disord 2004 ; 80 (2-3) : 155-162.
 
46) Lasalle VH, et al. Diagnostic interview assessed neuropsychiatric disorder comorbidity in 334 individuals with obsessive-compulsive disorder. Depress Anxiety 2004 ; 19 : 163-173.
 
47) Bloch MH, et al. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 2006 ; 160 : 65-69.
PubMed
48) Koran LM, et al. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007 ; 164 (suppl) : 1-56.
 
49) 松永寿人. 強迫症 (OCD) に対する薬物療法の意義と限界, そして最適化に必要なこと-OCD患者の横断的・縦断的特性に関する多様性を中心に. 精神神経学雑誌 2018 ; 120 (3) : 186-194.
 
50) Yanagisawa Y, et al. Clinically related or predictive factors and impacts on long-term treatment outcomes of involvement behaviors in patients with obsessive-compulsive disorder. Compr Psychiatry 2015 ; 60 : 105-113.
 
51) Matsunaga H, et al. A long-term effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. J Clin Psychiatry 2009 ; 70 : 863-868.
PubMed
52) Skapinakis P, et al. Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults : A systematic review and network meta-analysis. Lancet Psychiatry 2016 ; 3 : 730-739.
PubMed
53) Zhou DDa, et al. Augmentation agents to serotonin reuptake inhibitors for treatment resistant obsessive-compulsive disorder : A network meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2019 ; 90 : 277-287.
 
54) Katzman MA, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry 2014 ; 14 (Suppl 1) : S1.
 
55) Laoutidis ZG, et al. Glutamatergic Agents as Add-On Medication for the Treatment of Obsessive-Compulsive Disorder : A Systematic Review and Meta-Analysis. J Clin Psychiatry 2016 ; 77 (12) : e1576-e1583.
PubMed
56) 吉田賀一, 松永寿人. 強迫症への認知行動療法とその技法の適用. 最新精神医学 2018 ; 23 (2) : 97-104.
Medical*Online
57) Karas PJ, et al. Deep Brain Stimulation for Obsessive Compulsive Disorder : Evolution of Surgical Stimulation Target Parallels Changing Model of Dysfunctional Brain Circuits. Front Neurosci 2019 ; 12 : 998.
PubMed
58) Lusicic A, et al. Transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder : Current perspectives. Neuropsychiatr Dis Treat 2018 ; 14 : 1721-1736.
PubMed
59) Pasquini M, et al. Editorial : Advances in biological approaches to treating resistant/refractory obsessive-compulsive and related Disorders. Front Psychiatry 2020 ; 11 : 93.
PubMed
60) Rachid F. Transcranial direct current stimulation for the treatment of obsessive-compulsive disorder? A qualitative review of safety and efficacy. Psychiatry Res 2019 ; 271 : 259-264.
PubMed
松永寿人ほか. 強迫性障害. 塩入俊樹ほか (編), 不安障害診療のすべて. 医学書院 ; 2013, pp56-91.
 
Nakao T, et al. Neurobiological model of obsessive-compulsive disorder : evidence from recent neuropsychological and neuroimaging findings. Psychiatry Clin Neurosci 2014 ; 68 (8) : 587-605.
PubMed
Rapinesi C, et al. Brain Stimulation in Obsessive-Compulsive Disorder (OCD) : A Systematic Review. Curr Neuropharmacol 2019 ; 17 (8) : 787-807.
PubMed
P.160 掲載の参考文献
1) Soomro GM, et al. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev 2008 (1) : CD001765.
PubMed
2) Ost LG, et al. Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014. Clin Psychol Rev 2015 ; 40 : 156-169.
PubMed
3) Bandelow B, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders-first revision. World J Biol Psychiatry 2008 ; 9 (4) : 248-312.
PubMed
4) Koran LM, et al. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007 ; 164 (7 Suppl) : 5-53.
 
5) Denys D. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Psychiatr Clin North Am 2006 ; 29 (2) : 553-584, xi.
PubMed
6) Kumar KK, et al. Comparative effectiveness of neuroablation and deep brain stimulation for treatment-resistant obsessive-compulsive disorder : A meta-analytic study. J Neurol Neurosurg Psychiatry 2019 ; 90 (4) : 469-473.
PubMed
7) Nuttin B, et al. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 1999 ; 354 (9189) : 1526.
PubMed
8) van den Munckhof P, et al. Active Stimulation Site of Nucleus Accumbens Deep Brain Stimulation in Obsessive-Compulsive Disorder Is Localized in the Ventral Internal Capsule. In : Nikkhah G, et al (eds). Stereotactic and Functional Neurosurgery. Springer ; 2013, pp53-59.
 
9) Denys D, et al. Efficacy of Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Refractory Obsessive-Compulsive Disorder : A Clinical Cohort of 70 Patients. Am J Psychiatry 2020 ; 177 (3) : 265-271.
PubMed
10) Morishita T, et al. Surgical neuroanatomy and programming in deep brain stimulation for obsessive compulsive disorder. Neuromodulation 2014 ; 17 (4) : 312-319 ; discussion 319.
PubMed
11) Anderson D, Ahmed A. Treatment of patients with intractable obsessive-compulsive disorder with anterior capsular stimulation : Case report. J Neurosurg 2003 ; 98 (5) : 1104-1108.
PubMed
12) Abelson JL, et al. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry 2005 ; 57 (5) : 510-516.
PubMed
13) Aouizerate B, et al. Distinct striatal targets in treating obsessive-compulsive disorder and major depression : Case report. J Neurosurg 2009 ; 111 (4) : 775-779.
PubMed
14) Denys D, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2010 ; 67 (10) : 1061-1068.
PubMed
15) Greenberg BD, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 2006 ; 31 (11) : 2384-2393.
PubMed
16) Greenberg BD, et al. Invasive circuitry-based neurotherapeutics : Stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology 2010 ; 35 (1) : 317-336.
PubMed
17) Tyagi H, et al. A Randomized Trial Directly Comparing Ventral Capsule and Anteromedial Subthalamic Nucleus Stimulation in Obsessive-Compulsive Disorder : Clinical and Imaging Evidence for Dissociable Effects. Biol Psychiatry 2019 ; 85 (9) : 726-734.
PubMed
18) Nakajima T, et al. Reliability and validity of the Japanese version of the Yale-Brown Obsessive-Compulsive Scale. Psychiatry Clin Neurosci 1995 ; 49 (2) : 121-126.
PubMed
19) Mallet L, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 2008 ; 359 (20) : 2121-2134.
PubMed
20) Luyten L, et al. Electrical stimulation in the bed nucleus of the stria terminalis alleviates severe obsessive-compulsive disorder. Mol Psychiatry 2016 ; 21 (9) : 1272-1280.
PubMed
21) Huff W, et al. Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder : Outcomes after one year. Clin Neurol Neurosurg 2010 ; 112 (2) : 137-143.
PubMed
22) Vicheva P, et al. Deep brain stimulation for obsessive-compulsive disorder : A systematic review of randomised controlled trials. Neurosci Biobehav Rev 2020 ; 109 : 129-138.
PubMed
23) Greenberg B, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder : Worldwide experience. Mol Psychiatry 2010 ; 15 (1) : 64-79.
PubMed
24) Mantione M, et al. Cognitive-behavioural therapy augments the effects of deep brain stimulation in obsessive-compulsive disorder. Psychol Med 2014 ; 44 (16) : 3515-3522.
PubMed
25) Goodman WK, et al. Deep brain stimulation for intractable obsessive compulsive disorder : Pilot study using a blinded, staggered-onset design. Biol Psychiatry 2010 ; 67 (6) : 535-542.
PubMed
26) Barcia JA, et al. Personalized striatal targets for deep brain stimulation in obsessive-compulsive disorder. Brain Stimul 2019 ; 12 (3) : 724-734.
PubMed
27) von Economo C. Encephalitis lethargica : Its sequelae and treatment. Translated by Newman KO. Oxford University Press ; 1931.
 
28) Weiss AP, Jenike MA. Late-onset obsessive-compulsive disorder : A case series. J Neuropsychiatry Clin Neurosci 2000 ; 12 (2) : 265-268.
 
29) Maia AS, et al. Relationship between obsessive-compulsive disorders and diseases affecting primarily the basal ganglia. Revista do Hospital das Clinicas 1999 ; 54 (6) : 213-221.
PubMed
30) Saxena S, et al. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998 (35) : 26-37.
PubMed
31) Menzies L, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder : The orbitofronto-striatal model revisited. Neurosci Biobehav Rev 2008 ; 32 (3) : 525-549.
PubMed
32) Sakai Y, et al. Corticostriatal functional connectivity in non-medicated patients with obsessive-compulsive disorder. Eur Psychiatry 2011 ; 26 (7) : 463-469.
PubMed
33) Abe Y, et al. Hyper-influence of the orbitofrontal cortex over the ventral striatum in obsessive-compulsive disorder. Eur Neuropsychopharmacol 2015 ; 25 (11) : 1898-1905.
PubMed
34) Figee M, et al. Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. Nat Neurosci 2013 ; 16 (4) : 386-387.
PubMed
35) Goodman WK, et al. Deep Brain Stimulation for Intractable Obsessive-Compulsive Disorder : Progress and Opportunities. Am J Psychiatry 2020 ; 177 (3) : 200-203.
PubMed
36) Ruscio AM, et al. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 2010 ; 15 (1) : 53-63.
PubMed
37) Huys D, et al. Open-label trial of anterior limb of internal capsule-nucleus accumbens deep brain stimulation for obsessive-compulsive disorder : Insights gained. J Neurol Neurosurg Psychiatry 2019 ; 90 (7) : 805-812.
PubMed
38) Menchon JM, et al. A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder. Mol Psychiatry 2019. [Online ahead of print]
 
39) HarIz MI, et al. Deep brain stimulation between 1947 and 1987 : The untold story. Neurosurg Focus 2010 ; 29 (2) : E1.
PubMed
40) Nudeshima J, Taira T. A brief note on the history of psychosurgery in Japan. Neurosurg Focus 2017 ; 43 (3) : E13.
PubMed
41) Guzick A, et al. Improving long term patient outcomes from deep brain stimulation for treatment-refractory obsessive-compulsive disorder. Expert Rev Neurother 2020 ; 20 (1) : 95-107.
PubMed
Park YS, et al. Anatomic Review of the Ventral Capsule/Ventral Striatum and the Nucleus Accumbens to Guide Target Selection for Deep Brain Stimulation for Obsessive-Compulsive Disorder. World Neurosurg 2019 ; 126 : 1-10.
PubMed
Haq IU, et al. Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder. Neuroimage 2011 ; 54 (Suppl 1) : S247-S255.
 
Li N, et al. A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder. Nat Commun 2020 ; 11 (1) : 3364.
 
P.172 掲載の参考文献
1) Morselli E. Sulla dismorfofobia e sulla tafefobia, due forme non per anco descritte di pazzia con idee fisse. Bollettino della Regia Accademia Medica di Genova 1891 ; 6 : 110-119.
 
2) Hay G. Paranoia and dysmorphophobia. Br J Psychiatry 1983 ; 142 : 309-310.
PubMed
3) Veale D, Matsunaga H. Body dysmorphic disorder and olfactory reference disorder : Proposals for ICD-11. Braz J Psychiatry 2014 ; 36 (Suppl 1) : 14-20.
 
4) Stein DJ, et al. The classification of Obsessive-Compulsive and Related Disorders in the ICD-11. J Affect Disord 2016 ; 190 : 663-674.
PubMed
5) Bartz JA, Hollander E. Is obsessive-compulsive disorder an anxiety disorder? Prog Neuropsychopharmacol Biol Psychiatry 2006 ; 30 (3) : 338-352.
PubMed
6) Stein DJ, Hollander E. The spectrum of obsessive-compulsive-related disorders. In : Hollander E (ed). Obsessive-compulsive related disorders. American Psychiatric Publishing ; 1993, pp247-271.
 
7) Hollander E, et al. Obsessive-Compulsive Disorder and Obsessive-Compulsive Spectrum Disorders : Diagnostic and Dimensional Issues. CNS Spectr 2007 ; 12 (S3) : 5-13.
 
8) Phillips KA, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety 2010 ; 27 (6) : 528-555.
PubMed
9) 松永寿人. 強迫症の診断概念, そして中核病理に関するパラダイムシフト-神経症, あるいは不安障害から強迫スペクトラムへ. 不安症研究 2015 ; 6 (2) : 86-99.
 
10) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
11) 日本精神神経学会. ICD-11 診断ガイドライントレーニングセミナー 2019年版資料.
 
12) Phillips KA, et al. Body dysmorphic disorder : Treating an underrecognized disorder. Am J Psychiatry 2008 ; 165 (9) : 1111-1118.
PubMed
13) Phillips KA, Dufresne RG. Body dysmorphic disorder. A guide for dermatologists and cosmetic surgeons. Am J Clin Dermatol 2000 ; 1 (4) : 235-243.
PubMed
14) Albertini RS, Phillips KA. Thirty-three cases of body dysmorphic disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999 ; 38 (4) : 453-459.
PubMed
15) Phillips KA. Quality of life for patients with body dysmorphic disorder. J Nerv Ment Dis 2000 ; 188 (3) : 170-175.
PubMed
16) Gunstad J, Phillips KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry 2003 ; 44 (4) : 270-276.
PubMed
17) World Health Organization. The ICD-11. Classification of mental and behavioural disorders 2019. https://icd.who.int/en/
 
18) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. American Psychiatric Association ; 1987.
 
19) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision. American Psychiatric Association ; 2000.
 
20) Phillips KA, et al. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull 1994 ; 30 (2) : 179-186.
 
21) 松井徳造ほか. 身体醜形障害に対してparoxetine投与が有効であった1症例. 臨床精神医学 2002 ; 31 : 199-204.
Medical*Online
22) 大矢健造ほか. 低用量のfluvoxamineの投与が奏効した身体醜形障害の1症例. 九州神経精神医学 2005 ; 51 : 78-79.
 
23) Phillips KA, et al. Delusional versus nondelusional body dysmorphic disorder : Recommendations for DSM-5. CNS Spectr 2014 ; 19 (1) : 10-20.
 
24) Issa BA. Delusional disorder-somatic type (or body dysmorphic disorder) and schizophrenia : A case report. Afr J Psychiatry 2010 ; 13 (1) : 61-63.
PubMed
25) Krebs G, et al. Recent advances in understanding and managing body dysmorphic disorder. Evid Based Ment Health 2017 ; 20 (3) : 71-75.
PubMed
26) Hollander E, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder : Selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry 1999 ; 56 (11) : 1033-1039.
PubMed
27) Phillips KA, et al. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry 2002 ; 59 (4) : 381-388.
 
28) Phillips KA, Stein DJ. Handbook on Obsessive-Compulsive and Related Disorders. American Psychiatric Association ; 2015.
 
29) Enander J, et al. Therapist-guided, Internet-based cognitive-behavioural therapy for body dysmorphic disorder (BDD-NET) : A feasibility study. BMJ Open 2014 ; 4 (9) : e005923.
 
30) Veale D, et al. Efficacy of cognitive behaviour therapy versus anxiety management for body dysmorphic disorder : A randomised controlled trial. Psychother Psychosom 2014 ; 83 (6) : 341-353.
PubMed
31) Wilhelm S, et al. Development and Pilot Testing of a Cognitive-Behavioral Therapy Digital Service for Body Dysmorphic Disorder. Behav Ther 2020 ; 51 (1) : 15-26.
PubMed
32) 日本医師会. 未成年者の問題も含む美容処置に関するWMA声明. 日医ニュース ; 2013, pp1253.
 
33) 朝倉聡. 社交不安障害の診断と治療. 精神神経学雑誌 2015 ; 117 (6) : 413-430.
 
34) 山下格. 対人恐怖. 金原出版 ; 1977.
 
35) 松井徳造ほか. 身体醜形障害の臨床特徴と診断-統合失調症との相違とは. 精神科治療学 2017 ; 32 (3) : 323-328.
 
36) Kelly MM, et al. A comparison study of body dysmorphic disorder versus social phobia. Psychiatry Res 2013 ; 205 (1-2) : 109-116.
 
37) 笠原敏彦. 対人恐怖と社会不安障害-診断と治療の指針. 金剛出版 ; 2005.
 
38) Matsunaga H, et al. Taijin kyofusho : A form of social anxiety disorder that responds to serotonin reuptake inhibitors? Int J Neuropsychopharmacol 2001 ; 4 (3) : 231-237.
PubMed
39) Nagata T, et al. An open trial of paroxetine for the "offensive subtype" of taijin kyofusho and social anxiety disorder. Depress Anxiety 2006 ; 23 (3) : 168-174.
PubMed
40) Helen Zimmern. Criminal Anthropology in Italy. Popular Science Monthly 1898 ; 52 : 743-760.
 
41) Hugh Freeman. Century for Psychiatry. Mosby Ltd ; 1999, p27.
 
42) Shorter E. A Historical Dictionary of Psychiatry. Oxford University Press ; 2005/精神医学歴史事典. 江口重幸ほか (監訳). みすず書房 ; 2016, p438.
 
43) 原田輝一ほか (編). アピアランス <外見> 問題と包括的ケア構築の試み-医療福祉連携と心理学領域とのコラボレーション. 福村出版 ; 2018, p256.
 
原田輝一ほか (編). アピアランス <外見> 問題と包括的ケア構築の試み-医療福祉連携と心理領域とのコラボレーション. 福村出版 ; 2018.
 
Veale D, Matsunaga H. Body dysmorphic disorder and olfactory reference disorder : proposals for ICD-11. Braz J Psychiatry 2014 ; 36 (Suppl 1) : 14-20.
 
Shorter E. A Historical Dictionary of Psychiatry. Oxford University Press ; 2005/江口重幸ほか (監訳). 精神医学歴史事典. みすず書房 ; 2016.
 
P.182 掲載の参考文献
1) 森田正馬, 高良武久. 赤面恐怖の治し方. 白揚社 ; 1953.
 
2) 笠原嘉ほか (編). 正視恐怖・体臭恐怖-主として精神分裂病の境界例について. 医学書院 ; 1972.
 
3) 山下格. 対人恐怖. 金原出版 ; 1977.
 
4) 植元行男. 思春期における異常な確信的体験について (その1) -いわゆる思春期妄想症について. 児童精神医学とその近接領域 1967 ; 8 : 155-167.
 
5) Walter K. On The "Phobic Reference Syndrome". Nervenarzt 1965 ; 36 : 7-11.
PubMed
6) 藤縄昭. 自我漏洩症状群について. 土居健郎 (編), <分裂病の精神病理> 1. 東京大学出版会 ; 1972, pp33-50.
 
7) 村上仁. 統合失調症の精神症状論. みすず書房 ; 2009.
 
8) 朝倉聡. 社交不安症の診断と評価. 不安症研究 2015 ; 7 (1) : 4-17.
 
9) 中村敬ほか. 社会恐怖と対人恐怖症の比較-森田療法の視点から. 精神科治療学 2003 ; 18 (3) : 271-278.
 
10) 中村敬. Social phobiaと対人恐怖症-文献およびカナダ人自験例についての予備的考察. 精神医学 1994 ; 36 (2) : 131-139.
 
11) Matsunaga H, et al. Taijin kyofusho : A form of social anxiety disorder that responds to serotonin reuptake inhibitors? Int J Neuropsychopharmacol 2001 ; 4 (3) : 231-237.
PubMed
12) 朝倉聡ほか. 自己臭恐怖の臨床的研究-25年前の症例との比較から. 臨床精神医学 2000 ; 29 (3) : 313-320.
Medical*Online
13) 角田博之ほか. 自己臭症状 (口臭) を伴う思春期妄想症の1例. 日本歯科心身医学会雑誌 2003 ; 18 (2) : 85-88.
 
14) 増田豊ほか. Risperidoneが奏効した自己臭症の1例. 心身医学 1998 ; 38 (4) : 267-271.
Medical*Online
15) 名越泰秀ほか. Escitalopramが有用であった自己臭症の1例. 精神科治療学 2015 ; 30 (9) : 1259-1265.
 
16) 豊福明. 口臭, 口腔異常感症. 多賀須幸男ほか (編), 今日の治療指針 2000. 医学書院 ; 2000, pp906-907.
 
17) 永井哲夫ほか. 口臭に固執する自己臭症の臨床的検討 第1報 歯科口腔外科受診症例の臨床的特徴-精神神経科受診症例との比較. 日本歯科心身医学会雑誌 1998 ; 13 (1) : 33-37.
 
18) 豊福明, 都温彦. 口臭症に対する向精神薬の有効性. 日本歯科心身医学会雑誌 1998 ; 13 (1) : 1-5.
 
19) Yaegaki K, Coil JM. Genuine halitosis, pseudo-halitosis, and halitophobia : Classification, diagnosis, and treatment. Compend Contin Educ Dent 2000 ; 21 (10a) : 880-886, 888-889 ; quiz 890.
 
20) 永井哲夫ほか. 口臭に固執する自己臭症の臨床的検討 第3報 重症度と歯科的対応. 日本歯科心身医学会雑誌 2000 ; 15 (2) : 143-148.
 
21) 豊福明, 都温彦. フルボキサミンが奏効した口臭症 (自己臭恐怖症) の1例. Pharma Medica 2001 ; 19 (6) : 131-135.
Medical*Online
22) 水野詩子ほか. 口臭症患者の薬物療法の効果に対する臨床的検討. 日本歯科心身医学会雑誌 2002 ; 17 (2) : 69-73.
 
23) Potts CS. Two cases of hallucination of smell. University of Pennsylvania Medical Magazine 1891 ; 226.
 
24) Pryse-Phillips W. An olfactory reference syndrome. Acta Psychiatr Scand 1971 ; 47 (4) : 484-509.
PubMed
25) Munro A. Monosymptomatic hypochondriacal psychosis. Br J Psychiatry Suppl 1988 (2) : 37-40.
PubMed
26) Kleinknecht RA, et al. Cultural factors in social anxiety : A comparison of social phobia symptoms and Taijin kyofusho. J Anxiety Disord 1997 ; 11 (2) : 157-177.
PubMed
27) Choy Y, et al. Features of the offensive subtype of Taijin-Kyofu-Sho in US and Korean patients with DSM-IV social anxiety disorder. Depress Anxiety 2008 ; 25 (3) : 230-240.
PubMed
28) Clarvit SR, et al. The offensive subtype of Taijin-kyofu-sho in New York City : The phenomenology and treatment of a social anxiety disorder. J Clin Psychiatry 1996 ; 57 (11) : 523-527.
PubMed
29) Vriends N, et al. Taijin kyofusho and social anxiety and their clinical relevance in Indonesia and Switzerland. Front Psychol 2013 ; 4 : 3.
PubMed
30) Begum M, McKenna PJ. Olfactory reference syndrome : A systematic review of the world literature. Psychol Med 2011 ; 41 (3) : 453-461.
PubMed
31) Hollander E, et al. Obsessive-Compulsive Disorder and Obsessive-Compulsive Spectrum Disorders : Diagnostic and Dimensional Issues. CNS Spectr 2014 ; 12 (S3) : 5-13.
 
32) 松永寿人. 強迫スペクトラム障害の概念とその病態, 最新の動向. 臨床精神薬理 2011 ; 14 : 1025-1031.
 
33) Prazeres AM, et al. Olfactory reference syndrome as a subtype of body dysmorphic disorder. J Clin Psychiatry 2010 ; 71 (1) : 87-89.
PubMed
34) Lochner C, Stein DJ. Prevalence of olfactory reference syndrome in obsessive-compulsive disorder and social anxiety disorder. J Clin Psychiatry 2014 ; 75 (11) : 1266.
PubMed
35) Veale D, Matsunaga H. Body dysmorphic disorder and olfactory reference disorder : Proposals for ICD-11. Braz J Psychiatry 2014 ; 36 (Suppl 1) : 14-20.
 
36) Phillips KA, Menard W. Olfactory reference syndrome : Demographic and clinical features of imagined body odor. Gen Hosp Psychiatry 2011 ; 33 (4) : 398-406.
PubMed
37) Feusner JD, et al. Olfactory reference syndrome : Issues for DSM-V. Depress Anxiety 2010 ; 27 (6) : 592-599.
PubMed
38) Malasi TH, et al. Olfactory delusional syndrome with various aetiologies. Br J Psychiatry 1990 ; 156 : 256-260.
PubMed
39) Phillips KA, et al. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics 2005 ; 46 (4) : 317-325.
PubMed
40) 八重垣健. 一般歯科における口臭恐怖症患者への対応. ザ・クインテッセンス 1999 ; 18 : 947-954.
 
41) 小林伸行ほか. 排ガス (おなら) 臭を主訴とする自己臭症に過敏性腸症候群が高率に併発する. 心身医学 2015 ; 55 (12) : 1380-1385.
Medical*Online
42) 河西ひとみほか. 腸管ガスに関連する症状を主訴とする病態と治療法の研究の動向-過敏性腸症候群・呑気症・自己臭症の視点から. 心身医学 2018 ; 58 (6) : 488-497.
Medical*Online
43) 宮岡等, 阿部裕美. 思春期妄想症とその近縁領域-自己臭恐怖. 臨床精神医学 1990 ; 19 (6) : 877-881.
 
44) 吉岡眞吾, 村上靖彦. 思春期妄想症治療. 精神科治療学 2008 ; 23 : 301-305.
 
45) 大原一幸ほか. 発症から長期経過後も自己臭症を主症状とした精神分裂病の1症例. 臨床精神医学 1999 ; 28 (10) : 1253-1261.
Medical*Online
46) Kozak MJ, Foa EB. Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder. Behav Res Ther 1994 ; 32 (3) : 343-353.
PubMed
47) Michael S, et al. Two cases of olfactory reference syndrome responding to an atypical antipsychotic and SSRI. Aust N Z J Psychiatry 2014 ; 48 (9) : 878-879.
 
48) Tee CK, Suzaily W. Unremitting body odour : A case of Olfactory Reference Syndrome. Clin Ter 2015 ; 166 (2) : 72-73.
PubMed
49) Ozen M, et al. Successful treatment of olfactory reference syndrome with clomipramine. Psiq Biol 2018 ; 25 (1) : 29-31.
 
50) 木津明彦, 宮岸勉. 自己臭を訴えた2症例に対する行動療法. 行動療法研究 1993 ; 19 (2) : 116-123.
Medical*Online
51) Teraishi T, et al. Successful treatment of olfactory reference syndrome with paroxetine. J Neuropsychiatry Clin Neurosci 2012 ; 24 (1) : E24.
PubMed
52) 豊福明ほか. 口腔恐怖症に対するfluvoxamineの効果. 日本口臭学会会誌 2010 ; 1 (1) : 42-43.
 
53) Balaban OD, et al. The olfactory reference syndrome treated with escitalopram : A case report. Marmara Medical Journal 2015 ; 28 : 120-122.
 
54) Aksu E, et al. Olfactory reference syndrome : A case report. Du?unen Adam 2010 ; 2 (23) : 133-136.
 
55) Karia S, et al. Olfactory Reference Syndrome : A Case Report. International Journal of Scientific Research 2012 ; 2 (9) : 261.
 
56) Pusuroglu M, et al. Olfactory reference syndrome in adolescent : A case report. Journal of Mood Disorders 2014 ; 4 : 41-43.
 
57) 谷口敏淳. 自己臭恐怖症への認知行動療法の適用-症状の低減から就労支援まで. 行動療法研究 2012 ; 38 (3) : 247-257.
Medical*Online
58) 河西ひとみほか. 腸管ガスに関連する症状を主訴とする患者への認知行動療法の無効例から考える今後の研究の方向性. 心身医学 2020 ; 60 (1) : 50-57.
Medical*Online
59) National Collaborating Centre for Mental Health. National Institute for Health and Clinical Excellence : Guidance. Obsessive-Compulsive Disorder : Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder. British Psychological Society The British Psychological Society & The Royal College of Psychiatrists ; 2006.
 
60) Geremia GM, Neziroglu F. Cognitive therapy in the treatment of body dysmorphic disorder. Clinical Psychology & Psychotherapy 2001 ; 8 (4) : 243-251.
 
61) 鈴木知準. 神経症はこんな風に全治する-森田療法の道. 誠信書房 ; 1986, pp95-125.
 
P.191 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision. APA ; 2000.
PubMed
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition. APA ; 2013.
 
3) 松永寿人ほか. 強迫症および関連症群-ICD-11のチェックポイント. 精神医学 2019 ; 61 : 261-269.
 
4) Frances A. The new somatic symptom disorder in DSM-5 risks mislabeling many people as mentally ill. BMJ 2013 ; 346 : 580.
 
5) Katz J, et al. Chronic pain, psychopathology, and DSM-5 somatic symptom disorder. Can J Psychiatry 2015 ; 60 : 160-167.
PubMed
6) Tsang A, et al. Common chronic pain conditions in developed and developing countries : Gender and age differences and comorbidity with depression-anxiety disorders. J Pain 2008 ; 9 : 883-891.
PubMed
7) Stein DJ, et al. The classification of Obsessive-Compulsive and Related Disorders in the ICD-11. J Affect Disord 2016 ; 190 : 663-674.
PubMed
8) Stein DJ. Hypochondriasis in ICD-11. World Psychiatry 2012 ; 11 (Suppl 1) : 100-104.
 
9) 日本精神神経学会. ICD-11 診断ガイドライントレーニングセミナー 2019年版資料.
 
10) Cohen LJ, et al. Obsessive-compulsive spectrum disorders. In : Hollander E, et al (eds). Obsessive-Compulsive Disorders : Diagnosis, Etiology, Treatment. Marcel Dekker ; 1997.
 
11) 笠原敏彦. ヒポコンドリーの亜型分類. 高橋徹 (編), <精神医学レビュー> No.11. ヒポコンドリー (心気). ライフ・サイエンス ; 1994, pp15-22.
 
12) 吉松和哉ほか (編). <臨床精神医学講座> 第6巻. 身体表現性障害・心身症. 中山書店 ; 1999, pp113-132.
 
13) Sadock BJ, et al (eds). Kaplan & Sadock's Synopsis of Psychiatry : Behavioral Sciences/Clinical Psychiatry, 11th edition. Lippincott Williams & Wilkins ; 2014/井上令一 (監修), 四宮滋子ほか (監訳). カプラン臨床精神医学テキスト 第3版-DSM-5 診断基準の臨床への展開. メディカル・サイエンス・インターナショナル 2016 ; pp521-557.
 
中村敬. 病気不安症. 臨床精神医学 2016 ; 45 : 294-296.
Medical*Online
川瀬愛ほか. 病気不安症. 別冊日本臨牀 新領域別症候群シリーズ 精神医学症候群 (第2版) II. 日本臨牀社 ; 2017. pp242-246.
 
村松公美子. 身体症状症および関連症群の認知行動療法. 心身医学 2019 ; 59 (6) : 544-553.
Medical*Online
名越泰秀. 身体表現性障害 (身体症状症および関連症群) の薬物療法. 心身医学 2015 ; 55 (12) : 1308-1321.
Medical*Online
澤原光彦ほか. 成人の精神医学的諸問題の背景にある発達障害特性. 心身医学 2017 ; 57 (1) : 51-58.
Medical*Online
P.202 掲載の参考文献
1) Clark AN, et al. Diogenes syndrome. A clinical study of gross neglect in old age. Lancet 1975 ; 1 : 366-367.
PubMed
2) American Psychiatric Association. Diagnostic and Statistical Manual Of Mental Disorders, 5th edition (DSM-5). 2013/強迫症および関連症群. 日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014, pp233-261.
 
3) Furby L. Possessions : Toward a theory of their meaning and function throughout the life cycle. In Bates, P. B. Life span development and behavior (Vol I). Academic Press ; 1978.
 
4) 浜垣誠司ほか. 自己記入式Yale-Brown強迫観念・強迫行為尺度 (Y-BOCS) 日本語版の作成とその検討. 精神経誌 1999 ; 101 : 152-168.
 
5) Frost RO, et al. Hoarding and obsessive-compulsive symptoms. Behav Modif 1996 ; 20 : 116-132.
PubMed
6) Rasmussen SA, Eisen JL. The epidemiology and clinical features of obsessive-compulsive disorder. Psychiatr Clin North Am 1992 ; 15 : 743-758.
PubMed
7) Bloch MH, et al. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 2008 ; 165 : 1532-1542.
PubMed
8) Frost RO, Hartl TL. A cognitive-behavioral model of compulsive hoarding. Behav Res Ther 1996 ; 34 : 341-350.
PubMed
9) Mataix-Cols D, et al. Hoarding disorder : A new diagnosis for DSM-V? Depress Anxiety 2010 ; 27 : 556-572.
PubMed
10) Hollander E, Wong CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry 1995 ; 56 (Suppl 4) : 3-6.
 
11) Mataix-Cols D, et al. The London field trial for hoarding disorder. Psychol Med 2013 ; 43 : 837-847.
PubMed
12) Cath DC, et al. Age-specific prevalence of hoarding and obsessive-compulsive disorder : A population-based study. Am J Geriatr Psychiatry 2017 ; 25 : 245-255.
PubMed
13) Nordsletten AE, et al. A transcultural study of hoarding disorder : Insights from the United Kingdom, Spain, Japan, and Brazil. Transcult Psychiatry 2018 ; 55 : 261-285.
PubMed
14) Matsunaga H, et al. Clinical features and treatment characteristics of compulsive hoarding in Japanese patients with obsessive-compulsive disorder. CNS Spectr 2010 ; 15 : 258-265.
PubMed
15) Saxena S, et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 2004 ; 161 : 1038-1048.
PubMed
16) An SK, et al. To discard or not to discard : The neural basis of hoarding symptoms in obsessive-compulsive disorder. Mol Psychiatry 2009 ; 14 : 318-331.
PubMed
17) Valente AA Jr, et al. Regional gray matter abnormalities in obsessive-compulsive disorder : A voxel-based morphometry study. Biol Psychiatry 2005 ; 58 : 479-487.
PubMed
18) Gilbert AR, et al. Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings : A preliminary voxel-based morphometry study. Neurosci Lett 2008 ; 435 : 45-50.
PubMed
19) Alvarenga PG, et al. Obsessive-compulsive symptom dimensions correlate to specific gray matter volumes in treatment-naive patients. J Psychiatr Res 2012 ; 46 : 1635-1642.
PubMed
20) Hough CM, et al. Comparison of brain activation patterns during executive function tasks in hoarding disorder and non hoarding OCD. Psychiatry Res 2016 ; 255 : 50-59.
PubMed
21) Yamada S, et al. A unique increase in prefrontal graymatter volume in hoarding disorder compared to obsessive-compulsive disorder. PLoS One 2018 ; 13 : e0200814.
 
22) 中尾智博, 蓮澤優. 物をためこむ症状を診分ける. 精神科治療学 2017 ; 32 : 97-101.
 
23) O'Sulivan SS, et al. Excessive hoarding in Parkinson's disease. Mov Disord 2010 ; 25 : 1026-1033.
 
24) Dykens EM, et al. Obsessions and compulsions in Prader-Willi syndrome. J Child Psychol Psychiatry 1996 ; 37 : 995-1002.
PubMed
25) Faragian S, et al. Obsessive-compulsive symptom dimensions in schizophrenia patients with comorbid obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009 ; 33 : 1009-1012.
PubMed
26) 中尾智博, 桑野真澄. ためこみ症の病態と治療-OCD・ADHDとの関連性も含めて. 臨床精神薬理 2015 ; 18 : 1137-1144.
 
27) Pertusa A, et al. Do patients with hoarding disorder have autistic traits? Depress Anxiety 2012 ; 29 : 210-218.
PubMed
28) Ratchford E, et al. ADHD in hoarders, OCD patients, and community controls. Paper presented at the Annual Meeting of the Association of Behavioral and Cognitive Therapies, New York, 2009.
 
29) Tolin DF, Villavicencio A. Inattention, but not OCD, predicts the core features of hoarding disorder. Behav Res Ther 2011 ; 49 : 120-125.
 
30) Kuwano M, et al. Clinical characteristics of hoarding disorder in Japanese patients. Heliyon 2020 ; 6 : e03527.
PubMed
31) Mataix-Cols D, et al. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 1999 ; 156 : 1409-1416.
PubMed
32) Stein DJ, et al. Escitalopram in obsessive-compulsive disorder : Response of symptom dimensions to pharmacotherapy. CNS Spectr 2008 ; 13 : 492-498.
PubMed
33) Bloch MH, et al. Meta-analysis : Hoarding symptoms associated with poor treatment outcome in obsessive-compulsive disorder. Mol Psychiatry 2014 ; 19 : 1025-1030.
 
34) Saxena S, et al. Paroxetine treatment of compulsive hoarding. J Psychiatr Res 2007 ; 41 : 481-487.
PubMed
35) Tolin DF, et al. An open trial of cognitive behavioral therapy for compulsive hoarding. Behav Res Ther 2007 ; 45 : 1461-1470.
PubMed
36) Muroff J, et al. Group cognitive and behavioral treatment for compulsive hoarding : A preliminary trial. Depress Anxiety 2009 ; 26 : 634-640.
PubMed
Steketee G, FrostR. Compulsive Hoarding and Acquiring : Therapist guide. Oxford University Press ; 2006/五十嵐透子 (訳). ホーディングへの適切な理解と対応 認知行動療法的アプローチ-セラピストガイド. 金子書房 ; 2013.
 
中尾智博. ためこみ症. 臨床精神医学 2016 ; 45 (増刊) : 248-250.
Medical*Online
五十嵐透子. 片づけられないのは「ためこみ症」のせいだった!? 青春出版社 ; 2019.
 
溝部太郎, 中尾智博. ためこみ症は, 現代のディオゲネス症候群か? 精神科治療学 2019 ; 34 : 244-246.
 
P.209 掲載の参考文献
1) Macmillan D, Shaw P. Senile breakdown in standards of personal and environmental cleanliness. Br Med J 1966 ; 2 : 1032-1037.
PubMed
2) Clark AN, et al. Diogenes syndrome. A clinical study of gross neglect in old age. Lancet 1975 ; 1 : 366-368.
PubMed
3) Halliday G, et al. Community study of people who live in squalor. Lancet 2000 ; 355 : 882-886.
PubMed
4) Dong X, et al. Elder self-neglect and abuse and mortality risk in a community-dwelling population. JAMA 2009 ; 302 : 517-526.
 
5) Lachs MS, et al. The mortality of elder mistreatment. JAMA 1998 ; 280 : 428-432.
PubMed
6) 船山道隆, 加藤元一郎. 前頭葉と自律性の障害 特に強制行動と病的収集活動について. 分子生物医学 2008 ; 8 : 125-131.
 
7) Snowdon J, et al. Severe domestic squalor : A review. Int Psychogeriatr 2007 ; 19 : 37-51.
 
8) Snowdon J. Squalor syndrome. J Am Geriatr Soc 1997 ; 45 : 1539-1540.
PubMed
9) Dong X, et al. Association of personality traits with elder self-neglect in a community-dwelling population. Am J Geriatr Psychiatry 2011 ; 19 : 743-751.
 
10) Cipriani G, et al. Diogenes syndrome in patients suffering from dementia. Dialogues Clin Neurosci 2012 ; 14 : 455-460.
PubMed
11) Lavigne B, et al. [Diogenes syndrome and Hoarding disorder : Same or different?]. Encephale 2016 ; 42 : 421-425.
PubMed
12) Lee SM, LoGiudice D. Phenomenology of squalor, hoarding and self-neglect : An Australian aged care perspective. Intern Med J 2012 ; 42 : 98-101.
 
13) Monfort J-C, et al. [Diogenes's syndrome : an observatory study in a Paris district]. Psychol Neuropsychiatr Vieil 2010 ; 8 : 141-153.
 
14) Halliday G, Snowdon J. The Environmental Cleanliness and Clutter Scale (ECCS). Int Psychogeriatr 2009 ; 21 : 1041-1050.
PubMed
15) Herran A, Vazquez-Barquero JL. Treatment of Diogenes Syndrome with Risperidone. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 1999 ; 6 : 96-98.
 
16) Galvez-Andres A, et al. Secondary bipolar disorder and Diogenes syndrome in frontotemporal dementia : Behavioral improvement with quetiapine and sodium valproate. J Clin Psychopharmacol 2007 ; 27 : 722-723.
PubMed
17) Saxena S, Maidment KM. Treatment of compulsive hoarding. J Clin Psychol 2004 ; 60 : 1143-1154.
PubMed
18) Mataix-Cols D, et al. Neuropsychological and neural correlates of hoarding : A practice-friendly review. J Clin Psychol 2011 ; 67 : 467-476.
PubMed
19) Eslinger PJ, Damasio AR. Severe disturbance of higher cognition after bilateral frontal lobe ablation : Patient EVR. Neurology 1985 ; 35 : 1731-1741.
PubMed
20) Funayama M, et al. Pathological collecting behavior. Cortex 2018 ; 104 : 124-126.
PubMed
21) Iizuka O, et al. Severe amnesic syndrome and collecting behavior after surgery for craniopharyngioma. Cogn Behav Neurol 2007 ; 20 : 126-130.
PubMed
22) Anderson SW, et al. A neural basis for collecting behaviour in humans. Brain 2005 ; 128 : 201-212.
PubMed
23) Volle E, et al. Forced collectionism after orbitofrontal damage. Neurology 2002 ; 58 : 488-490.
PubMed
24) Hahm DS, et al. A compulsive collecting behavior following an A-com aneurysmal rupture. Neurology 2001 ; 56 : 398-400.
PubMed
25) Mendez MF, Shapira JS. The spectrum of recurrent thoughts and behaviors in frontotemporal dementia. CNS Spectr 2008 ; 13 : 202-208.
PubMed
26) Perry DC, et al. Voxel-based morphometry in patients with obsessive-compulsive behaviors in behavioral variant frontotemporal dementia. Eur J Neurol 2012 ; 19 : 911-917.
 
27) Hwang JP, et al. Hoarding behavior in dementia. A preliminary report. Am J Geriatr Psychiatry 1998 ; 6 : 285-289.
PubMed
28) Nakaaki S, et al. Impairment of Decision-making Cognition in a Case of Frontotemporal Lobar Degeneration (FTLD) Presenting With Pathologic Gambling and Hoarding as the Initial Symptoms. Cogn Behav Neurol 2007 ; 20 : 121.
 
Macmillan D, Shaw P. Senile breakdown in standards of personal and environmental cleanliness. Br Med J 1966 ; 2 : 1032-1037.
PubMed
Clark AN, et al. Diogenes syndrome. A clinical study of gross neglect in old age. Lancet 1975 ; 1 : 366-368.
PubMed
Mataix-Cols D, et al. Neuropsychological and neural correlates of hoarding : A practice-friendly review. J Clin Psychol 2011 ; 67 : 467-476.
PubMed
P.220 掲載の参考文献
1) 日本精神神経学会. ICD-11 診断ガイドライン 2019年版資料.
 
2) 松永寿人. 強迫症の診断概念, そして中核病理に関するパラダイムシフト-神経症, あるいは不安障害から強迫スペクトラムへ. 不安症研究 2015 ; 6 (2) : 86-99.
 
3) Woods DW, et al ; Trichotillomania Learning Center-Scientific Advisory Board. The Trichotillomania Impact Project (TIP) : Exploring phenomenology, functional impairment, and treatment utilization. J Clin Psychiatry 2006 ; 67 (12) : 1877-1888.
PubMed
4) Grant JE, et al. Trichotillomania, Skin-Picking, and Other Body-Focused Repetitive Behaviors. American Psychiatric Publishing ; 2012.
 
5) Houghton DC, et al. Comorbidity and quality of life in adults with hair pulling disorder. Psychiatry Res 2016 ; 239 : 12-19.
PubMed
6) Sampaio DG, Grant JE. Body-focused repetitive behaviors and the dermatology patient. Clin Dermatol 2018 ; 36 : 723-727.
PubMed
7) Jafferany M, Patel A. Therapeutic Aspects of Trichotillomania : A Review of Current Treatment Options. Prim Care Companion CNS Disord 2018 ; 20 (6) : 18nr02344.
PubMed
8) Grant JE, et al. Trichotillomania. Am J Psychiatry 2016 ; 173 (9) : 868-874.
PubMed
9) Duke DC, et al. Trichotillomania : A current review. Clin Psychol Rev 2010 ; 30 : 181-193.
PubMed
10) Christenson GA, et al. Characteristics of 60 adult chronic hair-pullers. Am J Psychiatry 1991 ; 148 : 365-370.
PubMed
11) Lochner C, et al. Comorbidity in trichotillomania (hair-pulling disorder) : A cluster analytical approach. Brain and Behavior 2019 ; 9 : e01456.
PubMed
12) Snorrason I, et al. How related are hair pulling disorder (trichotillomania) and skin picking disorder. Clin Psychol Rev 2012 ; 32 : 618-629.
PubMed
13) Turkoglu S, Cetin FH. Atomoxetine in the Treatment of Adolescent With Trichotillomania and Attention-Deficit/Hyperactivity Disorder. Clin Neuropharmacol 2018 ; 41 (2) : 84-85.
PubMed
14) Grant JE, et al. Trichotillomania and co-occurring anxiety. Compr Psychiatry 2017 ; 72 : 1-5.
PubMed
15) Tucker BT, et al. The Skin Picking Impact Project : Phenomenology, interference, and treatment utilization of pathological skin picking in a population-based sample. J Anxiety Disord 2011 ; 25 (1) : 88-95.
 
16) Grant JE, et al. N-Acetylcysteine in the treatment of excoriation disorder a randomized clinical trial. JAMA Psychiatry 2016 ; 73 : 490-496.
PubMed
17) Keuthen NJ, et al. The prevalence of pathologic skin picking in US adults. Compr Psychiatry 2010 ; 51 (2) : 183-186.
PubMed
18) Grant JE, et al. Longitudinal course of body-focused repetitive behaviors in obsessive-compulsive disorder. Ann Clin Psychiatry 2015 ; 27 (3) : 185-191.
PubMed
19) Lochner C, et al. Excoriation (skin-picking) disorder : A systematic review of treatment options. Neuropsychiatr Dis Treat 2017 ; 13 : 1867-1872.
PubMed
20) Wilhelm S, et al. Self-injurious skin picking : Clinical characteristics and co-morbidity. J Clin Psychiatry 1999 ; 60 (7) : 454-459.
PubMed
21) Machado MO, et al. Skin picking disorder : Prevalence, correlates, and associateons with quality of life in a large sample. CNS Spectr 2018 ; 23 (5) : 311-320.
 
22) Jafferany M, Osuagwu FC. Use of Topiramate in Skin-Picking Disorder : A Pilot Study. Prim Care Companion CNS Disord 2017 ; 19 (1) : 16m01961.
 
23) Bernardes C, et al. Skin picking disorder comorbid with ADHD successfully treated with methyleneidate. Rev Bras Psiquiatr 2018 ; 40 : 110-111.
 
24) Grant JE, et al. Assessment and treatment of trichotillomania (hair pulling disorder) and excoriateon (skin picking) disorder. Clin Dermatol 2018 ; 36 : 728-736.
 
25) Gupta MA, et al. Use of antipsychotic drugs in dermatology. Clin Dermatol 2018 ; 36 : 765-773.
PubMed
26) Peris TS, et al. Family functioning in pediatric trichotillomania, obsessive compulsive disorder, and healthy comparison youth. Psychiatry Res 2019 ; 281 : 112578.
PubMed
27) Gerstenblith TA, et al. Trichotillomania comorbidity in a sample enriched for familial obsessive-compulsive disorder. Compr Psychiatry 2019 ; 94 : 152123.
 
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
Stein DJ, et al. The classification of Obsessive-Compulsive and Related Disorders in the ICD-11. J Affect Disord 2016 ; 190 : 663-674.
PubMed
Jafferany M, Patel A. Therapeutic Aspects of Trichotillomania : A Review of Current Treatment Options. Prim Care Companion CNS Disord 2018 ; 20 (6) : 18nr02344.
PubMed
Grant JE, et al. Assessment and treatment of trichotillomania (hair pulling disorder) and excoriateon (skin picking) disorder. Clin Dermatol 2018 ; 36 : 728-736.
 
P.228 掲載の参考文献
1) Shakeri J, et al. The prevalence and clinical features of amphetamine-induced obsessive compulsive disorder. Drug Alcohol Depend 2016 ; 160 : 157-162.
PubMed
2) Faraone SV. The pharmacology of amphetamine and methylphenidate : Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev 2018 ; 87 : 255-270.
 
3) Denys D, et al. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder. Eur Neuropsychopharmacol 2013 ; 23 (11) : 1423-1431.
PubMed
4) Eagle DM, et al. The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement : A novel possible model of OCD. Behav Brain Res 2014 ; 264 : 207-229.
 
5) Zhou DD, et al. Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder : A network meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2019 ; 90 : 277-287.
PubMed
6) Bloch MH, et al. A systematic review : Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006 ; 11 (7) : 622-632.
PubMed
7) Dold M, et al. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder : A meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol 2013 ; 16 (3) : 557-574.
PubMed
8) Kim DD, et al. Clozapine-Associated Obsessive-Compulsive Symptoms and Their Management : A Systematic Review and Analysis of 107 Reported Cases. Psychother Psychosom 2020 ; 1-10.
 
9) Swets M, et al. The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res 2014 ; 152 (2-3) : 458-468.
 
10) Poyurovsky M, et al. Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder : Schizophrenic and OC symptoms in schizophrenia. J Clin Psychiatry 2003 ; 64 (11) : 1300-1307.
PubMed
11) Bottas A, et al. Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia : Is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci 2005 ; 30 (3) : 187-193.
PubMed
12) Patel DD, et al. The neuropsychology of the schizo-obsessive subtype of schizophrenia : A new analysis. Psychol Med 2010 ; 40 (6) : 921-933.
PubMed
13) Scheltema Beduin AA, et al. Outcome of Psychosis I. Obsessive-compulsive symptoms in patients with schizophrenia : A naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients. J Clin Psychiatry 2012 ; 73 (11) : 1395-1402.
PubMed
14) Kim DD, et al. Clozapine-induced obsessive-compulsive symptoms : Mechanisms and treatment. J Psychiatry Neurosci 2019 ; 44 (1) : 71-72.
PubMed
15) Dean SL, Singer HS. Treatment of Sydenham's Chorea : A Review of the Current Evidence. Tremor Other Hyperkinet Mov (NY) 2017 ; 7 : 456.
 
16) Gurkas E, et al. Predictors of recurrence in Sydenham's chorea : Clinical observation from a single center. Brain Dev 2016 ; 38 (9) : 827-834.
PubMed
17) Cardoso F, et al. Persistent Sydenham's chorea. Mov Disord 1999 ; 14 (5) : 805-807.
PubMed
18) Korn-Lubetzki I, et al. Recurrence of Sydenham chorea : Implications for pathogenesis. Archives of Neurology 2004 ; 61 (8) : 1261-1264.
PubMed
19) Punukollu M, et al. Neuropsychiatric manifestations of Sydenham's chorea : A systematic review. Dev Med Child Neurol 2016 ; 58 (1) : 16-28.
PubMed
20) Williams KA, Swedo SE. Post-infectious autoimmune disorders : Sydenham's chorea, PANDAS and beyond. Brain Res 2015 ; 1617 : 144-154.
PubMed
21) Asbahr FR, et al. Obsessive-compulsive symptoms among patients with Sydenham chorea. Biol Psychiatry 2005 ; 57 (9) : 1073-1076.
PubMed
22) Maia DP, et al. Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea. Neurology 2005 ; 64 (10) : 1799-1801.
PubMed
23) Gordon N. Sydenham's chorea, and its complications affecting the nervous system. Brain Dev 2009 ; 31 (1) : 11-14.
PubMed
24) Alvarenga PG, et al. Obsessive-compulsive symptoms in heart disease patients with and without history of rheumatic fever. J Neuropsychiatry Clin Neurosci 2006 ; 18 (3) : 405-408.
PubMed
25) Hanna GL, et al. Obsessive-compulsive disorder with and without tics in a clinical sample of children and adolescents. Depress Anxiety 2002 ; 16 (2) : 59-63.
 
26) Paz JA, et al. Randomized double-blind study with prednisone in Sydenham's chorea. Pediatr Neurol 2006 ; 34 (4) : 264-269.
PubMed
27) Perlmutter SJ, et al. A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry 1998 ; 155 (11) : 1592-1598.
PubMed
28) Swedo SE, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections : Clinical description of the first 50 cases. Am J Psychiatry 1998 ; 155 (2) : 264-271.
PubMed
29) Singer HS, et al. Moving from PANDAS to CANS. J Pediatr 2012 ; 160 (5) : 725-731.
PubMed
30) Sigra S, et al. Treatment of PANDAS and PANS : A systematic review. Neurosci Biobehav Rev 2018 ; 86 : 51-65.
 
31) Sokol MS. Infection-triggered anorexia nervosa in children : Clinical description of four cases. J Child Adolesc Psychopharmacol 2000 ; 10 (2) : 133-145.
 
32) Gilbert DL, Kurlan R. PANDAS : Horse or zebra? Neurology 2009 ; 73 (16) : 1252-1253.
PubMed
33) Kurlan R. The PANDAS hypothesis : Losing its bite? Mov Disord 2004 ; 19 (4) : 371-374.
 
34) Swedo SE, et al. From Research Subgroup to Clinical Syndrome : Modifying the PANDAS Criteria to Descrivbe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Pediatrics & Therapeutics 2012 ; 2 : 2.
 
35) Chang K, et al. Special issue on pediatric acute-onset neuropsychiatric syndrome. J Child Adolesc Psychopharmacol 2015 ; 25 (1) : 1-2.
 
36) Gerber MA, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis : A scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research : Endorsed by the American Academy of Pediatrics. Circulation 2009 ; 119 (11) : 1541-1551.
 
37) Johnson DR, et al. The human immune response to streptococcal extracellular antigens : Clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis 2010 ; 50 (4) : 481-490.
PubMed
38) Kaplan EL, et al. Antistreptolysin O and anti-deoxyribonuclease B titers : Normal values for children ages 2 to 12 in the United States. Pediatrics 1998 ; 101 (1 Pt 1) : 86-88.
 
39) Zibordi F, et al. CANS : Childhood acute neuropsychiatric syndromes. Eur J Paediatr Neurol 2018 ; 22 (2) : 316-320.
PubMed
40) Schrag A, et al. Streptococcal infection, Tourette syndrome, and OCD : Is there a connection? Neurology 2009 ; 73 (16) : 1256-1263.
 
41) Perrin EM, et al. Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Arch Pediatr Adolesc Med 2004 ; 158 (9) : 848-856.
 
42) Kurlan R, et al. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms : A prospective blinded cohort study. Pediatrics 2008 ; 121 (6) : 1188-1197.
PubMed
Mataix-Cols D, et al. A total-population multigenerational family clustering autoimmune disease in obsessive-compulsive disorder and Tourette's/chronic tic disorders. Molecular Psychiatry 2018 ; 23 : 1652-1658.
PubMed
Kathikeyan G, et al. Acute rheumatic fever. Lancet 2018 ; 392 : 161-174.
 
Zheng BS J, et al. Association of Pediatric Acute-Onset Neuropsychiatric Syndrome With Microstructural Differences in Brain Regions Detected via Diffusion-Weighted Magnetic Resonance Imaging. JAMA Network Open 2020 ; 3 (5) : e204063.
 
Sanju G, et al. Cocaine-induced trichotillomania. Addiction 2005 ; 100 : 255-256
 

3章 ストレス関連症群

P.241 掲載の参考文献
1) Weisaeth L. The history of psychic trauma. In : Friedman MJ, et al (eds). Handbook of PTSD : Science and Practice, 2nd edition. Guilford Press ; 2014, pp38-59.
 
2) Erichsen JE. On railway and other injuries of the nervous system. Walton & Maberly ; 1866.
 
3) Page HW. Injuries of the Spine and Spinal Cord Without Apparent Mechanical Lesion, and Nervous Shock, in their Surgical and Medico-Legal Aspects. J & A Churchill ; 1883.
 
4) Charcot JM. OEuvres completes. Lecons sur les maladies du systeme nerveux. Lecrosnier et Babe ; 1890.
 
5) Oppenheim H. Die traumatischen Neurosen nach den in der Nervenklinik der Charite in den 5 Jahren 1883-1888 gesammelten Beobachtungen. Hirschwald ; 1889.
 
6) サトウタツヤ (編・解説). <編集復刻版 近代日本PTSD関係資料集成> 第1巻. 六花出版 ; 2019.
 
7) Lerner P. From Traumatic Neurosis to Male Hysteria : The Decline and Fall of Hermann Oppenheim, 1889-1919. In : Micale MS, et al (eds). Traumatic pasts. Cambridge University Press ; 2001, pp140-171.
 
8) Eitinger L. Concentration camp survivors in Norway and Israe. Isr J Med Sci 1965 ; 1 : 883-895.
 
9) Crocq M-A, Crocq L. From shell shock and war neurosis to posttraumatic stress. Dialogues Clin Neurosci 2000 ; 2 (1) : 47-55.
PubMed
10) Wanke P. Russian/Soviet Military Psychiatry 1904-1945. Routledge ; 2005.
 
11) Micale MS, et al (eds). Traumatic Pasts : History, Psychiatry, and Trauma in the Modern Age, 1870-1930. Cambrige University Press ; 2001/金吉晴 (訳). トラウマの過去. みすず書房 ; 2017.
 
12) Myers CS. A contribution to the study of shell shock : Being an account of three cases of loss of memory, vision, smell, and taste, admitted into the Duchess of Westminster's War Hospital, Le Touquet. Lancet 1915 ; 185 (4772) : 316-320.
 
13) Gaupp R. Der Einflus der deutschen Unfallgesetzgebung auf den Verlauf der Nerven- und Geisteskrank-heiten. Munchener medizinische Wochenschrift 1906 ; 53 : 2233-2237.
 
14) Fischer-Homburger E. Die Traumatische Neurose : Vom Somatischen zum Sozialen Leiden. 1975.
 
15) Babinski J. Ma conception de l'hysterie et de l'hypnotisme (Pithiatisme). In : Conference faite a la Societe de l'Internat des hopitaux de Paris. Imprimerie Durand ; 1906.
 
16) Chavigny P. Psychiatrie aux armees. Paris Med 1916 ; 6 (January).
 
17) Kraepelin E. Psychiatrie : Ein Lehrbuch fur Studierende und Arzte. Johann Ambrosius Barth ; 1910.
 
18) Lifton R. Death in Life : Survivors of Hiroshima. Random House ; 1967.
 
19) Havenaar J, et al. Perception of risk and subjective health among victims of the Chernobyl disaster. Soc Sci Med 2003 ; 56 : 569-572.
PubMed
20) Bromet EJ, Havenaar JM. Psychological and perceived health effects of the Chernobyl disaster : A 20-year review. Health Phys 2007 ; 93 (5) : 516-521.
PubMed
21) Kim Y, et al. Persistent distress after psychological exposure to the Nagasaki atomic bomb explosion. Br J Psychiatry J Ment Sci 2011 ; 199 : 411-416.
 
22) Hammack SE, et al. Overlapping neurobiology of learned helplessness and conditioned defeat : Implications for PTSD and mood disorders NIH Public Access. Neuropharmacology 2012 ; 62 (2) : 565-575.
 
23) Kawamura N, et al. Suppression of cellular immunity in men with a past history of posttraumatic stress disorder. Am J Psychiatry 2001 ; 158 (3) : 484-486.
PubMed
24) Hori H. Inflammation and post-traumatic stress disorder. Psychiatry Clin Neurosci 2019 ; 73 : 143-153.
PubMed
25) Blashfield RK, et al. The cycle of classification : DSM-I through DSM-5. Annu Rev Clin Psychol 2014 ; 10 : 25-51.
PubMed
26) Maercker A, et al. Diagnosis and classification of disorders specifically associated with stress : Proposals for ICD-11. World Psychiatry 2013 ; 12 (3) : 198-206.
PubMed
27) 塩入俊樹. 不安障害の現在とこれから-DSM-5 改訂に向けての展望と課題 : パニック障害. 精神経誌 2012 ; 114 (9) : 1037-1048.
 
28) Matsuoka Y, et al. Incidence and prediction of psychiatric morbidity after a motor vehicle accident in Japan : The Tachikawa Cohort of Motor Vehicle Accident Study. Crit Care Med 2008 ; 36 (1) : 74-80.
PubMed
29) Naganuma Y, et al. Twelve-month use of mental health services in four areas in Japan : Findings from the World Mental Health Japan Survey 2002-2003. Psychiatry Clin Neurosci 2006 ; 60 (2) : 240-248.
PubMed
30) Brewin CR, et al. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol 2000 ; 68 (5) : 748-766.
PubMed
31) Friedman MJ, et al (editors). Handbook of PTSD : Science and Practice, 2nd edition. Guilford Press ; 2014.
 
32) Tanaka G, et al. Preserve Enduring Personality Change After Catastrophic Experience (EPCACE) as a diagnostic resource. Lancet Psychiatry 2018 ; 5 (5) : 1-6.
 
33) 中根允文, 岡崎祐士. ICD-10「精神・行動の障害」マニュアル-用語集・対照表付. 医学書院 ; 1994, p216.
 
P.253 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). American Psychiatric Association ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
2) World Health Organization. ICD-11-Mortality and Morbidity Statistics, 6B40 Post traumatic stress disorder. http://id.who.int/icd/entity/2070699808
 
3) Kessler RC, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995 ; 52 : 1048-1060.
PubMed
4) Kessler RC, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005 ; 62 : 617-627.
PubMed
5) Chapman C, et al. Remission from post-traumatic stress disorder in the general population. Psychol Med 2012 ; 42 : 1695-1703.
PubMed
6) Koenen KC, et al. Posttraumatic stress disorder in the World Mental Health Surveys. Psychol Med 2017 ; 47 : 2260-2274.
PubMed
7) 飛鳥井望. PTSDの臨床疫学. 臨床精神医学 2005 ; 34 : 893-898.
 
8) Sartor CE, et al. Common Heritable Contributions to Low-Risk Trauma, High-Risk Trauma, Posttraumatic Stress Disorder, and Major Depression. Arch Gen Psychiatry 2012 ; 69 : 293-299.
PubMed
9) Brewin CR, et al. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consul Clin Psychol 2000 ; 68 : 748-766.
 
10) Ozer EJ, et al. Predictors of posttraumatic stress disorder and symptoms in adults : A meta-analysis. Psychol Bull 2003 ; 129 : 52-73.
PubMed
11) 飛鳥井望. ICD-11におけるPTSD/CPTSD診断について-研究と臨床における新たな発展の始まりか, 長い混乱の幕開けか? トラウマティック・ストレス 2019 ; 17 : 73-79.
 
12) 飛鳥井望. DSM-IVからDSM-5へ-PTSDとASDの変更点とその背景. トラウマティック・ストレス 2014 ; 12 : 35-42.
Medical*Online
13) Lanius R, et al. Neural correlates of traumatic memories in posttraumatic stress disorder : A functional MRI investigation. Am J Psychiatry 2001 ; 158 : 1920-1922.
PubMed
14) Lanius R, et al. Brain activation during script-driven imagery induced dissociative responses in PTSD : A functional magnetic resonance imaging investigation. Biol Psychiatry 2002 ; 52 : 305-311.
PubMed
15) 飛鳥井望. 心的外傷およびストレス因関連障害群 PTSD. 臨床精神医学 2020 ; 49 (8) : 1340-1349.
Medical*Online
16) Pitman RK, et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci 2012 ; 13 : 769-787.
PubMed
17) Kilpatrick DG, et al. The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry 2007 ; 164 : 1693-1699.
PubMed
18) Binder EB, et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008 ; 299 : 1291-1305.
PubMed
19) Selemon LD, et al. Frontal lobe circuitry in posttraumatic stress disorder. Chronic Stress 2019 ; 3 : 1-17.
PubMed
20) 飛鳥井望, 鶴田信子. 性犯罪・性暴力被害者のトラウマケア. こころの科学 2019 ; 228 : 37-41.
 
21) National Institute for Health and Care Excellence (NICE). Evidene-based recommendations on recognising, assessing and treating post-traumatic stress disorder (PTSD) in children, young people and adults (NICE guideline, NG116). https://www.nice.org.uk/guidance/ng116
 
22) エドナ・B・フォアほか (著), 金吉晴ほか (監訳). PTSDの持続エクスポージャー療法-トラウマ体験の情動処理のために. 星和書店 ; 2009.
 
23) パトリシア・A・リーシックほか (著), 伊藤正哉ほか (監修). トラウマへの認知処理療法-治療者のための包括的手引き. 創元社 ; 2019.
 
24) ジュディス・A・コーエンほか (著), 白川美也子ほか (監訳). 子どものトラウマと悲嘆の治療-トラウマ・フォーカスト認知行動療法マニュアル. 金剛出版 ; 2014.
 
25) マギー・シャウアーほか (著), 森茂起ほか (訳). ナラティブ・エクスポージャー・セラピー-人生史を語るトラウマ治療. 金剛出版 ; 2010.
 
26) Asukai N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events : A randomized controlled study. J Trauma Stress 2010 ; 23 : 744-750.
PubMed
27) Kameoka S, et al. Effectiveness of trauma-focused cognitive behavioral therapy for Japanese children and adolescents in community settings : A multisite randomized controlled trial. Euro J Psychotraumatol 2020 ; 11 (1) : 1767987. DOI : 10.1080/20008198.2020.1767987
 
28) Bisson JI, et al. Pharmacological and other biological treatments. In : Forbes D, et al (eds). Effective Treat-ments for PTSD, 3rd edition : Practice Guidelines from the International Society for Traumatic Stress Studies. Guilford Press ; 2020. pp272-286.
 
日本トラウマティック・ストレス学会. PTSD初期対応マニュアル : プライマリケア医のために (第1版). www.jstss.org/wp/wp-content/uploads/2013/09/JSTSS-PTSD初期対応マニュアル第1版.pdf
 
Shalev AY, Marmar CR. Posttraumatic stress disorder. In : Sadock BJ, et al (eds). Kaplan & Sadock's Comprehensive Textbook of Psychiatry, tenth edition. Wolters Kluwer ; 2017, pp1812-1826.
 
Forbes D, et al (eds). Effective treatments for PTSD, 3rd edition : Practice guideline from the International Society for Traumatic Stress Studies. Guilford Press ; 2020.
 
P.260 掲載の参考文献
1) Ford, JD. (2017) Complex trauma and complex posttraumatic stress disorder. In : Gold SN, et al (eds). APA Handbook of Trauma Psychology. American Psychological Association ; 2017, pp281-305.
 
2) Herman JL. Trauma and Recovery. Basic Books ; 1992/中井久夫 (訳). 心的外傷と回復 (増補版). みすず書房 ; 1999, pp187.
 
3) van der Kolk BA, et al. Disorders of extreme stress : The empirical foundation of a complex adaptation to trauma. J Trauma Stress 2005 ; 18 : 389-399.
PubMed
4) Friedman MJ, et al. Considering PTSD for DSM-5. Depress Anxiety 2011 ; 28 : 750-769.
PubMed
5) Brewin CR, et al. A review of current evidence regarding the ICD-11 proposals for diagnosing PTSD and complex PTSD. Clin Psychol Rev 2017 ; 58 : 1-15.
PubMed
6) World Health Organization. ICD-11 Mortality and Morbidity Statistics, 6B41 Complex post traumatic stress disorder. 2018. http://id.who.int/icd/entity/585833559
 
7) Cloitre M, et al. Evidence for proposed ICD-11 PTSD and complex PTSD : A latent profile analysis. Eur J Psychotraumatol 2013 ; 4. doi : 10.3402/ejpt.v4i0.20706
 
8) Cloitre M, et al. The International Trauma Questionnaire : Development of a self-report measure of ICD-11 PTSD and Complex PTSD. Acta Psychiatr Scand 2018 ; 136 : 536-546. doi : 10.1111/acps.12956/日本語版 : 井上幸子 (訳). https://www.traumameasuresglobal.com/itq
 
9) Cloitre M, et al. Distinguishing PTSD, complex PTSD, and borderline personality disorder : A latent class analysis. Eur J Psychotraumatol 2014 ; 5 : 10.3402/ejpt.v5.25097
 
10) Cloitre M, et al. The ISTSS expert consensus treatment guidelines for complex PTSD in adults. 2012. http//www.istss.org
 
11) Cloitre M, et al. Treatment for PTSD related to childhood abuse : A randomized controlled trial. Am J Psychiatry 2010 ; 167 : 915-924.
PubMed
12) Resick PA, et al. Advocacy through science : Reply to comments on Resick et al. (2012). J Trauma Stress 2012 ; 25 : 260-263.
 
13) Resick PA, et al. A critical evaluation of the complex PTSD literature : Implications for DSM-5. J Trauma Stress 2012 ; 25 : 241-251.
PubMed
P.271 掲載の参考文献
1) Stroebe MS, et al. Bereavement research : Contemporary perspectives. In : Stroebe MS et al (eds). Handbook of bereavement research and practice : Advances in theory and intervention. American Psychological Association ; 2008 : pp3-25/森茂起ほか (訳). 死別体験-研究と介入の最前線. 誠信書房 ; 2014 : p4.
 
2) Prigerson HG, et al. Complicated grief and bereavement-related depression as distinct disorders : Preliminary empirical validation in elderly bereaved spouses. Am J Psychiatry 1995 ; 152 (1) : 22-30.
PubMed
3) Prigerson HG, Jacob SC. Traumatic Grief as a distinct disorder : A rationale, consensus criteria, and preliminary empirical test. American Psychological Association ; 2001.
 
4) Prigerson HG, et al. Traumatic grief as a risk factor for mental and physical morbidity. Am J Psychiatry 1997 ; 154 (5) : 616-623.
PubMed
5) Boelen PA, Prigerson HG. The influence of symptoms of prolonged grief disorder, depression, and anxiety on quality of life among bereaved adults : A prospective study. Eur Arch Psychiatry Clin Neurosci 2007 ; 257 (8) : 444-452.
PubMed
6) Prigerson HG, et al. A case for inclusion of prolonged grief disorder in DSM-V. In : Stroebe M, et al (eds). Handbook of bereavement research and practice : Advances in theory and intervention : American Psychological Association ; 2008 : pp165-186.
 
7) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fifth edition. American Pscyhiatric Publicatioin ; 2013.
 
8) Frued S. Trauer und melancholie. Internanationale zeidschrift fur arzriche. Psychoanalyse 1917 ; 4 : 288-301.
 
9) Bowlby J. Attachment and Loss, Vol3 Loss-Sadness and Depression. Tavistock Institute of Human Relations ; 1982.
 
10) Parkes CM. Bereavement-Studies of Grief in Adult life, third edition. Routledge ; 1996.
 
11) Worden JM. Grief Counseling and Grief Therapy : A Handbook for the Mental health Practitioner, 4th edition. Springer Publishing Company, LLC. ; 2008.
 
12) Stroebe M, Schut H. The dual process model of coping with bereavement : Rationale and description. Death Studies 1999 ; 23 (3) : 197-224.
PubMed
13) Maciejewski PK, et al. An empirical examination of the stage theory of grief. JAMA 2007 ; 297 (7) : 716-723.
PubMed
14) Lindemann E. Symptomatology and management of acute grief. Am J Psychiatry 1994 ; 151 (6 Suppl) : 155-160.
 
15) Shear MK, et al. Complicated grief and related bereavement issues for DSM-5. Depress Anxiety 2011 ; 28 (2) : 103-117.
PubMed
16) Boelen PA, Prigerson HG. Commentary on the inclusion of persistent complex bereavement-related disorder in DSM-5. Death Stud 2012 ; 36 (9) : 771-794.
PubMed
17) World Health Organization. ICD-11 for Mortality and Morbidity Statistics (Version : 04/2019) https://icd.who.int/browse11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f1183832314
 
18) Maciejewski PK, et al. "Prolonged grief disorder" and "persistent complex bereavement disorder", but not "complicated grief ", are one and the same diagnostic entity : An analysis of data from the Yale Bereavement Study. World Psychiatry 2016 ; 15 (3) : 266-275.
 
19) Bonanno GA, Malgaroli M. Trajectories of grief : Comparing symptoms from the DSM-5 and ICD-11 diagnoses. Depress Anxiety 2020 ; 37 (1) : 17-25.
PubMed
20) O'Connor M, et al. Comparison of proposed diagnostic criteria for pathological grief using a sample of elderly bereaved spouses in Denmark : Perspectives on future bereavement research. J Affect Disord 2019 ; 251 : 52-59.
 
21) Shear K, et al. Treatment of complicated grief : A randomized controlled trial. JAMA 2005 ; 293 (21) : 2601-2608.
PubMed
22) Simon NM, et al. The prevalence and correlates of psychiatric comorbidity in individuals with complicated grief. Compr Psychiatry 2007 ; 48 (5) : 395-399.
PubMed
23) O'Connor MF, et al. Craving love? Enduring grief activates brain's reward center. NeuroImage 2008 ; 42 (2) : 969-972.
 
24) Bartels A, Zeki S. The neural correlates of maternal and romantic love. NeuroImage 2004 ; 21 (3) : 1155-1166.
PubMed
25) Freed PJ, et al. Neural mechanisms of grief regulation. Biol Psychiatry 2009 ; 66 (1) : 33-40.
PubMed
26) Shor E, et al. Widowhood and mortality : A meta-analysis and meta-regression. Demography 2012 ; 49 (2) : 575-606.
PubMed
27) Lundorff M, et al. Prevalence of prolonged grief disorder in adult bereavement : A systematic review and meta-analysis. J Affect Disord 2017 ; 212 : 138-149.
PubMed
28) Ben-Ezra M, et al. A cross-country psychiatric screening of ICD-11 disorders specifically associated with stress in Kenya, Nigeria and Ghana. Eur J Psychotraumatol 2020 ; 11 (1) : 1720972.
PubMed
29) Mizuno Y, et al. A nationwide random sampling survey of potential complicated grief in Japan. Death Stud 2012 ; 36 (5) : 447-461.
PubMed
30) Miyajima K, et al. Association between quality of end-of-life care and possible complicated grief among bereaved family members. J Palliat Med 2014 ; 17 (9) : 1025-1031.
PubMed
31) Rynearson EK, McCreery JM. Bereavement after homicide : A synergism of trauma and loss. Am J Psychiatry 1993 ; 150 (2) : 258-261.
PubMed
32) 中島聡美ほか. 犯罪被害者遺族の精神健康とその回復に関連する因子の検討. 精神神経学雑誌 2009 ; 111 (4) : 423-429.
 
33) Williams JL, Rheingold AA. Barriers to care and service satisfaction following homicide loss : Associations with mental health outcomes. Death Stud 2015 ; 39 (1-5) : 12-18.
 
34) Neria Y, et al. Prevalence and psychological correlates of complicated grief among bereaved adults 2.5-3.5 years after September 11th attacks. J Trauma Stress 2007 ; 20 (3) : 251-262.
PubMed
35) Lee SH, et al. Factors Associated with Complicated Grief in Students Who Survived the Sewol Ferry Disaster in South Korea. Psychiatry Investig 2018 ; 15 (3) : 254-260.
PubMed
36) de Groot M, Kollen BJ. Course of bereavement over 8-10 years in first degree relatives and spouses of people who committed suicide : Longitudinal community based cohort study. BMJ 2013 ; 347 : f5519.
PubMed
37) Kristensen P, et al. Psychiatric disorders among disaster bereaved : An interview study of individuals directly or not directly exposed to the 2004 tsunami. Depress Anxiety 2009 ; 26 (12) : 1127-1133.
 
38) Simon NM. Treating complicated grief. JAMA 2013 ; 310 (4) : 416-423.
PubMed
39) Lobb EA, et al. Predictors of complicated grief : A systematic review of empirical studies. Death Stud 2010 ; 34 (8) : 673-698.
PubMed
40) Barry LC, et al. Psychiatric disorders among bereaved persons : The role of perceived circumstances of death and preparedness for death. Am J Geriatr Psychiatry 2002 ; 10 (4) : 447-457.
PubMed
41) Heeke C, et al. A systematic review and meta-analysis of correlates of prolonged grief disorder in adults exposed to violent loss. Eur J Psychotraumatol 2019 ; 10 (1) : 1583524.
PubMed
42) Latham AE, Prigerson HG. Suicidality and bereavement : Complicated grief as psychiatric disorder presenting greatest risk for suicidality. Suicide Life Threat Behav 2004 ; 34 (4) : 350-362.
PubMed
43) Silverman GK, et al. Quality of life impairments associated with diagnostic criteria for traumatic grief. Psychol Med 2000 ; 30 (4) : 857-862.
PubMed
44) Maccallum F, Bryant RA. A Network Approach to Understanding Quality of Life Impairments in Prolonged Grief Disorder. J Trauma Stress 2020 ; 33 (1) : 106-115.
 
45) Wittouck C, et al. The prevention and treatment of complicated grief : A meta-analysis. Clin Psychol Rev 2011 ; 31 (1) : 69-78.
PubMed
46) 中島聡美ほか. 災害による死別の遺族の悲嘆に対する心理的介入. トラウマティック・ストレス 2012 ; 10 (1) : 71-76.
Medical*Online
47) 中島聡美, 白井明美. 犯罪被害者の精神健康とメンタルヘルスサービス. 日本アルコール・薬物医学会雑誌 2007 ; 42 (1) : 21-31.
 
48) World Health Organization. War Trauma Foundation and World Vision International. Psychological first aid : Guide for field workers. World Health Organization ; 2011.
 
49) Vachon ML, et al. A controlled study of self-help intervention for widows. Am J Psychiatry 1980 ; 137 (11) : 1380-1384.
PubMed
50) Dyregrov K, et al. Participants' recommendations for the ideal grief group : A qualitative study. Omega (Westport) 2013 ; 67 (4) : 363-377.
 
51) Pasternak RE, et al. Acute open-trial nortriptyline therapy of bereavement-related depression in late life. J Clin Psychiatry 1991 ; 52 (7) : 307-310.
 
52) Zygmont M, et al. A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief. J Clin Psychiatry 1998 ; 59 (5) : 241-245.
PubMed
53) Simon NM, et al. Complicated grief : A case series using escitalopram. Am J Psychiatry 2007 ; 164 (11) : 1760-1761.
PubMed
54) Hensley PL, et al. Escitalopram : An open-label study of bereavement-related depression and grief. J Affect Disord 2009 ; 113 (1-2) : 142-149.
 
55) Shear MK, et al. Optimizing Treatment of Complicated Grief : A Randomized Clinical Trial. JAMA Psychiatry 2016 ; 73 (7) : 685-694.
PubMed
56) Johannsen M, et al. Psychological interventions for grief in adults : A systematic review and meta-analysis of randomized controlled trials. J Affect Disord 2019 ; 253 : 69-86.
PubMed
57) Shear MK, et al.Treatment of complicated grief in elderly persons : A randomized clinical trial. JAMA Psychiatry 2014 ; 71 (11) : 1287-1295.
 
58) Boelen PA, et al. Treatment of complicated grief : A comparison between cognitive-behavioral therapy and supportive counseling. J Consult Clin Psychol 2007 ; 75 (2) : 277-284.
PubMed
59) Bryant RA, et al. Treating prolonged grief disorder : A randomized clinical trial. JAMA Psychiatry 2014 ; 71 (12) : 1332-1339.
PubMed
60) Wagner B, et al. Internet-based cognitive-behavioral therapy for complicated grief : A randomized controlled trial. Death Stud 2006 ; 30 (5) : 429-453.
PubMed
61) Langner R, Maercker A. Complicated grief as a stress response disorder : Evaluating diagnostic criteria in a German sample. J Psychosom Res 2005 ; 58 (3) : 235-242.
 
62) Asukai N, et al. Pilot study on traumatic grief treatment program for Japanese women bereaved by violent death. J Trauma Stress 2011 ; 24 (4) : 470-473.
 
63) 中島聡美ほか. 日本における複雑性悲嘆の認知行動療法 (CGT) の有効性についての予備的研究. 精神神経学雑誌. 2017 (2017特別号) : S463.
 
64) Comtesse H, et al. When does grief become pathological? Evaluation of the ICD-11 diagnostic proposal for prolonged grief in a treatment-seeking sample. Eur J Psychotraumatol 2020 ; 11 (1) : 1694348.
 
65) 黒澤美枝ほか. 複雑性悲嘆の集団認知行動療法 (ENERGY) の実践. トラウマティック・ストレス 2018 ; 16 (1) : 17-23.
Medical*Online
66) 中島聡美ほか. 複雑性悲嘆治療 (CGT) のコンサルテーション-海外で開発された治療技法の日本への導入の課題. 認知療法研究 2020 ; 13 (1) : 25-27.
 
67) Nakajima S. Complicated grief : Recent developments in diagnostic criteria and treatment. Philos Trans R Soc Lond B Biol Sci 2018 ; 373 (1754).
PubMed
68) Prigerson HG, et al. Inventory of Complicated Grief : A scale to measure maladaptive symptoms of loss. Psychiatry Res 1995 ; 59 (1-2) : 65-79.
 
69) Shear KM, et al. Screening for complicated grief among Project Liberty service recipients 18 months after September 11, 2001. Psychiatr Serv 2006 ; 57 (9) : 1291-1297.
PubMed
70) 中島聡美ほか. 遷延性悲嘆障害の実態と危険因子に関する研究-罪責感の与える影響およびソーシャルサポートの役割を中心に. 明治安田こころの健康財団研究助成論文集 2010 ; 45 : 119-126.
 
71) 中井久夫ほか. 犯罪, 事故などにより家族, 肉親を失った遺族の心理的影響とケアのあり方に関する研究. (財) 21世紀ヒューマンケア機構こころのケア研究所 ; 2004.
 
72) Ito M, et al. Brief measure for screening complicated grief : Reliability and discriminant validity. PLoS One 2012 ; 7 (2) : e31209.
PubMed
73) ダギーセンター (編), NPO法人レジリエンス (日本語監修). グリーフケア・マニュアル-喪失の悲しみに向き合う. NPO法人レジリエンス ; 2008.
 
74) Boelen PA, et al. Comparison of DSM-5 criteria for persistent complex bereavement disorder and ICD-11 criteria for prolonged grief disorder in help-seeking bereaved children. J Affect Disord 2019 ; 250 : 71-78.
 
75) Cohen JA, et al. Treating Trauma and Traumatic Grief in Children and Adolescents. The Guilford Press ; 2006.
 
Stroebe MS, et al. Health outcomes of bereavement. Lancet 2007 ; 370 (9603) : 1960-1973.
 
Stroebe MS, et al. Handbook of bereavement research and practice : Advances in theory and intervention. American Psychological Association ; 2008. (一部は邦訳されている. 森茂起ほか<訳> . 死別体験-研究と介入の最前線. 誠信書房 ; 2014.)
 
Simon NM. Treating complicated grief. JAMA 2013 ; 310 (4) : 416-423.
PubMed
Nakajima S. Complicated grief : Recent developments in diagnostic criteria and treatment. Philos Trans R Soc Lond B Biol Sci 2018 ; 373 (1754) : 20170273.
PubMed
P.280 掲載の参考文献
1) Reed GM, et al. The WPA-WHO Global Survey of Psychiatrists' Attitudes Towards Mental Disorders Classification. World Psychiatry 2011 ; 10 (2) : 118-131.
PubMed
2) Evans SC, et al. Psychologists' perspectives on the diagnostic classification of mental disorders : Results from the WHO-IUPsyS Global Survey. Int J Psychol 2013 ; 48 (3) : 177-193.
PubMed
3) Maercker A, et al. Adjustment disorders as stress response syndromes : A new diagnostic concept and its exploration in a medical sample. Psychopathology 2007 ; 40 (3) : 135-146.
 
4) Baumeister H, Kufner K. It is time to adjust the adjustment disorder category. Curr Opin Psychiatry 2009 ; 22 (4) : 409-412.
PubMed
5) Patra BN, Sarkar S. Adjustment disorder : Current diagnostic status. Indian J Psychol Med 2013 ; 35 (1) : 4-9.
PubMed
6) Fard K, et al. Undiagnosed psychiatric illness in adolescents. A prospective study and seven-year follow-up. Arch Gen Psychiatry 1978 ; 35 (3) : 279-282.
PubMed
7) 日本精神神経学会. ICD-11 診断ガイドライントレーニングセミナー 2019年版資料.
 
8) Perkonigg A, et al. Prevalence and correlates of ICD-11 adjustment disorder : Findings from the Zurich Adjustment Disorder Study. Int J Clin Health Psychol 2018 ; 18 (3) : 209-217.
PubMed
9) Lorenz L, et al. Is adjustment disorder unidimensional or multidimensional? Implications for ICD-11. Int J Methods Psychiatr Res 2018 ; 27 (1) : e1591.
 
10) Bachem R, et al. ICD-11 Adjustment Disorder among Organ Transplant Patients and Their Relatives. Int J Environ Res Public Health 2019 ; 16 (17) : 3030.
PubMed
11) Killikelly C, et al. Prolonged grief disorder : Its co-occurrence with adjustment disorder and post-traumatic stress disorder in a bereaved Israeli general-population sample. J Affect Disord 2019 ; 249 : 307-314.
 
12) Kocalevent RD, et al. Adjustment disorders as a stress-related disorder : A longitudinal study of the associations among stress, resources, and mental health. PLoS One 2014 ; 9 (5) : e97303.
PubMed
13) O'Donnell ML, et al. A Longitudinal Study of Adjustment Disorder After Trauma Exposure. Am J Psychiatry 2016 ; 173 (12) : 1231-1238.
PubMed
14) Maercker A, et al. Adjustment disorders : Prevalence in a representative nationwide survey in Germany. Soc Psychiatry Psychiatr Epidemiol 2012 ; 47 (11) : 1745-1752.
 
15) Casey P, et al. Can adjustment disorder and depressive episode be distinguished? Results from ODIN. J Affect Disord 2006 ; 92 (2-3) : 291-297.
 
16) Einsle F, et al. Development and validation of a self-report for the assessment of adjustment disorders. Psychol Health Med 2010 ; 15 (5) : 584-595.
PubMed
17) Gradus JL. Prevalence and prognosis of stress disorders : A review of the epidemiologic literature. Clin Epidemiol 2017 ; 9 : 251-260.
PubMed
18) Glaesmer H, et al. Adjustment disorder as proposed for ICD-11 : Dimensionality and symptom differentiation. Psychiatry Res 2015 ; 229 (3) : 940-948.
PubMed
19) Dobricki M, et al. Adjustment disorders after severe life-events in four postconflict settings. Soc Psychiatry Psychiatr Epidemiol 2010 ; 45 (1) : 39-46.
PubMed
20) Strain JJ, et al. Adjustment disorder : A multisite study of its utilization and interventions in the consultation-liaison psychiatry setting. Gen Hosp Psychiatry 1998 ; 20 (3) : 139-149.
PubMed
21) Taggart C, et al. Accuracy of diagnosis at routine psychiatric assessment in patients presenting to an accident and emergency department. Gen Hosp Psychiatry 2006 ; 28 (4) : 330-335.
 
22) Mitchell AJ, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings : A meta-analysis of 94 interview-based studies. Lancet Oncol 2011 ; 12 (2) : 160-174.
PubMed
23) Okamura H, et al. Psychological distress following first recurrence of disease in patients with breast cancer : Prevalence and risk factors. Breast Cancer Res Treat 2000 ; 61 (2) : 131-137.
PubMed
24) Silverstone PH. Prevalence of psychiatric disorders in medical inpatients. J Nerv Ment Dis 1996 ; 184 (1) : 43-51.
PubMed
25) O'Donnell ML, et al. Adjustment Disorder : Current Developments and Future Directions. Int J Environ Res Public Health 2019 ; 16 (14) : 2537.
PubMed
26) Casey P. Adjustment disorder : New developments. Curr Psychiatry Rep 2014 ; 16 (6) : 451.
PubMed
27) Selye H. The Stress of Life. McGraw-Hill ; 1956 revised ed, 1976/一杉靖三郎ほか (訳). 現代社会とストレス. 法政大学出版局 ; 1988.
 
28) 土居健郎. 新訂 方法としての面接-臨床家のために. 医学書院 ; 1992, pp36-49.
 
29) Strain JJ, Diefenbacher A. The adjustment disorders : The conundrums of the diagnoses. Compr Psychiatry 2008 ; 49 (2) : 121-130.
PubMed
30) Casey P. Adjustment disorder : Epidemiology, diagnosis and treatment. CNS Drugs 2009 ; 23 (11) : 927-938.
PubMed
31) Carta MG, et al. Adjustment Disorder : Epidemiology, diagnosis and treatment. Clin Pract Epidemiol Ment Health 2009 ; 5 : 15.
PubMed
32) Richards DA, et al. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA) : A randomised, controlled, non-inferiority trial. Lancet 2016 ; 388 (10047) : 871-880.
 
33) Baumeister H. Behavioural activation training for depression. Lancet 2017 ; 389 (10067) : 366-367.
PubMed
34) Andersson G, et al. Guided Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders : A systematic review and meta-analysis. World Psychiatry 2014 ; 13 (3) : 288-295.
PubMed
35) Bachem R, Maercker A. Self-help interventions for adjustment disorder problems : A randomized waiting-list controlled study in a sample of burglary victims. Cogn Behav Ther 2016 ; 45 (5) : 397-413.
 
36) Maercker A, et al. Adjustment Disorders Are Uniquely Suited for eHealth Interventions : Concept and Case Study. JMIR Ment Health 2015 ; 2 (2) : e15.
PubMed
37) Spiegel D. Mind matters in cancer survival. Psychooncology 2012 ; 21 (6) : 588-593.
PubMed
38) Ruesch M, et al. Immediate help through group therapy for patients with somatic diseases and depressive or adjustment disorders in outpatient care : Study protocol for a randomized controlled trial. Trials 2015 ; 16 : 287.
PubMed
39) Davidson L, et al. Peer support among persons with severe mental illnesses : A review of evidence and experience. World Psychiatry 2012 ; 11 (2) : 123-128.
PubMed
40) Mahlke CI, et al. Peer support in mental health services. Curr Opin Psychiatry 2014 ; 27 (4) : 276-281.
PubMed
41) Bos EH, et al. Mindfulness training in a heterogeneous psychiatric sample : Outcome evaluation and comparison of different diagnostic groups. J Clin Psychol 2014 ; 70 (1) : 60-71.
 
42) Srivastava M, et al. Meditation for the management of adjustment disorder anxiety and depression. Complement Ther Clin Pract 2011 ; 17 (4) : 241-245.
PubMed
43) Andersson G, Hedman E. Effectiveness of guided internet-based cognitive behavior therapy in regular clinical settings. Verhaltenstherapie 2013 ; 23 : 140-148.
 
44) Andersson G, Titov N. Advantages and limitations of internet-based interventions for common mental disorders. World Psychiatry 2014 ; 13 : 4-11.
PubMed
45) Skruibis P, et al. Internet-based modular program BADI for adjustment disorder : Protocol of a randomized controlled trial. BMC Psychiatry 2016 ; 16 : 264.
PubMed
46) Domhardt M, Baumeister H. Psychotherapy of adjustment disorders : Current state and future directions. World J Biol Psychiatry 2018 ; 19 (Suppl 1) : S21-S35.
 
47) Stein DJ. Pharmacotherapy of adjustment disorder : A review. World J Biol Psychiatry 2018 ; 19 (Suppl 1) : S46-S52.
 
P.288 掲載の参考文献
1) 厚生労働省. 平成29年 労働安全衛生調査 (実態調査). 結果の概要. https://www.mhlw.go.jp/toukei/list/dl/h29-46-50_kekka-gaiyo01.pdf
 
2) Sado M, et al. Cost of depression among adults in Japan in 2005. Psychiatry Clin Neurosci 2011 ; 65 (5) : 442-450.
PubMed
3) Sado M, et al. Cost of anxiety disorders in Japan in 2008 : A prevalence-based approach. BMC Psychiatry 2013 ; 13 (1) : 338.
PubMed
4) Sado M, et al. The cost of schizophrenia in Japan. Neuropsychiatr Dis Treat 2013 ; 9 : 787-798.
PubMed
5) 厚生労働省. 平成24年 労働者健康状況調査. 結果の概要. https://www.mhlw.go.jp/toukei/list/dl/h24-46-50_01.pdf
 
6) Sado M, et al. Predictors of repeated sick leave in the workplace because of mental disorders. Neuropsychiatr Dis Treat 2014 ; 10 : 193-200.
PubMed
7) 厚生労働省. 改訂 心の健康問題により休業した労働者の職場復帰支援の手引き. 2019. https://www.mhlw.go.jp/content/000561013.pdf
 
P.295 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の分類と診断の手引き. 医学書院 ; 2014.
 
2) World Health Organization (WHO). International Classification of Disease, 10th revision (ICD-10)/融道男ほか (監訳). ICD-10 精神および行動の障害-臨床記述と診断ガイドライン 新訂版. 医学書院 ; 2005.
 
3) Gleason MM, et al. Validity of evidence-derived criteria for reactive attachment disorder : Indiscriminately social/disinhibited and emotionally withdrawn/inhibited types. J Am Acad Child Adolesc Psychiatry 2011 ; 50 (3) : 216-231.
PubMed
4) Minnis H, et al. Autism and attachment disorder symptoms in the general population : Prevalence, over-lap, and burden. Developmental Child Welfare 2020 : 1-15.
 
5) Allen B, et al. Attachment disorders diagnosed by community practitioners : A replication and extension. Child Adolesc Ment Health 2020 ; 25 (1) : 4-10.
PubMed
6) Guyon-Harris KL, et al. Adverse caregiving in early life : The trauma and deprivation distinction in young hildren. Infant Ment Health J ; 2020 : 1-9.
 
7) Zeanah CH, et al. Commentary : Increasing diagnostic precision in reactive attachment disorder-a commentary on Allen & Schuengel (2019). Child Adolesc Ment Health 2020 ; 25 (1) : 11-12.
PubMed
8) Bowlby J. Effects on behaviour of disruption of an affectional bond. Eugen Soc Symp 1968 ; 4 : 94-108.
PubMed
9) Guyon-Harris KL, et al. A prospective longitudinal study of reactive attachment disorder following early institutional care : Considering variable- and person-centered approaches. Attach Hum Dev 2019 ; 21 (2) : 95-110.
PubMed
10) Cicchetti D, et al. Fostering secure attachment in infants in maltreating families through preventive interventions. Dev Psychopathol 2006 ; 18 (3) : 623-649.
PubMed
11) Mayes SD, et al. Reactive attachment/disinhibited social engagement disorders : Callous-unemotional traits and comorbid disorders. Res Dev Disabil 2017 ; 63 : 28-37.
PubMed
12) Sonuga-Barke EJ, et al. Child-to-adult neurodevelopmental and mental health trajectories after early life deprivation : The young adult follow-up of the longitudinal English and Romanian Adoptees study. Lancet 2017 ; 389 : 1539-1548.
 
13) Nishiyama T, et al. The Kiddie Schedule for Affective Disorders and Schizophrenia Present and Lifetime Version (K-SADS-PL) for DSM-5 : A validation for neurodevelopmental disorders in Japanese outpatients. Compr Psychiatry 2020 ; 96 : 152148.
PubMed
14) Mackes NK, et al. Early childhood deprivation is associated with alterations in adult brain structure despite subsequent environmental enrichment. Proc Natl Acad Sci U S A 2020 ; 117 (1) : 641-649.
PubMed
15) Shimada K, et al. Reduced visual cortex grey matter volume in children and adolescents with reactive attachment disorder. Neuroimage Clin 2015 ; 9 : 13-19.
PubMed
16) Fujisawa TX, et al. Type and timing of childhood maltreatment and reduced visual cortex volume in children and adolescents with reactive attachment disorder. Neuroimage Clin 2018 ; 20 : 216-221.
PubMed
17) Jung M, et al. Thalamic Volume Is Related to Increased Anterior Thalamic Radiations in Children with Reactive Attachment Disorder. Cereb Cortex 2020 ; 30 : 4238-4245.
PubMed
18) Nelson CA, et al. Romania's Abandoned Children : Deprivation, Brain Development, and the Struggle for Recovery. Harvard University Press ; 2014/門脇陽子ほか (訳). ルーマニアの遺棄された子どもたちの発達への影響と回復への取り組み. 福村出版 ; 2018.
 
19) Rutter M, et al. Policy and Practice Implications from the English and Romanian Adoptees (ERA) Study. British Association for Adoption and Fostering (BAAF) ; 2009/上鹿渡和宏 (訳). イギリス・ルーマニア養子研究から社会的養護への示唆. 福村出版 ; 2012.
 
P.302 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR). American Psychiatric Association ; 2000.
 
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5). American Psychiatric Association ; 2013.
 
3) World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders : Clinical Descriptions and Diagnostic Guidelines. World Health Organization ; 1992.
 
4) World Health Organization. ICD-11 for Mortality and Morbidity Statistics (version : 09/2020). https://icd.who.int/browse11/l-m/en.
 
5) Nelson C, et al. Roumania's Abandoned Children : Deprevation, Brain Development, and the Struggle for Recovery. Harvard University Press ; 2014/上鹿渡和宏ほか (監訳). ルーマニアの遺棄された子どもたちの発達への影響と回復への取り組み. 福村出版 ; 2018.
 
6) Bowlby J. Attachment and loss : Vol. 1. Attachment. Basic Books ; 1982. (Original work published 1969)
 
7) Lamb M, et al. Infant-Mother Attachment : The Origins and Developmental Significance of Individual Differences in Strange Situation Behavior. Routledge ; 1985.
 
8) Cassidy J. The nature of the child's ties. In : Cassidy J, et al (eds). Handbook of Attachment. The Guklford Press ; 1999, pp3-20.
 
9) Zeanah C, et al. Practitioner Review : Clinical applications of attachment theory and research for infants and young children. J Child Psychol Psychiatry 2013 ; 52 : 819-833.
 
10) Ainsworth M, et al. Patterns of attachment, a psychological study of the Strange Situation. Erlbaum Associates ; 1978.
 
11) Carlson V, et al. Disorganized/Disoriented attachment relationships in maltreated infants. Developmental Psychology 1989 ; 25 : 525-531.
 
12) Thompson R. Early attachment and later development : Familiar Questions, New Answers. In : Cassidy J, et al (eds.). Handbook of Attachment. Guilford ; 2008, pp348-365.
 
13) Skeels H. Adult status of children with contrasting early life experiences. Monogr Soc Res Child Dev 1966 ; 31 (Serial no. 105).
 
14) Tizard B, Rees J. The effect of early institutional raring on the behavior problems and affectional relation-ships of four-year-old children. J Child Psychol Psychiatry 1975 ; 27 : 61-73.
 
15) Tizard B, Hodges J. The effect of early institutional raring on the development of eight-year-old children. J Child Psychol Psychiatry 1978 ; 19 : 99-118.
 
16) Gaensbauer T, Sands S. Distorted affective communications in abused/neglected infants and their potential impact on caretakers. J Am Acad Child Psychiatry 1979 ; 18 : 236-250.
 
17) Hoffman-Plokin D, Twentyman C. A multimodal assessment of behavioral and cognitie deficits in abused and neglected preschoolers. Child Development 1984 ; 55 : 794-802.
 
18) Smyke A, et al. Disturbances of the attachment in young children. I : The continuum of caretaking casualty. J Am Acad Child Adolesc Psychiatry 2002 ; 41 : 972-982.
PubMed
19) Boris N, et al. Comparing criteria for attachment disorders : Establishing reliability and validity in high-risk samples. J Am Acad Child Adolesc Psychiatry 2004 ; 44 : 1206-1219.
 
20) AACAP official action. Practice Parameter for the Assessment and Treatment of Children and Adolescents With Reactive Attachment Disorder and Disinhibited Social Engagement Disorder. J Am Acad Child Adolesc Psychiatry 2016 ; 55 : 990-1003.
 
21) Gleason MM, et al. Validity of evidence-derived criteria for reactive attachment disorder : Indiscriminately social/disinhibited and emotionally withdrawn/inhibited types. J Am Acad Child Adolesc Psychiatry 2011 ; 50 : 216-231.
PubMed
22) Hoksbergen R, et al. Post-institutional autistic syndrome in Romanian adoptees. J Autism Dev Disord 2005 ; 35 : 615-623.
PubMed
23) Rutter M, et al. Early adolescent outcomes of institutionally deprived and non-deprived adoptees. III. Quasi-autism. J Child Psychol Psychiatry 2007 ; 48 : 1200-1207.
PubMed
24) Gleason MM, et al. Epidemiology of psychiatric disorders in very young children in a Romanian pediatric setting. Eur J Child Adolesc Psychiatry 2011 ; 20 : 527-535.
 
25) Zeanah C, Gleason M. Annual research review : Attachment disorders in early childhood-clinical presentation, causes, correlates, and treatment. J Child Psychol Psychiatry 2015 ; 56 : 207-222.
PubMed
26) O'Connor T, et al. Attachment disturbances and disorders in children exposed to early severe deprivation. Infant Mental Health Journal 1999 ; 20 : 10-29.
 
27) Van Den Dries, et al. Infants' responsiveness, attachment, and indiscriminate friendliness after ineternational adoption from institutions or foster care in China : Application of Emotional Availability Scales to adoptive families. Development and Psychopathology 2012 ; 24 : 49-64.
PubMed
28) Love L, et al. Factors associated with indiscriminate friendliness in high-risk children. Infant Ment Health J 2015 ; 36 (4) : 427-445.
PubMed
29) Bruce J, et al. Disinhibited social behavior among internationally adopted children. Development and Psychopathology 2009 ; 21 : 157-171.
PubMed
30) Bakersman-Kranenberg MJ, et al. Impact of institutional care on attachment disorganization and insecurity of Ukrainian prescoolers : Protective effect of the long variant of the serotonin transporter gene (5-HTT). Int J Behav Dev 2011 ; 36 : 1-8.
 
31) Drury S, et al. Genetic sensitivity to the caregiving context : The influence of 5httpr and BDNF val66net on indiscriminate social behavior. Physiology and Behavior 2012 ; 106 : 728-735.
 
32) Zeanah C, Smyke A. Attachment Disorders. In : Zeanah C (ed). Handbook of Infant Mental Health, 3rd edition. Guilford Press ; 2009, pp421-434.
 
33) AACAP official action. Practice parameters for the assessment and treatment of children and adolescents with reactive attachment disorder of infancy and early childhood. J Am Acad Child Adolesc Psychiatry 2005 ; 44 : 1206-1219.
 
34) Zeanah C, et al. Practitioner Review : Clinical Applications of Attachment Theory and Research for Infants and Young Children. J Child Psychol Psychiatry 2011 ; 52 (8) : 819-833.
PubMed
35) Boris N, et al. Attachment and Developmental Psychopathology. Psychiatry 2000 ; 63 (1) : 75-84.
PubMed
36) Zeanah C, et al. Attachment disturbances in young children. II : Indiscriminate behavior and institutional care. J Am Acad Child Adolesc Psychiatry 2002 ; 41 : 983-989.
 
37) 青木豊ほか. 児童虐待等の子どもの被害, 及び子どもの問題行動の予防・介入・ケアに関する研究. 平成17年度厚生労働科学研究費補助金 (子ども家庭総合研究事業). 2006, pp425-442.
 
38) Hart A, Thomas H. Controversial attachments : The indirect treatment of fostered and adopted children via Parent Co-Therapy. Attach Hum Dev 2000 ; 2 : 306-327.
 
39) Rushton A, Minnis H. Residential and Foster Family Care. In : Rutter M, et al (eds). Rutter's Child and Adolescent Psychiatry, 5th edition. Blackwell Publishing ; 2008, pp487-501.
 
40) 森田展彰, 徳山美知代. アタッチメント・ベイスト・プログラム. 青木豊 (編), 乳幼児虐待のアセスメントと支援. 岩崎学術出版社 ; 2015, pp156-174.
 
41) 西澤哲. トラウマとアタッチメントに焦点を当てた心理療法. 青木豊 (編), 乳幼児虐待のアセスメントと支援. 岩崎学術出版社 ; 2015, pp175-191.
 
42) 青木豊ほか. アタッチメント・プログラム. 青木豊 (編), 乳幼児虐待のアセスメントと支援. 岩崎学術出版社 ; 2015, pp145-155.
 
43) 御園生直美. 乳幼児虐待における里親支援. 青木豊 (編), 乳幼児虐待のアセスメントと支援. 岩崎学術出版社 ; 2015, pp192-208.
 
44) Cline F. Hope for High Risk and Rage Filled Children. EC Publication ; 1992.
 
45) Adams B. Families struggle to bond with kids. The Salt Lake Tribune ; September 29. 2002.
 
46) Chisholm K. A three year follow-up of attachment and indiscriminate friendliness in children adopted from Romanian orphanages. Child Development 1998 ; 69 : 1092-1106.
 
47) Rutter M, et al. Emanuel Miller Lecture : Attachment insecurity, disinhibited attachment, and attachment disorders : Where do research findings leave the concepts? J Child Psychol Psychiatry 2009 ; 50 : 529-543.
 
48) Guyon-Harris KL, et al. Course of Disinhibited Social Engagement Disorder From Early Childhood to Early Adolescence. J Am Acad Child Adolesc Psychiatry 2018 ; 57 (5) : 329-335.e2.
 
49) Guyon-Harris KL, et al. Disinhibited Social Engagement Disorder in Early Childhood Predicts Reduced Competence in Early Adolescence. J Abnorm Child Psychol 2019 ; 47 (10) : 1735-1745.
PubMed
P.316 掲載の参考文献
1) American Psychiatric Association (APA). Diagnostic Statistical Manual of Mental Disorders, 5th edition (DSM-5). American Psychiatric Publishing (APP) ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (訳). DSM-5-精神疾患の診断・統計マニュアル. 医学書院 ; 2014, pp278-284.
 
2) Maercker A, et al. Diagnosis and classification of disorders specifically associated with stress : Proposals for ICD-11. World Psychiatry 2013 ; 12 (3) : 198-206.
PubMed
3) Bryant RA. The Current Evidence for Acute Stress Disorder. Curr Psychiatry Rep 2018 ; 20 (12) : 111.
PubMed
4) World Health Organization : ICD-11. https://icd.who.int/en
PubMed
5) 河野友信. 12) 不安と保健医療行動. 河野友信ほか (編), 不安の科学と健康. 朝倉書店 ; 1987, pp185-190.
 
6) 鈴木友理子. ICD分類の改訂に向けて-ストレス関連障害の動向. 精神神経誌 2013 ; 115 (1) : 69-75.
 
7) Cannon WB. The James-Lange theory of emotions : A critical examination and an alternative theory. Am J Psychol 1927 ; 39 : 106-124.
 
8) Selye E. A syndrome produced by diverse nocuous agents. Nature 1936 ; 138 : 32.
 
9) Schneider K. Klinishe Psychopathologie, 6 Aufl. Thieme ; 1950.
 
10) 塩入俊樹, 植木啓文. F43 重度ストレス反応 (重度ストレスへの反応) および適応障害. 中根允文ほか (監修), 岡崎祐司 (総編), 大久保善朗ほか (編), ICD-10 精神科診断ガイドブック. 中山書店 ; 2013, pp325-345.
 
11) Bryant RA. Acute stress disorder as a predictor of posttraumatic stress disorder : Asystematic review. J Clin Psychiatry 2011 ; 72 (2) : 233-239.
 
12) 大塚耕太郎, 酒井明夫. 東日本大震災に対するこころのケア活動・岩手の最前線から (1). 岩手医科大学における初動期から初期の支援. こころの科学 2011 ; 159 : 2-9.
 
13) 大塚耕太郎, 酒井明夫. 東日本大震災に対するこころのケア活動・岩手の最前線から (2). 中長期的なこころのケアの対策. こころの科学 2011 ; 160 : 2-15.
 
14) Wilkinson R, et al (eds). Social determinants of health. The solid facts, 2nd edition. World Health Organization ; 2003. http://www.euro.who.int/__data/assets/pdf_file/0005/98438/e81384.pdf
 
15) Kristensen P, et al. Prevalence of psychiatric disorders and functional impairment after loss of a family member : A longitudinal study after the 2004 tsunami. Depress Anxiety 2015 ; 32 : 49-56.
PubMed
16) 大塚耕太郎, 酒井明夫. 災害精神保健の視点に立った心身の健康回復. 教育と医学 2013 ; 3 : 184-191.
 
17) World Health Organization, War Trauma Foundation and World Vission International. Psychological first aid : Guide for field workers. World Health Organization ; 2011/国立精神・神経医療研究センター, ケア・宮城, プラン・ジャパン (訳). 心理的応急処置 (サイコロジカル・ファーストエイド : PFA) フィールド・ガイド. 2011. http://saigai-kokoro.ncnp.go.jp/pdf/who_pfa_guide.pdf
 
18) 大塚耕太郎. 危機に陥った状況を支える こころのケアを巡る基本視点. 社会と倫理 2016 ; 31 : 121-131.
 
19) Carlat DJ. The Psychiatric Interview : A Practical Guide. Lippincott Williams & Wilkins ; 1999.
 
20) 飛鳥井望, 鶴田信子. 性犯罪・性暴力被害者のトラウマケア. こころの科学 2019 ; 208 : 37-41.
 
21) 警察庁. 性犯罪・性暴力被害者のためのワンストップ支援センター開設・運営の手引-地域における性犯罪・性暴力被害者支援の一層の充実のために. 2012. https://www.npa.go.jp/hanzaihigai/kohyo/shien_tebiki/pdf/zenbun.pdf
 
22) 岩手県. はまなすサポート (岩手県性犯罪・性暴力被害者支援). 2017. http://www.pref.iwate.jp/anzenanshin/higaisha/059316.html
 
23) 有賀徹ほか. 自殺未遂者への対応-救急外来 (ER) ・救急科・救命救急センターのスタッフのための手引き. 日本臨床救急医学会 ; 2009.
 
24) 大塚耕太郎ほか. 第5章 自殺未遂者対応. 精神科救急医療ガイドライン 2015年版. へるす出版 ; 2015, pp135-184.
 
25) 河西千秋. 病院内の自殺事故. 河西千秋ほか (監修), 患者安全推進ジャーナル別冊 病院内の自殺対策のすすめ方. 日本医療機能評価機構 認定病院患者安全推進協議会 ; 2011, pp6-7.
 
26) 杉山直也. 自殺事故の実態 (協議会検討会の院内自殺事故調査データより). 河西千秋ほか (監修), 患者安全推進ジャーナル別冊 病院内の自殺対策のすすめ方. 日本医療機能評価機構 認定病院患者安全推進協議会 ; 2011, pp8-11.
 
27) 河西千秋ほか (監修). 患者安全推進ジャーナル別冊 病院内の自殺対策のすすめ方. 日本医療機能評価機構 認定病院患者安全推進協議会 ; 2011.
 
28) Inoue K, et al. A large-scale survey of inpatient suicides : Comparison between medical and psychiatric settings. Psychiatry Res 2017 ; 250 : 155-158.
 
29) B・キッチナー, A・ジョーム. メンタルヘルス・ファーストエイド・ジャパン (編訳). 専門家に相談する前のメンタルヘルス・ファーストエイド. 創元社 ; 2013.
 
30) Suzuki Y, et al. Effectiveness of brief suicide management training programme for medical residents in Japan : A cluster randomized controlled trial. Epidemiol Psychiatr Sci 2014 ; 23 : 167-176.
PubMed
31) Nakagami Y, et al. Development of a 2-h suicide prevention program for medical staff including nurses and medical residents : A two-center pilot trial. J Affect Disord 2018 ; 225 : 569-576.
 
32) 大塚耕太郎ほか. Mental Health First Aid-Japanチームの活動について. 精神神経誌 2013 ; 115 (7) : 792-796.
 
濱田秀伯. 精神病理学 臨床講義<第2版> . 弘文堂 ; 2017.
 
酒井明夫ほか (監), 大塚耕太郎ほか (編). 災害時のメンタルヘルス. 医学書院 ; 2016.
 
三村將 (編). DSM-5を読み解く 4. 不安症群, 強迫症および関連症群, 心的外傷およびストレス因関連障害群, 解離症群, 身体症状症および関連症群. 中山書店 ; 2014.
 
P.323 掲載の参考文献
1) Wilson SA, et al. Eye movement desensitization and reprocessing (EMDR) treatment for psychologically traumatized individuals. J Consult Clin Psychol 1995 ; 63 : 928-937.
PubMed
2) Wilson SA, et al. Fifteen-month follow-up of eye movement desensitization and reprocessing (EMDR) treatment for posttraumatic stress disorder and psychological trauma. J Consult Clin Psychol 1997 ; 65 : 1047-1056.
PubMed
3) Knipe J. EMDR Toolbox : Theory and treatment of complex PTSD and dissociation. Springer Publishing Company ; 2014/菊池安希子, 大澤智子 (訳). EMDRツールボックス-複雑性PTSDと解離の理論と治療. 星和書店 ; 2019.
 
4) Gonzalez A, Mosquera D. EMDR and dissociation : The progressive approach. A. I ; 2012.
 
5) Hofmann A, et al. Eye Movement Desensitization and Reprocessing as an Adjunctive Treatment of Unipolar Depression : A Controlled Study. J EMDR Pract Res 2014 ; 8 : 103-112.
 
6) De Jongh AD, et al. Usefulness of a trauma-focused treatment approach for travel phobia. Clin Psychol Psychother 2011 ; 18 : 124-137.
PubMed
7) Doering S, et al. Efficacy of a trauma-focused treatment approach for dental phobia : A randomized clinical trial. Eur J Oral Sci 2013 ; 121 : 584-593.
PubMed
8) Fernandez I, Faretta E. Eye movement desensitization and reprocessing in the treatment of panic disorder with agoraphobia. Clin Case Stud 2007 ; 6 : 44-63.
 
9) Hase M, et al. EMDR Reprocessing of the Addiction Memory : Pretreatment, Posttreatment, and 1-Month Follow-Up. J EMDR Pract Res 2008 ; 2 : 170-179.
 
10) 市井雅哉, 大塚美奈子. EMDR-PTSD以外の精神疾患への適用の有効性. 精神科治療学 2015 ; 30 : 129-133.
 
11) Maxfield L, Hyer L. The relationship between efficacy and methodology in studies investigating EMDR treatment of PTSD. J Clin Psychol 2002 ; 58 : 23-41.
PubMed
12) Leeds AM. A guide to the standard EMDR therapy protocols for clinicians, supervisors, and consultants. Springer Publishing Company ; 2016/太田茂行, 市井雅哉 (監訳). EMDR標準プロトコル実践ガイドブック-臨床家, スーパーバイザー, コンサルタントのために. 誠信書房 ; 2019.
 
13) Shapiro F. Eye movement desensitization and reprocessing (EMDR) therapy : Basic principles, protocols, and procedures, 3rd edition. The Guilford Press ; 2017.
 
14) Amano T, Seiyama A, Toichi M. Brain activity measured with near-infrared spectroscopy during EMDR treatment of phantom limb pain. J EMDR Pract Res 2013 ; 7 : 144-153.
 
15) 天野玉記ほか. 眼球運動による脱感作と再処理法 (EMDR) と自我状態療法を併用した面接過程でみられた脳血流変化-近赤外分光法 (NIRS) による検討. EMDR研究 ; 4 : 18-28.
 
16) Korn DL, Leeds AM. Preliminary evidence of efficacy for EMDR resource development and installation in the stabilization phase of treatment of complex posttraumatic stress disorder. J Clin Psychol 2002 ; 58 : 1465-1487.
PubMed
17) Shapiro E, Laub B. Early EMDR intervention following a community critical incident : A randomized clinical trial. J EMDR Pract Res 2015 ; 9 : 17-27.
 
18) Lehnung M, et al. Evaluating the EMDR group traumatic episode protocol with refugees : A field study. J EMDR Pract Res 2016 ; 11 : 129-138.
 
19) Jarero I, et al. EMDR integrative group treatment protocol : A postdisaster trauma intervention for children and adults. Traumatology (Tallahass Fla) 2006 ; 12 : 121-129.
 
20) Ichii M. Support Returning to Work after Reprocessing of Power Harassment Memory by EMDR. In : Paper presented at EMDR Asia 4th conference in Bangkok. 2020.
 
21) 市井雅哉. EMDR. ブリーフサイコセラピー学会 (編), ブリーフセラピー入門. 遠見書房 ; 2020.
 

4章 パーソナリティ症および関連特性群と作為症群

P.338 掲載の参考文献
1) 林直樹. パーソナリティ障害概念の歴史 DSM-III 以前. 神庭重信ほか (編), DSM-5を読み解く. 中山書店 ; 2014, pp138-150.
 
2) Millon T. Disorders of Personality : Introducing a DSM/ICD Spectrum from Normal to Abnormal, 3rd edition. Wiley & Sons ; 2011.
 
3) 武村信義. 精神病質の概念. 金剛出版 ; 1983.
 
4) 福島章. 精神病質から人格障害へ 歴史と展望. 福島章ほか (編), 人格障害. 金剛出版 ; 1995.
 
5) 中谷陽二. 人格障害の90年-Koch, SchneiderそしてDSM-III. 精神医学 2004 ; 46 (7) : 674-684.
 
6) Kraepelin E. Psychiatrie. Ein Lehrbuch fur Studierende und Arzte, Achte Auflage. Johann Ambrosius Barth ; 1913.
 
7) Schneider K. Die Psychopathischen Personlichkeiten. Franz Deuticke ; 1923/懸田克躬ほか (訳). 精神病質人格. みすず書房 ; 1954.
 
8) Kretschmer E. Medizinische Psychologie, Zehnte, verbesserte und vermehrte Auflage. Georg Thieme ; 1950/西丸四方, 高橋義夫 (訳). 医学的心理学 I, II. みすず書房 ; 1955.
 
9) Kretschmer E. Korperbau und Charakter. Springer-Verlag ; 1955/相場均 (訳). 体格と性格. 文光堂 ; 1960.
 
10) Griesinger W. Die Pathologie und Therapie der psychischen Krankheiten, 2. Aufl., 2. Abdr. Verlag von Adolf Krabbe ; 1867/小俣和一郎, 市野川容孝 (訳). 精神病の病理と治療. 東京大学出版会 ; 2011.
 
11) Cleckley HM. The Mask of Sanity : An Attempt to Clarify Some Issues About the So-called Psychopathic Personality (first published in 1955). Literary Licensing, LLC ; 2011.
 
12) McCord W, McCord J. Psychopathy and Delinquency. Grune & Stratton ; 1956/袴田正巳 (訳). 性格異常-その環境療法. 岩崎学術出版社 ; 1967.
 
13) Hare RD. Without conscience : The disturbing world of the psychopaths among us. Pocket Books ; 1993.
 
14) 小此木啓吾, 狩野力八郎. パーソナリティ障害の精神分析的研究. 福島章ほか (編). 人格障害. 金剛出版 ; 1995.
 
15) Reich W. Der triebhafte Chararter. Internationaler Psychoanalytischer Verlag 1925/片岡啓治 (訳). 衝動的性格. イザラ書房 ; 1973.
 
16) Kohut H. The analysis of the self. International Universities Press ; 1971/水野信義ほか (訳). 自己の分析. みすず書房 ; 1994.
 
17) Paris J. Treatment of borderline personality disorder : A guide to evidence-based practice. The Guilford Press ; 2008/黒田章史 (訳). 境界性パーソナリティ障害の治療-エビデンスに基づく治療方針. 金剛出版 ; 2014.
 
18) Conway CC, et al. Borderline personality disorder is equally trait-like and state-like over ten years in adult psychiatric patients. J Abnorm Psychol 2018 ; 127 (6) : 590-601.
PubMed
19) Spitzer RL, et al. Crossing the border into borderline personality and borderline schizophrenia. The development of criteria. Arch Gen Psychiatry 1979 ; 36 (1) : 17-24.
PubMed
20) World Health Organization. International Classification of Diseases, 6th revision. World Health Organization ; 1948.
 
21) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association ; 1952.
 
22) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 2nd edition. American Psychiatric Association ; 1968.
 
23) World Health Organization. The international classification of diseases, 9th revision, clinical modification. World Health Organization ; 1978.
 
24) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, third edition (DSM-III). American Psychiatric Association ; 1980/高橋三郎ほか (訳), DSM-III 精神障害の分類と診断の手引. 医学書院 ; 1982.
 
25) World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostical Guidlines. WHO ; 1992/融道男ほか (監訳). ICD-10 精神および行動の障害-臨床記述と診断ガイドライン, 新訂版. 医学書院 ; 2005.
 
26) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). American Psychiatric Association ; 2013/高橋三郎ほか (監訳). 精神疾患の診断・統計マニュアル DSM-5. 医学書院 ; 2014.
 
27) Kretschmer E. Der sensitive Beziehungswahn. 4. Auflage. Springer Verlag ; 1966/切替辰哉 (訳). 新敏感関係妄想-パラノイア問題と精神医学的性格研究への寄与. 星和書店 ; 1979.
 
28) Tolle R, Lempp R. Psychiatrie, 7 Aufl. Springer Verlag ; 1985/飯田眞ほか (訳). テレ 精神医学. 西村書店 ; 1991.
 
29) World Health Organization. ICD-11 for Mortality and Morbidity Statistics (ICD-11 MMS). 2018. https://icd.who.int/browse11/l-m/en (accessed 2019/2/13 2018)
 
30) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). American Psychiatric Association ; 1994/高橋三郎ほか (訳), DSM-IV 精神疾患の診断・統計マニュアル. 医学書院 ; 1996.
 
31) World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders : Diagnostic criteria for research. World Health Organization ; 1993/中根允文ほか (訳). ICD-10 精神および行動の障害-RDC研究用診断基準, 新訂版. 医学書院 ; 2008.
 
32) Costa PT, McCrae RR. Personality Disorders and The Five-Factor Model of Personality. J Pers Disord 1990 ; 4 (4) : 362-371.
 
33) American Psychiatric Association. Diagnostic and statistical manual of mental disorders, third editionrevised. American Psychiatric Association ; 1987/高橋三郎ほか (訳). DSM-III-R 精神障害の診断・統計マニュアル. 医学書院 ; 1988.
 
34) Gunderson JG. Personality disorders. In : Nicoli AM (ed). The Harvard Guide to Psychiatry, 3rd edition. The Belknap Press ; 1999, pp308-327.
 
35) 林直樹. パーソナリティ障害から見た精神障害の重層. 精神科診断学 2019 ; 12 (1) : 16-24.
 
36) 林直樹. パーソナリティ障害 脳科学辞典. 2016. https://bsd.neuroinf.jp/wiki/パーソナリティ障害
 
37) Torgersen S, et al. A twin study of personality disorders. Compr Psychiatry 2000 ; 41 (6) : 416-425.
PubMed
38) Silverman JM, et al. Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder. Am J Psychiatry 1991 ; 148 (10) : 1378-1385.
PubMed
39) 林直樹. 境界性パーソナリティ障害の生活歴・現病歴・家族関係. 精神科治療学 2010 ; 25 (11) : 1459-1463.
 
40) Jaffee SR. Child Maltreatment and Risk for Psychopathology in Childhood and Adulthood. Annu Rev Clin Psychol 2017 ; 13 : 525-551.
PubMed
41) Herzog JI, Schmahl C. Adverse Childhood Experiences and the Consequences on Neurobiological, Psychosocial, and Somatic Conditions Across the Lifespan. Front Psychiatry 2018 ; 9 : 420.
PubMed
42) Johnson JG, et al. Parenting behaviors associated with risk for offspring personality disorder during adult-hood. Arch Gen Psychiatry 2006 ; 63 (5) : 579-587.
 
43) Cloitre M, et al. Evidence for proposed ICD-11 PTSD and complex PTSD : A latent profile analysis. Eur J Psychotraumatol 2013 ; 4.
PubMed
44) Agrawal HR, et al. Attachment studies with borderline patients : A review. Harv Rev Psychiatry 2004 ; 12 (2) : 94-104.
PubMed
45) Storebo OJ, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 2020 ; 5 : CD012955.
PubMed
46) National Institute for Health and Clinical Excellence. Borderline personality disorder : Treatment and management : NICE clinical guideline 78. National Institute for Health and Clinical Excellence ; 2009.
 
47) National Institute for Health and Care Excellence. Antisocial personality disorder : Treatment, management and prevention, NICE clinical guideline 77. National Institute for Health and Care Excellence ; 2009.
 
48) National Institute for Health and Clinical Excellence. Self-harm : The short-term physical and psychological management : NICE clinical guideline 16. National Institute for Health and Clinical Excellence ; 2004.
 
49) Ripoll LH, et al. Evidence-based pharmacotherapy for personality disorders. Int J Neuropsychopharmacol 2011 ; 14 (9) : 1257-1288.
PubMed
50) Stoffers-Winterling J, et al. Pharmacotherapy for Borderline Personality Disorder : An Update of Published, Unpublished and Ongoing Studies. Curr Psychiatry Rep 2020 ; 22 (8) : 37.
PubMed
51) 林直樹. 境界性パーソナリティ障害の長期予後. 臨床精神医学 2014 ; 43 (10) : 1457-1463.
Medical*Online
52) Zanarini MC, et al. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects : A 16-year prospective follow-up study. Am J Psychiatry 2012 ; 169 (5) : 476-483.
PubMed
53) Zanarini MC, et al. Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years. J Pers Disord 2005 ; 19 (1) : 19-29.
 
54) Seivewright H, et al. Change in personality status in neurotic disorders. Lancet 2002 ; 359 (9325) : 2253-2254.
PubMed
Paris J. Treatment of Borderline Personality Disorder : A Guide to Evidence-Based Practice. Guilford Press ; 2010/黒田章史 (訳). 境界性パーソナリティ障害の治療-エビデンスに基づく治療指針. 金剛出版 ; 2014.
 
Livesley WJ, et al (eds). Handbook of Personality Disorders, Theory, Research, and Treatment, second edition. Guilford ; 2018.
 
P.350 掲載の参考文献
1) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). American Psychiatric Association ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
2) World Health Organization. ICD-11 for Mortality and Morbidity Statistics (Version : 04/2019). 2019. https://icd.who.int/browse11/l-m/en (accessed 2020/8/14 2018).
 
3) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). American Psychiatric Association ; 1994/高橋三郎ほか (訳). DSM-IV 精神疾患の診断・統計マニュアル. 医学書院 ; 1996.
 
4) Schneider K. Die Psychopathischen Personlichkeiten. Franz Deuticke ; 1923/懸田克躬ほか (訳). 精神病質人格. みすず書房 ; 1954.
 
5) Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry 1999 ; 56 (10) : 921-926.
PubMed
6) Kotov R, et al. New dimensions in the quantitative classification of mental illness. Arch Gen Psychiatry 2011 ; 68 (10) : 1003-1011.
PubMed
7) World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostical Guidlines. World Health Organization ; 1992/融道男ほか (監訳). ICD-10 精神および行動の障害-臨床記述と診断ガイドライン, 新訂版. 医学書院 ; 2005.
 
8) Costa PT, McCrae RR. Personality Disorders and The Five-Factor Model of Personality. J Pers Disord 1990 ; 4 (4) : 362-371.
 
9) Herpertz SC, et al. The Challenge of Transforming the Diagnostic System of Personality Disorders. J Pers Disord 2017 ; 31 (5) : 577-589.
PubMed
10) Watts J. Problems with the ICD-11 classification of personality disorder. Lancet Psychiatry 2019 ; 6 (6) : 461-463.
PubMed
林直樹ほか (編著). 心理療法のケースをどう読むか? パーソナリティ障害を軸にした事例検討. 福村出版 ; 2020.
 
P.355 掲載の参考文献
1) Herman JL, Perry JC. Childhood trauma in borderline personality disorder. Am J Psychiatry 1989 ; 146 (4) : 490-495.
PubMed
2) Links PS, et al. Characteristics of borderline personality disorder : A Canadian study. Can J Psychiatry 1988 ; 33 (5) : 336-340.
PubMed
3) Zanarini MC, et al. Childhood experiences of borderline patients. Compr Psychiatry 1989 ; 30 (1) : 18-25.
PubMed
4) 総務省統計局. 平成27年国勢調査結果. https://www.stat.go.jp/data/kokusei/2015/index.html
 
5) 厚生労働省. 平成27年度福祉行政報告例. https://www.mhlw.go.jp/toukei/saikin/hw/gyousei/15/index.html
 
6) Stoltenborgh M, et al. The prevalence of child maltreatment across the globe : Review of a series of meta-analyses. Child Abuse Review 2015 ; 24 (1) : 37-50.
 
7) Winsper C, et al. The aetiological and psychopathological validity of borderline personality disorder in youth : A systematic review and meta-analysis. Clin Psychol Rev 2016 ; 44 : 13-24.
PubMed
8) Porter C, et al. Childhood adversity and borderline personality disorder : A meta-analysis. Acta Psychiatr Scand 2020 ; 141 (1) : 6-20.
PubMed
9) Ip P, et al. Mental health consequences of childhood physical abuse in Chinese populations : A meta-analysis. Trauma, Violence, & Abuse 2016 ; 17 (5) : 571-584.
PubMed
10) Hillberg T, et al. Review of meta-analyses on the association between child sexual abuse and adult mental health difficulties : A systematic approach. Trauma, Violence, & Abuse 2011 ; 12 (1) : 38-49.
PubMed
11) de Aquino Ferreira LF, et al. Borderline personality disorder and sexual abuse : A systematic review. Psychiatry Res 2018 ; 262 : 70-77.
PubMed
12) Ball JS, Links PS. Borderline personality disorder and childhood trauma : Evidence for a causal relation-ship. Current Psychiatry Reports 2009 ; 11 (1) : 63-68.
 
13) Hall J, et al. Hippocampal and amygdala volumes in borderline personality disorder : A meta-analysis of magnetic resonance imaging studies. Personality and Mental Health 2010 ; 4 (3) : 172-179.
 
14) Paquola C, et al. Understanding heterogeneity in grey matter research of adults with childhood maltreatment : A meta-analysis and review. Neurosci Biobehav Rev 2016 ; 69 : 299-312.
PubMed
15) Hailes HP, et al. Long-term outcomes of childhood sexual abuse : An umbrella review. The Lancet Psychiatry 2019 ; 6 (10) : 830-839.
PubMed
P.362 掲載の参考文献
1) Strauman TJ. Self-regulation and psychopathology : Toward an integrative translational research paradigm. Annu Rev Clin Psychol 2017 ; 13 : 497-523.
PubMed
2) Gray JA. The neuropsychology of anxiety : An enquiry into the functions of the septohippocampal system. Oxford University Press ; 1982.
PubMed
3) Gray JA. The psychology of fear and stress, 2nd edition. Cambridge University Press ; 1987.
 
4) Cloninger CR. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987 ; 44 : 573-588.
PubMed
5) Quay HC. The psychobiology of undersocialized aggressive conduct disorder : A theoretical perspective. Dev Psychopathol 1993 ; 5 : 165-180.
 
6) Quay HC. Inhibition and attention deficit hyperactivity disorder. J Abnorm Child Psychol 1997 ; 25 (1) : 7-13.
PubMed
7) Depue RA, et al. A two-dimensional threshold model of seasonal bipolar affective disorder. In : Magnusson D, et al (eds). Personality, psychopathology, and psychotherapy. Psychopathology : An interactional perspective. Academic Press ; 1987, pp95-123.
 
8) Ross SR, et al. Reinforcement sensitivity theory and symptoms of personality disorder : Specificity of the BIS in Cluster C and BAS in Cluster B. Pers Individ Differ 2013 ; 54 (2) : 289-293.
 
9) Kimbrel NA, et al. BIS and BAS interact with perceived parental affectionless control to predict personality disorder symptomatology. J Affect Disord 2012 ; 26 (2) : 203-212.
 
10) Rothbart MK, et al. Temperament and personality : Origins and outcomes. J Pers Soc Psychol 2000 ; 78 (1) : 122.
PubMed
11) Rothbart MK, et al. A psychobiological approach to the development of temperament. In : Bates JE, et al (eds). Temperament : Individual differences at the interface of biology and behavior. American Psychological Association ; 1994, pp83-116.
 
12) Rueda M, et al. Development of attentional networks in childhood. Neuropsychologia 2004 ; 42 (8) : 1029-1040.
PubMed
13) 山形伸二ほか. 内在化・外在化問題行動はなぜ相関するか. パーソナリティ研究 2006 ; 15 (1) : 103-119.
Medical*Online
14) Claes L, et al. Emotional reactivity and self-regulation in relation to personality disorders. Pers Individ Differ 2009 ; 47 (8) : 948-953.
 
15) De Panfilis C, et al. Effortful control, rejection sensitivity, and borderline personality disorder features in adulthood. J Pers Disord 2016 ; 30 (5) : 595-612.
PubMed
16) Sato M, et al. Rejection sensitivity and borderline personality disorder features : A mediation model of effortful control and intolerance of ambiguity. Psychiatry Res 2018 ; 269 : 50-55.
PubMed
17) Zimmerman M, Morgan TA. Problematic boundaries in the diagnosis of bipolar disorder : The interface with borderline personality disorder. Curr Psychiatr Rep 2013 ; 15 (12) : 422.
 
18) Bayes A, et al. Differential Diagnosis of Bipolar II Disorder and Borderline Personality Disorder. Curr Psychiatr Rep 2019 ; 21 (12) : 125.
 
19) 永田利彦. 境界性パーソナリティ障害 vs. 双極性障害. 精神科 2013 ; 23 (6) : 600-605.
 
20) Kernberg OF, Yeomans FE. Borderline personality disorder, bipolar disorder, depression, attention deficit/hyperactivity disorder, and narcissistic personality disorder : Practical differential diagnosis. Bull Menninger Clin 2013 ; 77 (1) : 1-22.
PubMed
21) 永田利彦. 不安症を併存する双極性障害の治療-自閉スペクトラム症, 境界性パーソナリティ障害の視点から. 不安症研究 2019 ; 11 (1) : 24-34.
 
22) Cristea IA, et al. Efficacy of psychotherapies for borderline personality disorder : A systematic review and meta-analysis. JAMA Psychiatry 2017 ; 74 (4) : 319-328.
PubMed
23) Eisner L, et al. Dialectical behavior therapy group skills training for bipolar disorder. Behav Ther 2017 ; 48 (4) : 557-566.
PubMed
24) Van Dijk S, et al. A randomized, controlled, pilot study of dialectical behavior therapy skills in a psychoeducational group for individuals with bipolar disorder. J Affect Disord 2013 ; 145 (3) : 386-393.
 
25) Calvo N, et al. The role of environmental influences in the complex relationship between borderline personality disorder and attention-deficit/hyperactivity disorder : Review of recent findings. Borderline Personal Disord Emot Dysregulation 2020 ; 7 (1) : 1-7.
 
26) Asherson P, et al. Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults. Curr Med Res Opin 2014 ; 30 (8) : 1657-1672.
 
27) 宮岡等, 小川陽子. 大人の発達障害と精神疾患の鑑別と合併. 心身医学 2019 ; 59 (5) : 416-421.
Medical*Online
28) Philipsen A. Differential diagnosis and comorbidity of attention-deficit/hyperactivity disorder (ADHD) and borderline personality disorder (BPD) in adults. Eur Arch Psychiatry Clin Neurosci 2006 ; 256 (1) : i42-i46.
 
29) 牛島定信. 大人のADHD臨床におけるパーソナリティ障害との鑑別をめぐって. 精神神経学雑誌 2015 ; 117 (9) : 775-779.
 
30) Robinson MD, et al. Cognitive control moderates relations between impulsivity and bulimic symptoms. Cognit Ther Res 2009 ; 33 (4) : 356-367.
 
31) Farmer RF, Nelson-Gray RO. Personality-guided behavior therapy. American Psychological Association ; 2005.
 
P.370 掲載の参考文献
1) World Health Organization. ICD-11 for Mortality and Morbidity Statistics. 2018.
 
2) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Publishing ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
3) 林直樹. パーソナリティ障害と現代精神科臨床. 精神医学 2019 ; 61 : 144-149.
 
4) Costa PT, McCrae RR. Personality Disorders and The Five-Factor Model of Personality. Journal of Personality Disorders 1990 ; 4 : 362-371.
 
5) Trull TJ, et al. Dimensional models of personality disorder : Diagnostic and Statistical Manual of Mental Disorders Fifth Edition and beyond. Curr Opin Psychiatry 2007 ; 20 (1) : 52-56.
PubMed
6) Raskin JD. Abnormal Psychology : Contrasting perspectives. Red Globe Press ; 2018.
 
7) Watts J. Problems with the ICD-11 classification of personality disorder. Lancet Psychiatry 1919 ; 6 : 461-463.
 
8) Ekselius L. Personality disorder : A disease in disguise. Ups J Med Sci 2018 ; 123 : 194-204.
PubMed
9) Bach B, et al. ICD-11 and DSM-5 personality trait domains capture categorical personality disorders : Finding a common ground. Aust NZ J Psychiatry 2018 ; 52 : 425-434.
 
10) Parnas J, et al. Cluster A personality disorders : A review. In : Maj M, et al (eds). Personality Disorders. WPA Series Evidence and Experience in Psychiatry, Classification. John Wiley & Sons Ltd ; 2005, pp1-74.
 
11) Bach B, First M. Application of the ICD-11 classification of personality disorders. BMC Psychiatry 2018 ; 18 : 351.
PubMed
P.379 掲載の参考文献
1) World Health Organization. Personality disorders and related traits. ICD-11. https://icd.who.int/dev11/f/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f919081088 (最終閲覧 : 2020年8月8日)
 
2) World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders : Clinical descriptions and diagnostic guidelines. World Health Organization ; 1992/融道男ほか (監訳). ICD-10 精神および行動の障害-臨床記述と診断ガイドライン 新訂版. 医学書院 ; 2013.
 
3) Tyrer P, et al. The Development of the ICD-11 Classification of Personality Disorders : An Amalgam of Science, Pragmatism, and Politics. Annu Rev Clin Psychol 2019 ; 15 : 481-502.
PubMed
4) Herpertz SC, et al. The Challenge of Transforming the Diagnostic System of Personality Disorders. J Personal Disord 2017 ; 31 : 577-589.
 
5) 大野裕. 「境界例」の現代的位置づけをめぐって. imago 1990 ; 1 (10) : 56-62.
 
6) Nettle D. 竹内和世 (訳). パーソナリティを科学する-特性5因子であなたがわかる. 白揚社 ; 2009.
 
7) Mulder RT, et al. Validating the proposed ICD-11 domains. Personal Ment Health 2016 ; 10 : 84-95.
PubMed
8) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). American Psychiatric Association ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
9) 日本精神神経学会. ICD-11 診断ガイドライントレーニングセミナー 2019年版資料.
 
10) Bach Bo, First MB. Application of the ICD-11 classification of personality disorders. BMC Psychiatr 2018 ; 18 : 351.
 
11) Ramleth RK, et al. The impact of borderline personality disorder and sub-threshold borderline personality on the course of self-reported and clinician-rated depression in self-harming adolescents. Borderline Personal Disord Emot Dysregul 2017 ; 4 : 22.
PubMed
12) 山中康裕, 森省二. 境界例の精神病理. 現代のエスプリ 1982 ; 175 : 5-23.
 
13) 笠原嘉, 加藤雄一. ホックの偽神経症性分裂. 現代のエスプリ 1982 ; 175 : 33-37.
 
14) Knight RP. Borderline State. In : Knight RP, et al (eds). Psychoanalytic Psychiatry and Psychology : Clinical and Theoretical Papers. International Universities Press ; 1954.
 
15) Kernberg O. Borderline personality organization. J Am Psychoanal Assoc 1967 ; 15 : 641-685.
PubMed
16) Masterson JF. 成田善弘ほか (訳). 青年期境界例の治療. 金剛出版 ; 1979.
 
17) Dahl EK, et al. Clinical and multivariate approaches to the nosology of pervasive developmental disorders. J Am Acad Child Psychiatry 1986 ; 25 : 170-180.
 
18) Akiskal HS. The bipolar spectrum-the shaping of a new paradigm in psychiatry. Curr Psychiatry Rep 2002 ; 4 : 1-3.
PubMed
19) Witt SH, et al. Analysis of genome-wide significant bipolar disorder genes in borderline personality disorder. Psychiatr Genet 2014 ; 24 : 262-265.
PubMed
20) Herman JL. 中井久夫 (訳). 心的外傷と回復. みすず書房 ; 1996, pp181-201.
 
21) Linehan MM. 大野裕 (監訳). 境界性パーソナリティ障害の弁証法的行動療法-DBTによるBPDの治療. 誠信書房 ; 2007.
 
22) 新村出 (編). 広辞苑 第7版. 岩波書店 ; 2018.
 
23) Bateman A, Fonagy P. Treatment of borderline personality disorder with psychoanalytically orientes partial hospetalization : An 18-month follow-up. Am J Psychiatry 2001 ; 158 : 36-42.
 
24) Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry 2009 ; 166 : 1355-1364.
PubMed
25) Clarkin JF, et al. Psychotherapy for Borderline Personality : Focusing on Object Relations. American Psychiatric Publishing ; 2004.
 
26) Young JE, et al. 伊藤絵美 (監訳). スキーマ療法-パーソナリティの問題に対する統合的認知行動療法. 金剛出版 ; 2008.
 
27) Herpetz SC, et al. World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry 2007 : 8 ; 212-244.
 
28) McGlashan TH. The Chestnut Lodge follow-up study. I. Follow-up methodology and study sample. Arch Gen Psychiatry 1984 ; 41 : 573-585.
PubMed
29) McGlashan TH. The Chestnut Lodge follow-up study. III. Long-term outcome of borderline personalities. Arch Gen Psychiatry 1986 ; 43 : 20-30.
PubMed
30) Paris J, et al. Long-term follow-up of borderline patients in a general hospital. Compr Psychiatry 1987 ; 28 : 530-535.
 
31) Paris J. The treatment of borderline personality disorder on light of research on its long term outcome. Can J Psychiatry 1993 ; 38 (Suppl 1) : 28-34.
 
32) Stone MH, et al. The PI 500 : Long-term follow-up of borderline inpatients meeting DSM-III criteria I. Global outcome. J Pers Disord 1987 ; 1 : 291-298.
 
33) Stone MH, et al. Natural history of borderline patients treated by intensive hospitalization. Psychiatr Clin North Am 1987 ; 10 : 185-206.
PubMed
34) Stone MH. Psychotherapy of borderline patients in light of long-term follow-up. Bull Menninger Clin 1987 ; 51 : 231-247.
PubMed
35) Gunderson JG, et al. Ten-year course of borderline personality disorder. Psychopathology and function from the Collaborative Longitudinal Personality Disorders Study. Arch Gen Psychiatry 2011 ; 68 : 827-837.
PubMed
36) Zanarini MC, et al. Time to attainment of recovery from borderline personality disorder and stability of recovery : A 10-year prospective follow-up study. Am J Psychiatry 2010 ; 167 : 663-667.
PubMed
37) Zanarini MC, et al. The 10-year course of psychosocial functioning among patients with borderline personality disorder and axis II comparison subjects. Acta Psychiatr Scand 2010 ; 122 : 103-109.
PubMed
Hopwood CJ, et al. The time has come for dimensional personality disorder diagnosis. Personal. Mental Health 2018 ; 12 : 82-86.
 
Lingiardi V, et al (eds). Psychodynamic Diagnostic Manual, 2nd edition. Guilford Press ; 2017.
 
P.386 掲載の参考文献
1) 林直樹. パーソナリティ障害診断の現状と問題点-都立松沢病院病歴統計から. 精神経誌 2008 ; 110 (9) : 805-812.
 
2) 林直樹ほか. 都立松沢病院夜間休日救急入院患者の精神科診断の21年間 (1986～2006年) の変化-性比および自殺関連行動, 暴力の変化との関連性に着目して. 精神医学 2013 ; 55 (1) : 45-55.
 
3) Clarkin JF, et al. Evaluating three treatments for borderline personality disorder : A multiwave study. Am J Psychiatry 2007 ; 164 : 922-928.
PubMed
4) Gunderson JG, et al. Ten-year course of borderline personality disorder : Psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry 2011 ; 68 : 827-837.
PubMed
5) Zanarini MC, et al. The longitudinal course of borderline psychopathology : 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry 2003 ; 160 : 274-283.
PubMed
6) Zanarini MC, et al. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and Axis II comparison subjects : A 16-year prospective follow-up study. Am J Psychiatry 2012 ; 169 : 476-483.
PubMed
7) 田中伸一郎. 統合失調症は本当に軽症化しているのか? 精神科治療学 2018 ; 33 (1) : 95-100.
 
8) Gunderson JG. Borderline personality disorder : Ontogeny of a diagnosis. Am J Psychiatry 2009 ; 166 : 530-539.
PubMed
9) Gunderson JG, et al. Borderline personality disorder. Nat Rev Dis Primers 2018 ; 4 : 18029. Doi : 10.1038/nrdp.2018.29.
 
10) 笠原嘉. 境界パーソナリティ障害 (DSM) 研究の昨今. <笠原嘉臨床論集> 境界例研究の50年. みすず書房 ; 2012, pp199-215.
 
11) Jana V, et al. Prevalence of personality disorders in the general adult population in Western countries : Systematic review and meta-analysis. Br J Psychiatry 2018 ; 213 : 709-715.
 
12) Jeffrey GJ, et al. Cumulative prevalence of personality disorders between adolescence and adulthood. Acta Psychiatr Scand 2008 ; 118 : 410-413.
 
13) Grant BF, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder : Results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2008 ; 69 : 533-545.
PubMed
14) Tomko RL, et al. Characteristics of borderline personality disorder in a community sample : Comorbidity, treatment utilization, and general functioning. J Pers Disord 2014 ; 28 : 734-750.
 
15) Bender DS, et al. Treatment utilization by patients with personality disorders. Am J Psychiatry 2001 ; 158 : 295-302.
PubMed
16) Chanen AM, et al. Screening for borderline personality disorder in outpatient youth. J Pers Disord 2008 ; 22 : 353-364.
PubMed
17) Zimmerman M, et al. The frequency of personality disorders in psychiatric patients. Psychiatr Clin North Am 2008 ; 31 : 405-420.
PubMed
18) Korzekwa MI, et al. Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure. Compr Psychiatry 2008 ; 49 : 380-386.
PubMed
19) Gross R, et al. Borderline personality disorder in primary care. Arch Intern Med 2002 ; 162 : 53.
PubMed
20) Chaput YJ, et al. Demographic and clinical profiles of patients who make multiple visits to psychiatric emergency services. Psychiatr Serv 2007 ; 58 : 335-341.
PubMed
21) 今井淳司. 精神科急性期治療におけるパーソナリティ障害の現在-グレーゾーン事例との関連も含めて. 精神医学 2019 ; 61 (2) : 182-185.
 
22) 牛島定信. パーソナリティ障害は今. 精神医学 2019 ; 61 (2) : 134-137.
 
23) 衣笠隆幸. パーソナリティ障害は減少しているのか. 精神医学 2019 ; 61 (2) : 138-142.
 
24) 衣笠隆幸. 境界性パーソナリティ障害と発達障害 : 「重ね着症候群」について-治療的アプローチの違い. 精神科治療学 2004 ; 19 (6) : 693-699.
 
25) 市橋秀夫. パーソナリティ障害は本当に減少しているのか? 精神医学 2019 ; 61 (2) : 150-153.
 
26) 岡野憲一郎. パーソナリティ障害の概念を問い直す. 精神医学 2019 ; 61 (2) : 154-158.
 
27) 岡野憲一郎. ボーダーライン反応で仕事を失う. こころの臨床アラカルト 2006 ; 25 : 65-69.
 
28) 平島奈津子. パーソナリティのダイナミズム. 精神医学 2019 ; 61 (2) : 164-167.
 
29) 岡田尊司. 愛着関連障害としてのパーソナリティ障害. 精神医学 2019 ; 61 (2) : 174-177.
 
P.394 掲載の参考文献
1) World Health Organization. Manual of the international statistical classification of diseases, injuries, and causes of death. sixth revision ; ICD-6. World Health Organization ; 1949.
 
2) American Psychiatric Association. Diagnostic and Statistical Manual : Mental Disorders ; DSM-I. American Psychiatric Association Mental Hospital Service ; 1952.
PubMed
3) World Health Organization. International Statistical Classification of Diseases, Injuries, and Causes of Death, seventh revision ; ICD-7. World Health Organization ; 1957.
 
4) World Health Organization. International Statistical Classification of Diseases, Injuries, and Causes of Death, eighth revision ; ICD-8. World Health Organization ; 1967.
 
5) World Health Organization. International Statistical Classification of Diseases, Injuries, and Causes of Death, ninth revision ; ICD-9. World Health Organization ; 1979.
 
6) World Health Organization. International Statistical Classification of Diseases and Related Health Problems, tenth revision ; ICD-10. World Health Organization ; 2010.
 
7) World Health Organization. International Statistical Classification of Diseases, eleventh revision ; ICD-11. World Health Organization ; 2019. https://gcp.network/en/private/icd-11-guidelines/categories/personality-disorders (2020年8月16日閲覧)
 
8) American Psychiatric Association. Diagnostic and Statistical Manual : Mental Disorders, second edition ; DSM-II. American Psychiatric Association ; 1968.
 
9) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, third edition ; DSM-III. American Psychiatric Association ; 1980.
 
10) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, third edition-revised ; DSM-III-R. American Psychiatric Association ; 1987/高橋三郎ほか (訳). DSM-III-R 精神障害の診断・統計マニュアル. 医学書院 ; 1988.
 
11) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth edition ; DSM-IV. American Psychiatric Press ; 1994/高橋三郎ほか (訳). DSM-IV 精神疾患の診断・統計マニュアル. 医学書院 ; 1996.
 
12) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision : DSM-IV-TR. American Psychiatric Press ; 2000/高橋三郎ほか (訳). DSM-IV-TR 精神疾患の診断・統計マニュアル. 医学書院 ; 2002.
 
13) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth edition : DSM-5. American Psychiatric Press ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
14) 松本ちひろ. パーソナリティ障害. 精神医学 2019 ; 61 (3) : 293-300.
 
15) 北村俊則. 精神疾患診断の問題点と操作診断の必要性. 精神科診断学 2000 ; 11 (2) : 191-218.
 
16) Mayes R, Horwitz AV. DSM-III and the revolution in the classification of mental illness. J Hist Behav Sci 2005 ; 41 (3) : 249-267.
PubMed
17) Kendell R. The Role of Diagnosis of Psychiatry. Blackwell Science Ltd ; 1975.
 
18) Verheul R, Widiger TA. A meta-analysis of the prevalence and usage of the personality disorder not otherwise specified (PDNOS) diagnosis. J Personal Disord 2004 ; 18 : 309-319.
PubMed
19) Wilberg T, et al. A study of patients with personality disorder not otherwise specified. Comprehensive Psychiatry 2008 ; 49 : 460-468.
 
20) Zachar P, First MB. Transitioning to a dimensional model of personality disorder in DSM 5.1 and beyond. Curr Opin Psychiatry 2015 ; 28 : 66-72.
PubMed
21) Borstein RF, et al. Toward a firmer foundation for DSM-5.1 : Domains of impairment in DSM-IV/DSM-5 personality disorders. J Pers Disord 2014 ; 28 : 212-224.
 
22) World Health Organization. ICF-10/ICD-11 mapping Tables. https://icd.who.int/browse11/l-m/en の「Info」タブよりダウンロード (2020年8月16日閲覧)
 
23) 中谷陽二. 人格障害の90年-Koch, Schneider, そしてDSM-III. 精神医学 2004 ; 46 (7) : 674-684.
 
P.403 掲載の参考文献
1) World Health Organization Factitious disorders. ICD-11. https://icd.who.int/browse11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f430567349 (最終閲覧 : 2020年8月19日)
 
2) World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostical Guidlines. World Health Organization ; 1992/融道男ほか (監訳). ICD-10 精神および行動の障害-臨床記述と診断ガイドライン 新訂版. 医学書院 ; 2013.
 
3) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). American Psychiatric Association ; 2013/日本精神神経学会 (日本語版用語監修), 高橋三郎ほか (監訳). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014.
 
4) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM-IV-TR). American Psychiatric Association ; 2000/高橋三郎ほか (訳). DSM-IV-TR 精神疾患の診断・統計マニュアル. 医学書院 ; 2002.
 
5) Yates GP, Feldman MD. Factitious disorder : A systematic review of 455 cases in the professional literature. Gen Hosp Psychiatry 2016 ; 41 : 20-28.
PubMed
6) Feldman MD. Munchausen by Internet : Detecting factitious illness and crisis on the Internet. South Med J 2000 ; 93 : 669-672.
PubMed
7) Yates G, Bass C. The perpetrators of medical child abuse (Munchausen Syndrome by Proxy) -A systematic review of 796 cases. Child Abuse Negl 2017 ; 72 : 45-58.
PubMed
8) Deimel IV GW, et al. Minchausen syndrome by proxy : An adult dyad. Psychosom 2012 ; 25 : 294-299.
 
9) Gomila L, et al. Alimemazine poisoning as evidence of Munchausen syndrome by proxy : A pediatric case report. Foren Sci Int 2016 ; 266 : e18-e22.
 
10) Feldman MD, et al. Concurrent factitious disorder and factitious disorder by proxy : Double Jeopardy. Gen Hosp Psychiatr 1997 ; 19 : 24-28.
 
11) Bass C, Jones D. Psychopathology of perpetrators of fabricated or induces illness in children : Case series. Br J Psychiatr 2011 ; 199 : 113-118.
PubMed
12) Asher R. Munchausen's syndrome. Lancet 1951 ; 1 : 339-341.
PubMed
13) Fisher JA. Investigating the Barons : Narrative and nomenclature in Munchausen syndrome. Perspect Biol Med 2006 ; 49 : 250-262.
PubMed
14) Olry R, Haines DE. Historical and literary roots of Munchhausen syndromes : As intriguing as the syndromes themselves. Prog Brain Res 2013 ; 206 : 123-141.
PubMed
15) Meadow R. Munchausen syndrome by proxy. The hinterland of child abuse. Lancet 1977 ; 2 : 343-345.
PubMed
16) Bryk M, Siegal PT. Me mother caused my illness : The story of a survivor of Munchausen by proxy syndrome. Pediat 1997 ; 100 : 1-7.
 
17) Faravelli C, et.al. The Sesto Fiorentino study : Background, methods and preliminary results. Lifetime prevalence of psychiatric disorders in an Italian community sample using clinical interviewers. Psychother Psychosom 2004 ; 73 : 216-225.
 
18) Sanders MJ, Bursch B. Psychological Treatment of Factitious Disorders Imposed on Another/Munchausen by Proxy Abuse. J Clin Psychol Med Set 2020 ; 27 : 139-149.
 
19) Earle JR, Folks DG. Factitious disorder and coexisting depression : A report of successful psychiatric management consultation and case management. Gen Hosp Psychiatr 1986 ; 8 : 448-450.
 
20) Eastwood S, Bisson JI. Management of factitious disorders : A systematic review. Psychother Psychosom 2008 ; 77 : 209-218.
PubMed
Bass C, Johns D. Psychopathology of perpetrators of fabricated or induced illness in children : Case studies. Br J Psychiatr 2011 ; 199 : 113-118.
 
Adshead G, Bluglass K. Attachment representations in mothers with abnormal illness behavior by proxy. Br J Psychiatr 2005 ; 187 : 328-333.
 

書評

最近チェックした商品履歴

Loading...